SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-03-25 16:55
Tx date 2024-03-25
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$1,842,750
+351,000 vol
$5.25 each
12,750,500
Filed 2024-03-25 16:51
Tx date 2024-03-21
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$38,257
+7,300 vol
$5.24 each
12,399,500
Filed 2024-03-19 20:26
Tx date 2024-03-15
$GUD
Knight Therapeutics Inc.
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,782
+525 vol
$5.30 each
1,603
Filed 2024-03-19 20:22
Tx date 2024-03-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$14,341
+2,706 vol
$5.30 each
199,189
Filed 2024-03-19 20:20
Tx date 2024-03-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,667
+1,258 vol
$5.30 each
12,080
Filed 2024-03-19 20:18
Tx date 2024-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,506
+1,039 vol
$5.30 each
821,766
Filed 2024-03-19 20:12
Tx date 2024-03-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,017
+1,324 vol
$5.30 each
22,475
Filed 2024-03-19 20:09
Tx date 2024-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,426
+2,156 vol
$5.30 each
142,139
Filed 2024-03-13 15:27
Tx date 2024-03-12
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$402,150
+76,600 vol
$5.25 each
12,392,200
Filed 2024-03-13 15:26
Tx date 2024-03-12
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$262,500
+50,000 vol
$5.25 each
12,315,600
Filed 2024-02-01 08:51
Tx date 2024-01-31
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$786,391
+147,000 vol
$5.35 each
12,265,600
Filed 2024-01-23 12:51
Tx date 2024-01-22
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-162,150
-28,200 vol
$5.75 each
12,118,600
Filed 2024-01-04 20:05
Tx date 2023-12-31
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$17,495
+3,371 vol
$5.19 each
44,438
Filed 2024-01-03 11:44
Tx date 2023-12-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-3,036,997 vol
0
Filed 2024-01-03 11:42
Tx date 2023-12-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,297,434
+2,999,497 vol
$5.10 each
3,036,997
Filed 2024-01-03 11:41
Tx date 2023-12-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,605
+700 vol
$5.15 each
37,500
Filed 2024-01-03 11:39
Tx date 2023-12-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$120,940
+23,500 vol
$5.15 each
36,800
Filed 2024-01-03 11:37
Tx date 2023-12-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,219
+5,500 vol
$5.13 each
13,300
Filed 2024-01-03 11:36
Tx date 2023-12-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,085
+600 vol
$5.14 each
7,800
Filed 2024-01-03 11:34
Tx date 2023-12-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,541
+300 vol
$5.14 each
7,200
Filed 2024-01-03 11:33
Tx date 2023-12-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,374
+6,900 vol
$5.13 each
6,900
Filed 2023-12-19 10:41
Tx date 2023-12-15
$GUD
Knight Therapeutics Inc.
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,610
+502 vol
$5.20 each
1,078
Filed 2023-12-19 10:39
Tx date 2023-12-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$16,728
+3,217 vol
$5.20 each
196,483
Filed 2023-12-19 10:37
Tx date 2023-12-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,347
+1,413 vol
$5.20 each
10,822
Filed 2023-12-19 10:35
Tx date 2023-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,682
+1,285 vol
$5.20 each
820,727
Filed 2023-12-19 10:32
Tx date 2023-12-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,047
+1,163 vol
$5.20 each
21,151
Filed 2023-12-19 10:00
Tx date 2023-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$13,332
+2,564 vol
$5.20 each
139,983
Filed 2023-12-05 11:56
Tx date 2023-11-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-174,200 vol
0
Filed 2023-12-05 11:55
Tx date 2023-11-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,607
+4,800 vol
$5.13 each
174,200
Filed 2023-12-05 11:54
Tx date 2023-11-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$85,760
+16,800 vol
$5.10 each
169,400
Filed 2023-12-05 11:53
Tx date 2023-11-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,000
+1,200 vol
$5.00 each
152,600
Filed 2023-12-05 11:52
Tx date 2023-11-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,226
+22,900 vol
$4.94 each
151,400
Filed 2023-12-05 11:50
Tx date 2023-11-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,769
+2,700 vol
$4.73 each
128,500
Filed 2023-12-05 11:48
Tx date 2023-11-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,028
+4,800 vol
$4.80 each
125,800
Filed 2023-12-05 11:47
Tx date 2023-11-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$89,404
+18,600 vol
$4.81 each
121,000
Filed 2023-12-05 11:45
Tx date 2023-11-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$109,260
+23,500 vol
$4.65 each
102,400
Filed 2023-12-05 11:07
Tx date 2023-11-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$108,168
+23,500 vol
$4.60 each
78,900
Filed 2023-12-05 11:06
Tx date 2023-11-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$72,125
+15,700 vol
$4.59 each
55,400
Filed 2023-11-13 14:39
Tx date 2023-11-10
$GUD
Knight Therapeutics Inc.
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$24,871
+4,925 vol
$5.05 each
4,925
Filed 2023-11-13 14:38
Tx date 2023-09-18
$GUD
Knight Therapeutics Inc.
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2023-11-13 14:36
Tx date 2023-11-10
$GUD
Knight Therapeutics Inc.
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$24,871
+4,925 vol
$5.05 each
4,925
Filed 2023-11-13 14:32
Tx date 2023-09-18
$GUD
Knight Therapeutics Inc.
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2023-11-07 10:28
Tx date 2023-10-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-684,075 vol
39,700
Filed 2023-11-07 10:26
Tx date 2023-10-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$87,589
+19,300 vol
$4.54 each
723,775
Filed 2023-11-07 10:25
Tx date 2023-10-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$92,167
+20,400 vol
$4.52 each
704,475
Filed 2023-11-07 10:23
Tx date 2023-10-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$105,077
+23,500 vol
$4.47 each
684,075
Filed 2023-11-07 10:22
Tx date 2023-10-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$676,350
+150,300 vol
$4.50 each
660,575
Filed 2023-11-07 10:20
Tx date 2023-10-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$106,224
+23,500 vol
$4.52 each
510,275
Filed 2023-11-07 10:18
Tx date 2023-10-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$106,713
+23,500 vol
$4.54 each
486,775
Filed 2023-11-07 10:16
Tx date 2023-10-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$95,348
+21,600 vol
$4.41 each
463,275
Filed 2023-11-07 10:13
Tx date 2023-10-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,259
+23,500 vol
$4.39 each
441,675
Filed 2023-11-07 10:11
Tx date 2023-10-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$85,155
+19,300 vol
$4.41 each
418,175
Filed 2023-11-07 10:09
Tx date 2023-10-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$561,405
+123,375 vol
$4.55 each
398,875
Filed 2023-11-07 10:07
Tx date 2023-10-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$108,060
+23,500 vol
$4.60 each
275,500
Filed 2023-11-07 10:04
Tx date 2023-10-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$93,336
+20,200 vol
$4.62 each
252,000
Filed 2023-11-07 10:02
Tx date 2023-10-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$69,977
+15,300 vol
$4.57 each
231,800
Filed 2023-11-07 09:58
Tx date 2023-10-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$107,420
+23,500 vol
$4.57 each
216,500
Filed 2023-11-07 09:55
Tx date 2023-10-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$82,141
+17,900 vol
$4.59 each
193,000
Filed 2023-11-07 09:53
Tx date 2023-10-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$49,036
+10,600 vol
$4.63 each
175,100
Filed 2023-11-07 09:49
Tx date 2023-10-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$109,195
+23,500 vol
$4.65 each
164,500
Filed 2023-11-07 09:47
Tx date 2023-10-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$110,236
+23,500 vol
$4.69 each
141,000
Filed 2023-11-07 09:45
Tx date 2023-10-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$108,010
+23,500 vol
$4.60 each
117,500
Filed 2023-11-07 09:43
Tx date 2023-10-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$106,212
+23,500 vol
$4.52 each
94,000
Filed 2023-11-07 09:40
Tx date 2023-10-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$106,100
+23,500 vol
$4.51 each
70,500
Filed 2023-10-30 14:15
Tx date 2023-10-23
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$4,785
+1,100 vol
$4.35 each
12,237,800
Filed 2023-10-05 15:35
Tx date 2023-09-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,372,857 vol
47,000
Filed 2023-10-05 15:34
Tx date 2023-09-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$105,590
+23,500 vol
$4.49 each
1,419,857
Filed 2023-10-05 15:32
Tx date 2023-09-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$105,216
+23,500 vol
$4.48 each
1,396,357
Filed 2023-10-05 15:31
Tx date 2023-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$871,232
+199,157 vol
$4.37 each
1,372,857
Filed 2023-10-05 15:28
Tx date 2023-09-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,164
+23,500 vol
$4.39 each
1,173,700
Filed 2023-10-05 15:26
Tx date 2023-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$49,957
+11,300 vol
$4.42 each
1,150,200
Filed 2023-10-05 15:21
Tx date 2023-09-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,773
+23,500 vol
$4.42 each
1,138,900
Filed 2023-10-05 15:20
Tx date 2023-09-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$81,840
+18,600 vol
$4.40 each
1,115,400
Filed 2023-10-05 15:18
Tx date 2023-09-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,729
+23,500 vol
$4.41 each
1,096,800
Filed 2023-10-05 15:17
Tx date 2023-09-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,331,429
+753,700 vol
$4.42 each
1,073,300
Filed 2023-10-05 15:15
Tx date 2023-09-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,599
+23,500 vol
$4.41 each
319,600
Filed 2023-10-05 15:14
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$102,883
+23,500 vol
$4.38 each
296,100
Filed 2023-10-05 15:12
Tx date 2023-09-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$498,148
+111,700 vol
$4.46 each
272,600
Filed 2023-10-05 15:11
Tx date 2023-09-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$58,379
+13,200 vol
$4.42 each
160,900
Filed 2023-10-05 15:09
Tx date 2023-09-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,667
+23,500 vol
$4.41 each
147,700
Filed 2023-10-05 15:08
Tx date 2023-09-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$105,601
+23,500 vol
$4.49 each
124,200
Filed 2023-10-05 15:07
Tx date 2023-09-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$87,323
+19,800 vol
$4.41 each
100,700
Filed 2023-10-05 15:06
Tx date 2023-09-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,524
+23,500 vol
$4.41 each
80,900
Filed 2023-10-05 15:04
Tx date 2023-09-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$104,126
+23,500 vol
$4.43 each
57,400
Filed 2023-10-05 15:03
Tx date 2023-09-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,742
+7,900 vol
$4.52 each
33,900
Filed 2023-10-05 15:01
Tx date 2023-09-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$49,963
+10,900 vol
$4.58 each
26,000
Filed 2023-10-02 17:06
Tx date 2023-09-27
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$13,049
+3,000 vol
$4.35 each
12,236,700
Filed 2023-10-02 17:05
Tx date 2023-09-26
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$217,499
+50,000 vol
$4.35 each
12,233,700
Filed 2023-10-02 17:05
Tx date 2023-09-26
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$130,716
+29,900 vol
$4.37 each
12,183,700
Filed 2023-09-26 12:54
Tx date 2023-09-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$110,500
+25,000 vol
$4.42 each
819,442
Filed 2023-09-25 21:12
Tx date 2023-09-25
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$25,519
+5,800 vol
$4.40 each
12,153,800
Filed 2023-09-25 21:11
Tx date 2023-09-22
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$12,305
+2,800 vol
$4.39 each
12,148,000
Filed 2023-09-25 21:11
Tx date 2023-09-21
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$94,496
+21,500 vol
$4.40 each
12,145,200
Filed 2023-09-25 21:10
Tx date 2023-09-20
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$57,519
+13,200 vol
$4.36 each
12,123,700
Filed 2023-09-21 14:07
Tx date 2023-09-18
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$17,498
+3,950 vol
$4.43 each
41,067
Filed 2023-09-20 09:33
Tx date 2023-09-19
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$78,717
+18,000 vol
$4.37 each
12,110,500
Filed 2023-09-19 11:30
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,545
+576 vol
$4.42 each
576
Filed 2023-09-19 11:29
Tx date 2023-06-30
$GUD
Knight Therapeutics Inc.
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-09-19 11:27
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$14,723
+3,331 vol
$4.42 each
193,266
Filed 2023-09-19 11:26
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,302
+1,426 vol
$4.42 each
9,409
Filed 2023-09-19 11:24
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,581
+1,489 vol
$4.42 each
794,442
Filed 2023-09-19 11:22
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,046
+1,368 vol
$4.42 each
19,988
Filed 2023-09-19 11:19
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,739
+2,656 vol
$4.42 each
137,419
Filed 2023-09-18 10:02
Tx date 2023-09-15
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$115,737
+26,400 vol
$4.38 each
12,092,500
Filed 2023-09-18 10:02
Tx date 2023-09-14
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$440.00
+100 vol
$4.40 each
12,066,100
Filed 2023-09-18 10:01
Tx date 2023-09-13
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$36,068
+8,200 vol
$4.40 each
12,066,000
Filed 2023-09-11 21:50
Tx date 2023-09-07
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$108,383
+24,700 vol
$4.39 each
12,031,100
Filed 2023-09-11 21:45
Tx date 2023-09-08
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$116,751
+26,700 vol
$4.37 each
12,057,800
Filed 2023-09-11 21:44
Tx date 2023-09-07
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$116,751
+26,700 vol
$4.37 each
Filed 2023-09-05 10:31
Tx date 2023-08-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-370,200 vol
15,100
Filed 2023-09-05 10:30
Tx date 2023-08-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$42,514
+9,200 vol
$4.62 each
385,300
Filed 2023-09-05 10:29
Tx date 2023-08-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,295
+5,900 vol
$4.63 each
376,100
Filed 2023-09-05 10:28
Tx date 2023-08-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,246
+5,300 vol
$4.57 each
370,200
Filed 2023-09-05 10:26
Tx date 2023-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,123
+5,500 vol
$4.57 each
364,900
Filed 2023-09-05 10:21
Tx date 2023-08-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,402
+5,300 vol
$4.60 each
359,400
Filed 2023-09-05 10:20
Tx date 2023-08-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$37,183
+8,100 vol
$4.59 each
354,100
Filed 2023-09-05 10:18
Tx date 2023-08-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,119
+6,100 vol
$4.61 each
346,000
Filed 2023-09-05 10:17
Tx date 2023-08-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$42,525
+9,300 vol
$4.57 each
339,900
Filed 2023-09-05 10:16
Tx date 2023-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$48,708
+10,600 vol
$4.60 each
330,600
Filed 2023-09-05 10:15
Tx date 2023-08-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$64,647
+14,000 vol
$4.62 each
320,000
Filed 2023-09-05 10:14
Tx date 2023-08-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$55,002
+11,900 vol
$4.62 each
306,000
Filed 2023-09-05 10:12
Tx date 2023-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$108,386
+23,500 vol
$4.61 each
294,100
Filed 2023-09-05 10:11
Tx date 2023-08-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$108,882
+23,500 vol
$4.63 each
270,600
Filed 2023-09-05 10:10
Tx date 2023-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$109,987
+23,500 vol
$4.68 each
247,100
Filed 2023-09-05 10:08
Tx date 2023-08-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$111,507
+23,500 vol
$4.75 each
223,600
Filed 2023-09-05 10:07
Tx date 2023-08-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,610
+23,500 vol
$4.83 each
200,100
Filed 2023-09-05 10:06
Tx date 2023-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,364
+23,500 vol
$4.82 each
176,600
Filed 2023-09-05 09:59
Tx date 2023-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$82,675
+17,200 vol
$4.81 each
153,100
Filed 2023-09-05 09:58
Tx date 2023-08-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$112,327
+23,500 vol
$4.78 each
135,900
Filed 2023-09-05 09:57
Tx date 2023-08-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$111,803
+23,500 vol
$4.76 each
112,400
Filed 2023-09-05 09:55
Tx date 2023-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,009
+23,500 vol
$4.81 each
88,900
Filed 2023-09-05 09:54
Tx date 2023-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,293
+23,500 vol
$4.82 each
65,400
Filed 2023-08-21 10:20
Tx date 2023-08-14
$GUD
Knight Therapeutics Inc.
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$27,154
+5,741 vol
$4.73 each
5,741
Filed 2023-08-21 10:18
Tx date 2023-08-01
$GUD
Knight Therapeutics Inc.
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-21 10:14
Tx date 2023-08-14
$GUD
Knight Therapeutics Inc.
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$27,154
+5,741 vol
$4.73 each
5,741
Filed 2023-08-21 10:09
Tx date 2023-08-01
$GUD
Knight Therapeutics Inc.
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-21 10:04
Tx date 2023-08-01
$GUD
Knight Therapeutics Inc.
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-08-10 11:15
Tx date 2023-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-412,634 vol
41,900
Filed 2023-08-10 11:13
Tx date 2023-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,474
+23,500 vol
$4.83 each
454,534
Filed 2023-08-10 11:12
Tx date 2023-07-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$88,367
+18,400 vol
$4.80 each
431,034
Filed 2023-08-10 11:11
Tx date 2023-07-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,340
+23,500 vol
$4.82 each
412,634
Filed 2023-08-10 11:10
Tx date 2023-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$74,283
+15,300 vol
$4.86 each
389,134
Filed 2023-08-10 11:09
Tx date 2023-07-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$114,447
+23,500 vol
$4.87 each
373,834
Filed 2023-08-10 11:08
Tx date 2023-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$81,499
+16,700 vol
$4.88 each
350,334
Filed 2023-08-10 11:06
Tx date 2023-07-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$73,300
+15,139 vol
$4.84 each
333,634
Filed 2023-08-10 11:05
Tx date 2023-07-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,712
+23,539 vol
$4.83 each
318,495
Filed 2023-08-10 11:04
Tx date 2023-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$53,149
+10,839 vol
$4.90 each
294,956
Filed 2023-08-10 11:03
Tx date 2023-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,005
+7,339 vol
$4.91 each
284,117
Filed 2023-08-10 11:01
Tx date 2023-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$51,938
+10,639 vol
$4.88 each
276,778
Filed 2023-08-10 10:59
Tx date 2023-07-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$44,756
+9,039 vol
$4.95 each
266,139
Filed 2023-08-10 10:57
Tx date 2023-07-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$246,324
+49,100 vol
$5.02 each
257,100
Filed 2023-08-10 10:55
Tx date 2023-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$76,162
+15,400 vol
$4.95 each
208,000
Filed 2023-08-10 10:54
Tx date 2023-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$126,952
+26,000 vol
$4.88 each
192,600
Filed 2023-08-10 10:53
Tx date 2023-07-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$216,650
+44,100 vol
$4.91 each
166,600
Filed 2023-08-10 10:52
Tx date 2023-07-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$72,829
+14,900 vol
$4.89 each
122,500
Filed 2023-08-10 10:50
Tx date 2023-07-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$145,349
+30,200 vol
$4.81 each
107,600
Filed 2023-08-10 10:49
Tx date 2023-07-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$116,099
+23,900 vol
$4.86 each
77,400
Filed 2023-08-10 10:47
Tx date 2023-07-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$43,866
+8,900 vol
$4.93 each
53,500
Filed 2023-07-04 13:36
Tx date 2023-06-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-776,700 vol
44,600
Filed 2023-07-04 13:35
Tx date 2023-06-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$76,680
+15,700 vol
$4.88 each
821,300
Filed 2023-07-04 13:33
Tx date 2023-06-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$138,809
+28,900 vol
$4.80 each
805,600
Filed 2023-07-04 13:32
Tx date 2023-06-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$109,866
+23,000 vol
$4.78 each
776,700
Filed 2023-07-04 13:31
Tx date 2023-06-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$90,873
+19,200 vol
$4.73 each
753,700
Filed 2023-07-04 13:29
Tx date 2023-06-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$126,567
+27,100 vol
$4.67 each
734,500
Filed 2023-07-04 13:28
Tx date 2023-06-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$107,865
+22,700 vol
$4.75 each
707,400
Filed 2023-07-04 13:27
Tx date 2023-06-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$87,265
+18,300 vol
$4.77 each
684,700
Filed 2023-07-04 13:25
Tx date 2023-06-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$136,116
+28,500 vol
$4.78 each
666,400
Filed 2023-07-04 13:23
Tx date 2023-06-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$70,227
+14,700 vol
$4.78 each
637,900
Filed 2023-07-04 13:22
Tx date 2023-06-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$105,165
+21,800 vol
$4.82 each
623,200
Filed 2023-07-04 13:21
Tx date 2023-06-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$236,342
+49,200 vol
$4.80 each
601,400
Filed 2023-07-04 13:20
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$238,506
+49,200 vol
$4.85 each
552,200
Filed 2023-07-04 13:18
Tx date 2023-06-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$137,658
+28,200 vol
$4.88 each
503,000
Filed 2023-07-04 13:17
Tx date 2023-06-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$242,546
+49,200 vol
$4.93 each
474,800
Filed 2023-07-04 13:16
Tx date 2023-06-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$244,425
+49,200 vol
$4.97 each
425,600
Filed 2023-07-04 13:14
Tx date 2023-06-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$75,130
+15,100 vol
$4.98 each
376,400
Filed 2023-07-04 13:13
Tx date 2023-06-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$501,031
+101,200 vol
$4.95 each
361,300
Filed 2023-07-04 13:12
Tx date 2023-06-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$180,589
+36,700 vol
$4.92 each
260,100
Filed 2023-07-04 13:09
Tx date 2023-06-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$222,690
+45,500 vol
$4.89 each
223,400
Filed 2023-07-04 13:06
Tx date 2023-06-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$102,259
+21,000 vol
$4.87 each
177,900
Filed 2023-07-04 13:05
Tx date 2023-06-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$151,463
+31,100 vol
$4.87 each
156,900
Filed 2023-07-04 13:03
Tx date 2023-06-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$197,526
+40,300 vol
$4.90 each
125,800
Filed 2023-06-19 14:57
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,247
+1,473 vol
$4.92 each
7,983
Filed 2023-06-19 14:55
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,742
+2,590 vol
$4.92 each
134,763
Filed 2023-06-19 13:43
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$15,965
+3,245 vol
$4.92 each
189,935
Filed 2023-06-19 13:40
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,252
+1,474 vol
$4.92 each
Filed 2023-06-19 13:40
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,252
+1,474 vol
$4.92 each
7,984
Filed 2023-06-19 13:38
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,292
+466 vol
$4.92 each
873
Filed 2023-06-19 13:35
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,661
+1,354 vol
$4.92 each
792,953
Filed 2023-06-19 13:32
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,899
+1,199 vol
$4.92 each
18,620
Filed 2023-06-19 13:28
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,737
+2,589 vol
$4.92 each
Filed 2023-06-19 13:28
Tx date 2023-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,737
+2,589 vol
$4.92 each
134,762
Filed 2023-06-07 14:04
Tx date 2023-05-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,355,300 vol
85,500
Filed 2023-06-07 14:02
Tx date 2023-05-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$235,456
+49,200 vol
$4.79 each
1,440,800
Filed 2023-06-07 14:00
Tx date 2023-05-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$178,134
+36,300 vol
$4.91 each
1,391,600
Filed 2023-06-07 13:59
Tx date 2023-05-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$117,276
+23,800 vol
$4.93 each
1,355,300
Filed 2023-06-07 13:58
Tx date 2023-05-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$335,125
+68,400 vol
$4.90 each
1,331,500
Filed 2023-06-07 13:56
Tx date 2023-05-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$238,359
+49,200 vol
$4.84 each
1,263,100
Filed 2023-06-07 13:55
Tx date 2023-05-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$231,805
+49,200 vol
$4.71 each
1,213,900
Filed 2023-06-07 13:48
Tx date 2023-05-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$240,115
+49,200 vol
$4.88 each
1,164,700
Filed 2023-06-07 13:46
Tx date 2023-05-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$241,301
+49,200 vol
$4.90 each
1,115,500
Filed 2023-06-07 13:45
Tx date 2023-05-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$215,802
+44,900 vol
$4.81 each
1,066,300
Filed 2023-06-07 13:44
Tx date 2023-05-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$232,656
+49,200 vol
$4.73 each
1,021,400
Filed 2023-06-07 13:42
Tx date 2023-05-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$232,233
+49,200 vol
$4.72 each
972,200
Filed 2023-06-07 13:41
Tx date 2023-05-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,519,603
+314,000 vol
$4.84 each
923,000
Filed 2023-06-07 13:39
Tx date 2023-05-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$70,849
+14,600 vol
$4.85 each
609,000
Filed 2023-06-07 13:38
Tx date 2023-05-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$236,322
+49,200 vol
$4.80 each
594,400
Filed 2023-06-07 13:37
Tx date 2023-05-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$233,921
+49,200 vol
$4.75 each
545,200
Filed 2023-06-07 13:35
Tx date 2023-05-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$118,689
+25,400 vol
$4.67 each
496,000
Filed 2023-06-07 13:34
Tx date 2023-05-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$115,150
+24,500 vol
$4.70 each
470,600
Filed 2023-06-07 13:33
Tx date 2023-05-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$140,203
+29,800 vol
$4.70 each
446,100
Filed 2023-06-07 13:32
Tx date 2023-05-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$181,324
+38,900 vol
$4.66 each
416,300
Filed 2023-06-07 13:30
Tx date 2023-05-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$229,842
+49,200 vol
$4.67 each
377,400
Filed 2023-06-07 13:28
Tx date 2023-05-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$227,382
+49,200 vol
$4.62 each
328,200
Filed 2023-06-07 13:26
Tx date 2023-05-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$155,760
+34,200 vol
$4.55 each
279,000
Filed 2023-05-24 12:32
Tx date 2023-05-24
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$95,000
+20,000 vol
$4.75 each
186,690
Filed 2023-05-15 11:56
Tx date 2023-05-12
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$44,998
+9,259 vol
$4.86 each
23,189
Filed 2023-05-15 11:53
Tx date 2023-05-12
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$44,998
+9,259 vol
$4.86 each
37,117
Filed 2023-05-15 11:50
Tx date 2023-05-12
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$54,995
+11,316 vol
$4.86 each
29,817
Filed 2023-05-15 11:48
Tx date 2023-05-12
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$44,998
+9,259 vol
$4.86 each
23,189
Filed 2023-05-15 11:43
Tx date 2023-05-12
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$44,998
+9,259 vol
$4.86 each
23,189
Filed 2023-05-09 12:46
Tx date 2023-04-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-796,820 vol
244,800
Filed 2023-05-09 12:33
Tx date 2023-04-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$899,486
+195,600 vol
$4.60 each
1,041,620
Filed 2023-05-09 12:31
Tx date 2023-04-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$230,575
+49,200 vol
$4.69 each
846,020
Filed 2023-05-09 12:29
Tx date 2023-04-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$235,805
+49,200 vol
$4.79 each
796,820
Filed 2023-05-09 12:16
Tx date 2023-04-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$235,436
+49,200 vol
$4.79 each
747,620
Filed 2023-05-09 12:05
Tx date 2023-04-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$166,521
+34,700 vol
$4.80 each
698,420
Filed 2023-05-09 12:04
Tx date 2023-04-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$237,153
+49,200 vol
$4.82 each
663,720
Filed 2023-05-09 12:02
Tx date 2023-04-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$236,420
+49,200 vol
$4.81 each
614,520
Filed 2023-05-09 12:01
Tx date 2023-04-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$110,533
+23,000 vol
$4.81 each
565,320
Filed 2023-05-09 11:59
Tx date 2023-04-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$235,431
+49,200 vol
$4.79 each
542,320
Filed 2023-05-09 11:58
Tx date 2023-04-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$106,548
+22,200 vol
$4.80 each
493,120
Filed 2023-05-09 11:55
Tx date 2023-04-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$235,987
+49,200 vol
$4.80 each
470,920
Filed 2023-05-09 11:53
Tx date 2023-04-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$234,565
+49,200 vol
$4.77 each
421,720
Filed 2023-05-09 11:51
Tx date 2023-04-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$119,484
+25,300 vol
$4.72 each
372,520
Filed 2023-05-09 11:45
Tx date 2023-04-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$230,757
+49,200 vol
$4.69 each
347,220
Filed 2023-05-09 11:37
Tx date 2023-04-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$96,902
+20,900 vol
$4.64 each
298,020
Filed 2023-05-09 11:34
Tx date 2023-04-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$226,743
+49,200 vol
$4.61 each
277,120
Filed 2023-05-09 11:32
Tx date 2023-04-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$229,015
+49,220 vol
$4.65 each
227,920
Filed 2023-05-09 11:31
Tx date 2023-04-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$140,167
+31,100 vol
$4.51 each
178,700
Filed 2023-05-09 11:29
Tx date 2023-04-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$216,967
+49,200 vol
$4.41 each
147,600
Filed 2023-04-10 15:41
Tx date 2023-03-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,326,005 vol
98,400
Filed 2023-04-10 15:34
Tx date 2023-03-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$217,995
+49,200 vol
$4.43 each
1,424,405
Filed 2023-04-10 15:33
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$216,504
+49,200 vol
$4.40 each
1,375,205
Filed 2023-04-10 15:31
Tx date 2023-03-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$213,867
+49,200 vol
$4.35 each
1,326,005
Filed 2023-04-10 15:30
Tx date 2023-03-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$215,761
+49,200 vol
$4.39 each
1,276,805
Filed 2023-04-10 15:28
Tx date 2023-03-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,885,598
+660,305 vol
$4.37 each
1,227,605
Filed 2023-04-10 15:27
Tx date 2023-03-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$186,866
+41,200 vol
$4.54 each
567,300
Filed 2023-04-10 15:26
Tx date 2023-03-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$166,975
+34,300 vol
$4.87 each
526,100
Filed 2023-04-10 15:25
Tx date 2023-03-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$127,400
+25,800 vol
$4.94 each
491,800
Filed 2023-04-10 15:23
Tx date 2023-03-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$94,148
+18,900 vol
$4.98 each
466,000
Filed 2023-04-10 15:22
Tx date 2023-03-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$116,567
+23,500 vol
$4.96 each
447,100
Filed 2023-04-10 15:20
Tx date 2023-03-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$243,613
+49,200 vol
$4.95 each
423,600
Filed 2023-04-10 15:19
Tx date 2023-03-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$210,648
+41,900 vol
$5.03 each
374,400
Filed 2023-04-10 15:17
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$244,435
+49,200 vol
$4.97 each
332,500
Filed 2023-04-10 15:15
Tx date 2023-03-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$185,828
+36,900 vol
$5.04 each
283,300
Filed 2023-04-10 15:13
Tx date 2023-03-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$106,789
+21,300 vol
$5.01 each
246,400
Filed 2023-04-10 15:10
Tx date 2023-03-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$107,797
+21,300 vol
$5.06 each
225,100
Filed 2023-04-10 15:08
Tx date 2023-03-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$189,255
+37,400 vol
$5.06 each
203,800
Filed 2023-04-10 15:05
Tx date 2023-03-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$182,479
+35,900 vol
$5.08 each
166,400
Filed 2023-04-10 15:03
Tx date 2023-03-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$49,342
+9,700 vol
$5.09 each
130,500
Filed 2023-04-10 15:01
Tx date 2023-03-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$142,409
+27,900 vol
$5.10 each
120,800
Filed 2023-04-10 14:59
Tx date 2023-03-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$67,476
+13,100 vol
$5.15 each
92,900
Filed 2023-04-10 14:57
Tx date 2023-03-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$154,854
+30,500 vol
$5.08 each
79,800
Filed 2023-04-10 14:54
Tx date 2023-03-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,832
+20,300 vol
$5.11 each
49,300
Filed 2023-04-04 21:57
Tx date 2023-03-31
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$17,498
+3,977 vol
$4.40 each
27,858
Filed 2023-04-03 22:06
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$17,493
+3,940 vol
$4.44 each
6,802
Filed 2023-04-03 22:04
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$17,493
+3,940 vol
$4.44 each
6,802
Filed 2023-04-03 22:02
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$19,988
+4,502 vol
$4.44 each
8,395
Filed 2023-04-03 22:00
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$19,988
+4,502 vol
$4.44 each
8,395
Filed 2023-04-03 21:58
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$20,019
+4,509 vol
$4.44 each
12,970
Filed 2023-04-03 21:57
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$20,019
+4,509 vol
$4.44 each
12,970
Filed 2023-04-03 21:55
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$22,128
+4,984 vol
$4.44 each
8,859
Filed 2023-04-03 21:54
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
50 - Grant of options
$44,253
+9,967 vol
$4.44 each
17,718
Filed 2023-04-03 21:49
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$71,284
+16,055 vol
$4.44 each
29,283
Filed 2023-04-03 21:46
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$18,949
+4,268 vol
$4.44 each
11,299
Filed 2023-04-03 21:44
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$37,908
+8,538 vol
$4.44 each
16,536
Filed 2023-04-03 21:43
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$61,054
+13,751 vol
$4.44 each
30,770
Filed 2023-04-03 21:41
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$23,887
+5,380 vol
$4.44 each
18,144
Filed 2023-04-03 21:40
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$47,774
+10,760 vol
$4.44 each
23,692
Filed 2023-04-03 21:38
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$76,954
+17,332 vol
$4.44 each
46,401
Filed 2023-04-02 23:58
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$103,469
+23,304 vol
$4.44 each
56,159
Filed 2023-04-02 23:57
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$51,734
+11,652 vol
$4.44 each
28,079
Filed 2023-04-02 23:55
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$166,655
+37,535 vol
$4.44 each
317,544
Filed 2023-04-02 23:53
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$391,030
+88,070 vol
$4.44 each
210,985
Filed 2023-04-02 23:51
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$419,886
+94,569 vol
$4.44 each
863,388
Filed 2023-04-02 23:47
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$41,736
+9,400 vol
$4.44 each
24,283
Filed 2023-04-02 23:44
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$20,868
+4,700 vol
$4.44 each
15,196
Filed 2023-04-02 23:42
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$67,226
+15,141 vol
$4.44 each
90,443
Filed 2023-04-02 23:39
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$103,469
+23,304 vol
$4.44 each
56,159
Filed 2023-04-02 23:32
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$51,734
+11,652 vol
$4.44 each
28,079
Filed 2023-04-02 23:28
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$166,655
+37,535 vol
$4.44 each
337,293
Filed 2023-04-02 23:22
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Performance stock Unit
56 - Grant of rights
$145,125
+32,686 vol
$4.44 each
99,085
Filed 2023-04-02 23:12
Tx date 2023-03-30
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
$155,835
+35,098 vol
$4.44 each
1,964,646
Filed 2023-03-30 10:56
Tx date 2023-03-29
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$155,980
+36,100 vol
$4.32 each
12,006,400
Filed 2023-03-30 10:54
Tx date 2023-03-28
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$146,414
+33,800 vol
$4.33 each
11,970,300
Filed 2023-03-30 10:53
Tx date 2023-03-27
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$3,205,472
+735,200 vol
$4.36 each
11,936,500
Filed 2023-03-24 09:22
Tx date 2023-03-23
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
11,201,300
Filed 2023-03-21 21:36
Tx date 2023-03-17
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-970,000
-125,000 vol
$7.76 each
299,758
Filed 2023-03-21 21:28
Tx date 2023-03-17
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
$-1,940,000
-250,000 vol
$7.76 each
1,929,548
Filed 2023-03-21 21:24
Tx date 2023-03-17
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-155,200
-20,000 vol
$7.76 each
100,000
Filed 2023-03-21 21:20
Tx date 2023-03-17
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-155,200
-20,000 vol
$7.76 each
110,000
Filed 2023-03-20 23:29
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,274
+1,245 vol
$5.04 each
791,599
Filed 2023-03-19 23:19
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,051
+407 vol
$5.04 each
407
Filed 2023-03-19 23:16
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2023-03-19 23:08
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,997
+1,190 vol
$5.04 each
6,510
Filed 2023-03-19 23:04
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,494
+495 vol
$5.04 each
8,493
Filed 2023-03-19 23:01
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$13,174
+2,614 vol
$5.04 each
166,690
Filed 2023-03-19 23:00
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,523
+1,096 vol
$5.04 each
17,421
Filed 2023-03-19 22:55
Tx date 2023-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,664
+2,116 vol
$5.04 each
132,173
Filed 2023-03-10 17:56
Tx date 2023-02-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-481,700 vol
29,000
Filed 2023-03-10 17:50
Tx date 2023-02-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$74,039
+14,500 vol
$5.11 each
510,700
Filed 2023-03-10 17:49
Tx date 2023-02-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$74,176
+14,500 vol
$5.12 each
496,200
Filed 2023-03-10 17:48
Tx date 2023-02-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$89,792
+17,500 vol
$5.13 each
481,700
Filed 2023-03-10 17:45
Tx date 2023-02-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$162,139
+31,600 vol
$5.13 each
464,200
Filed 2023-03-10 17:43
Tx date 2023-02-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$94,607
+18,500 vol
$5.11 each
432,600
Filed 2023-03-10 17:42
Tx date 2023-02-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$128,565
+24,700 vol
$5.21 each
414,100
Filed 2023-03-10 17:40
Tx date 2023-02-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$162,076
+31,600 vol
$5.13 each
389,400
Filed 2023-03-10 17:39
Tx date 2023-02-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$80,027
+15,700 vol
$5.10 each
357,800
Filed 2023-03-10 17:38
Tx date 2023-02-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$81,808
+15,900 vol
$5.15 each
342,100
Filed 2023-03-10 17:36
Tx date 2023-02-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$170,114
+33,100 vol
$5.14 each
326,200
Filed 2023-03-10 17:35
Tx date 2023-02-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$74,496
+14,400 vol
$5.17 each
293,100
Filed 2023-03-10 17:34
Tx date 2023-02-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$62,800
+12,100 vol
$5.19 each
278,700
Filed 2023-03-10 17:33
Tx date 2023-02-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$260,292
+49,200 vol
$5.29 each
266,600
Filed 2023-03-10 17:32
Tx date 2023-02-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$119,129
+22,800 vol
$5.22 each
217,400
Filed 2023-03-10 17:30
Tx date 2023-02-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$51,446
+9,900 vol
$5.20 each
194,600
Filed 2023-03-10 17:29
Tx date 2023-02-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$119,683
+23,100 vol
$5.18 each
184,700
Filed 2023-03-10 17:28
Tx date 2023-02-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$215,265
+40,600 vol
$5.30 each
161,600
Filed 2023-03-10 17:27
Tx date 2023-02-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$140,925
+26,700 vol
$5.28 each
121,000
Filed 2023-03-10 16:10
Tx date 2023-02-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$101,957
+19,700 vol
$5.18 each
94,300
Filed 2023-02-03 13:50
Tx date 2023-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-827,300 vol
74,600
Filed 2023-02-03 13:50
Tx date 2023-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$182,044
+35,600 vol
$5.11 each
901,900
Filed 2023-02-03 13:49
Tx date 2023-01-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$199,500
+39,000 vol
$5.12 each
866,300
Filed 2023-02-03 13:48
Tx date 2023-01-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$187,138
+36,100 vol
$5.18 each
827,300
Filed 2023-02-03 13:47
Tx date 2023-01-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$165,789
+32,300 vol
$5.13 each
791,200
Filed 2023-02-03 13:47
Tx date 2023-01-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$145,501
+28,500 vol
$5.11 each
758,900
Filed 2023-02-03 13:46
Tx date 2023-01-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$155,587
+30,300 vol
$5.13 each
730,400
Filed 2023-02-03 13:45
Tx date 2023-01-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$127,442
+24,700 vol
$5.16 each
700,100
Filed 2023-02-03 13:45
Tx date 2023-01-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$196,613
+37,900 vol
$5.19 each
675,400
Filed 2023-02-03 13:44
Tx date 2023-01-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$150,438
+29,100 vol
$5.17 each
637,500
Filed 2023-02-03 13:43
Tx date 2023-01-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$129,767
+24,600 vol
$5.28 each
608,400
Filed 2023-02-03 13:43
Tx date 2023-01-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$228,914
+43,300 vol
$5.29 each
583,800
Filed 2023-02-03 13:42
Tx date 2023-01-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$125,811
+23,800 vol
$5.29 each
540,500
Filed 2023-02-03 13:41
Tx date 2023-01-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$142,802
+27,200 vol
$5.25 each
516,700
Filed 2023-01-17 17:45
Tx date 2023-01-13
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,998
+1,883 vol
$5.31 each
7,998
Filed 2023-01-10 11:59
Tx date 2022-12-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,860
+1,500 vol
$5.24 each
489,500
Filed 2023-01-10 11:58
Tx date 2022-12-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$117,222
+22,500 vol
$5.21 each
488,000
Filed 2023-01-10 11:58
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$77,964
+15,000 vol
$5.20 each
465,500
Filed 2023-01-10 11:57
Tx date 2022-12-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,635
+6,400 vol
$5.26 each
450,500
Filed 2023-01-10 11:56
Tx date 2022-12-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$155,768
+29,500 vol
$5.28 each
444,100
Filed 2023-01-10 11:55
Tx date 2022-12-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$78,699
+14,700 vol
$5.35 each
414,600
Filed 2023-01-10 11:47
Tx date 2022-12-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$133,017
+24,600 vol
$5.41 each
399,900
Filed 2023-01-10 11:46
Tx date 2022-12-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$931,707
+177,600 vol
$5.25 each
375,300
Filed 2023-01-10 11:45
Tx date 2022-12-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$49,057
+9,200 vol
$5.33 each
197,700
Filed 2023-01-10 11:44
Tx date 2022-12-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$154,155
+29,000 vol
$5.32 each
188,500
Filed 2023-01-10 11:43
Tx date 2022-12-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$131,500
+25,000 vol
$5.26 each
159,500
Filed 2023-01-10 11:42
Tx date 2022-12-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,717
+36,000 vol
$5.30 each
134,500
Filed 2023-01-10 11:42
Tx date 2022-12-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$77,866
+14,400 vol
$5.41 each
98,500
Filed 2023-01-10 11:40
Tx date 2022-12-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$113,867
+20,900 vol
$5.45 each
84,100
Filed 2023-01-10 11:40
Tx date 2022-12-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$129,506
+23,900 vol
$5.42 each
63,200
Filed 2023-01-02 10:29
Tx date 2022-12-31
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$17,503
+3,379 vol
$5.18 each
23,881
Filed 2022-12-23 15:59
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,998
+1,318 vol
$5.31 each
5,320
Filed 2022-12-23 15:55
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,701
+321 vol
$5.30 each
164,076
Filed 2022-12-23 15:54
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$13,057
+2,459 vol
$5.31 each
163,755
Filed 2022-12-23 15:53
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,812
+342 vol
$5.30 each
790,354
Filed 2022-12-23 15:51
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,842
+912 vol
$5.31 each
790,012
Filed 2022-12-23 15:49
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$583.00
+110 vol
$5.30 each
16,325
Filed 2022-12-23 15:49
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,207
+604 vol
$5.31 each
16,215
Filed 2022-12-23 15:47
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,526
+288 vol
$5.30 each
130,057
Filed 2022-12-23 15:46
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,365
+1,952 vol
$5.31 each
129,769
Filed 2022-12-23 13:17
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,894
+2,240 vol
$5.31 each
130,057
Filed 2022-12-23 13:17
Tx date 2022-12-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,894
+2,240 vol
$5.31 each
Filed 2022-12-05 11:46
Tx date 2022-11-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-449,400 vol
39,300
Filed 2022-12-05 11:46
Tx date 2022-11-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$148,260
+27,800 vol
$5.33 each
488,700
Filed 2022-12-05 11:45
Tx date 2022-11-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$60,798
+11,500 vol
$5.29 each
460,900
Filed 2022-12-05 11:44
Tx date 2022-11-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$49,991
+9,400 vol
$5.32 each
449,400
Filed 2022-12-05 11:43
Tx date 2022-11-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$117,941
+22,100 vol
$5.34 each
440,000
Filed 2022-12-05 11:42
Tx date 2022-11-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$62,171
+11,800 vol
$5.27 each
417,900
Filed 2022-12-05 11:41
Tx date 2022-11-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$43,428
+8,300 vol
$5.23 each
406,100
Filed 2022-12-05 11:39
Tx date 2022-11-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$105,318
+20,200 vol
$5.21 each
397,800
Filed 2022-12-05 11:38
Tx date 2022-11-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,252
+4,800 vol
$5.26 each
377,600
Filed 2022-12-05 11:37
Tx date 2022-11-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$216,872
+40,900 vol
$5.30 each
372,800
Filed 2022-12-05 11:37
Tx date 2022-11-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$122,822
+23,100 vol
$5.32 each
220,100
Filed 2022-12-05 11:35
Tx date 2022-11-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$126,647
+24,100 vol
$5.26 each
303,000
Filed 2022-12-05 11:34
Tx date 2022-11-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$151,814
+28,900 vol
$5.25 each
331,900
Filed 2022-12-05 11:33
Tx date 2022-11-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$162,793
+30,800 vol
$5.29 each
278,900
Filed 2022-12-05 11:32
Tx date 2022-11-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$148,178
+28,000 vol
$5.29 each
248,100
Filed 2022-12-05 11:31
Tx date 2022-11-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$126,723
+23,800 vol
$5.32 each
197,000
Filed 2022-12-05 11:30
Tx date 2022-11-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$120,821
+22,200 vol
$5.44 each
173,200
Filed 2022-12-05 11:29
Tx date 2022-11-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$45,704
+8,400 vol
$5.44 each
151,000
Filed 2022-12-05 11:28
Tx date 2022-11-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,513
+5,900 vol
$5.34 each
142,600
Filed 2022-12-05 11:27
Tx date 2022-11-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$129,785
+24,100 vol
$5.39 each
136,700
Filed 2022-12-05 11:26
Tx date 2022-11-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$88,392
+16,400 vol
$5.39 each
112,600
Filed 2022-12-05 11:25
Tx date 2022-11-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$241,024
+44,100 vol
$5.47 each
96,200
Filed 2022-12-05 11:24
Tx date 2022-11-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$85,200
+15,400 vol
$5.53 each
52,100
Filed 2022-11-02 18:32
Tx date 2022-10-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$129,732
+24,000 vol
$5.41 each
534,700
Filed 2022-11-02 18:27
Tx date 2022-10-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-836,800 vol
36,700
Filed 2022-11-02 18:27
Tx date 2022-10-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$115,420
+20,900 vol
$5.52 each
873,500
Filed 2022-11-02 18:26
Tx date 2022-10-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$84,955
+15,800 vol
$5.38 each
852,600
Filed 2022-11-02 18:25
Tx date 2022-10-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$134,120
+25,000 vol
$5.36 each
836,800
Filed 2022-11-02 18:24
Tx date 2022-10-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$265,542
+49,200 vol
$5.40 each
811,800
Filed 2022-11-02 18:24
Tx date 2022-10-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$178,283
+33,900 vol
$5.26 each
762,600
Filed 2022-11-02 18:23
Tx date 2022-10-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$111,643
+21,200 vol
$5.27 each
728,700
Filed 2022-11-02 18:22
Tx date 2022-10-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$134,053
+25,200 vol
$5.32 each
707,500
Filed 2022-11-02 18:22
Tx date 2022-10-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$262,339
+49,200 vol
$5.33 each
682,300
Filed 2022-11-02 18:21
Tx date 2022-10-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$260,715
+49,200 vol
$5.30 each
633,100
Filed 2022-11-02 18:20
Tx date 2022-10-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$266,304
+49,200 vol
$5.41 each
583,900
Filed 2022-11-02 18:19
Tx date 2022-10-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$129,732
+24,000 vol
$5.41 each
Filed 2022-11-02 18:18
Tx date 2022-10-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$207,836
+39,100 vol
$5.32 each
510,700
Filed 2022-11-02 17:33
Tx date 2022-10-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$162,469
+30,400 vol
$5.34 each
471,600
Filed 2022-11-02 17:31
Tx date 2022-10-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,174
+49,200 vol
$5.21 each
441,200
Filed 2022-11-02 17:29
Tx date 2022-10-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$149,871
+28,700 vol
$5.22 each
392,000
Filed 2022-11-02 17:28
Tx date 2022-10-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$240,320
+44,800 vol
$5.36 each
314,600
Filed 2022-11-02 17:25
Tx date 2022-10-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,473
+48,700 vol
$5.27 each
363,300
Filed 2022-11-02 17:22
Tx date 2022-10-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$264,267
+49,200 vol
$5.37 each
269,800
Filed 2022-11-02 17:20
Tx date 2022-10-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$263,372
+49,200 vol
$5.35 each
220,600
Filed 2022-11-02 17:19
Tx date 2022-10-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$263,229
+49,200 vol
$5.35 each
171,400
Filed 2022-10-07 11:27
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$13,185
+2,342 vol
$5.63 each
161,296
Filed 2022-10-07 11:22
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,277
+1,115 vol
$5.63 each
789,100
Filed 2022-10-07 11:20
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,438
+966 vol
$5.63 each
15,611
Filed 2022-10-07 11:18
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,674
+1,896 vol
$5.63 each
127,817
Filed 2022-09-21 16:29
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$22,401
+3,979 vol
$5.63 each
Filed 2022-09-21 16:27
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,326
+1,479 vol
$5.63 each
Filed 2022-09-21 16:25
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$18,950
+3,366 vol
$5.63 each
Filed 2022-09-21 16:22
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$16,118
+2,863 vol
$5.63 each
Filed 2022-10-06 15:59
Tx date 2022-09-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$280,267
+49,200 vol
$5.70 each
144,600
Filed 2022-10-06 15:39
Tx date 2022-09-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-495,700 vol
122,200
Filed 2022-10-06 15:38
Tx date 2022-09-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$262,816
+49,200 vol
$5.34 each
617,900
Filed 2022-10-06 15:38
Tx date 2022-09-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$244,324
+45,800 vol
$5.33 each
568,700
Filed 2022-10-06 15:37
Tx date 2022-09-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$148,136
+27,200 vol
$5.45 each
522,900
Filed 2022-10-06 15:36
Tx date 2022-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$200,361
+36,000 vol
$5.57 each
495,700
Filed 2022-10-06 15:36
Tx date 2022-09-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$145,445
+26,900 vol
$5.41 each
459,700
Filed 2022-10-06 15:35
Tx date 2022-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$224,292
+41,400 vol
$5.42 each
432,800
Filed 2022-10-06 15:34
Tx date 2022-09-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$131,188
+24,200 vol
$5.42 each
391,400
Filed 2022-10-06 15:33
Tx date 2022-09-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,294
+46,500 vol
$5.51 each
367,200
Filed 2022-10-06 15:33
Tx date 2022-09-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$104,622
+19,100 vol
$5.48 each
320,700
Filed 2022-10-06 15:32
Tx date 2022-09-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$72,908
+13,200 vol
$5.52 each
301,600
Filed 2022-10-06 15:31
Tx date 2022-09-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$174,663
+31,300 vol
$5.58 each
288,400
Filed 2022-10-06 15:31
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$275,303
+49,200 vol
$5.60 each
257,100
Filed 2022-10-06 15:30
Tx date 2022-09-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$96,165
+17,300 vol
$5.56 each
207,900
Filed 2022-10-06 15:29
Tx date 2022-09-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$179,447
+31,900 vol
$5.63 each
190,600
Filed 2022-10-06 15:28
Tx date 2022-09-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$80,213
+14,100 vol
$5.69 each
158,700
Filed 2022-10-06 15:27
Tx date 2022-09-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$280,267
+49,200 vol
$5.70 each
Filed 2022-10-06 15:26
Tx date 2022-09-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$80,017
+14,200 vol
$5.63 each
95,400
Filed 2022-10-06 15:26
Tx date 2022-09-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$164,957
+29,600 vol
$5.57 each
81,200
Filed 2022-10-06 15:25
Tx date 2022-09-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,465
+34,400 vol
$5.54 each
51,600
Filed 2022-10-03 10:27
Tx date 2022-09-30
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$17,496
+3,295 vol
$5.31 each
20,502
Filed 2022-09-21 16:31
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,503
+267 vol
$5.63 each
4,002
Filed 2022-09-21 16:29
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$22,401
+3,979 vol
$5.63 each
162,933
Filed 2022-09-21 16:27
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,326
+1,479 vol
$5.63 each
16,124
Filed 2022-09-21 16:25
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$18,950
+3,366 vol
$5.63 each
129,287
Filed 2022-09-21 16:22
Tx date 2022-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$16,118
+2,863 vol
$5.63 each
790,848
Filed 2022-09-15 10:54
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$20,188
+3,875 vol
$5.21 each
3,875
Filed 2022-09-15 10:52
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$14,939
+2,862 vol
$5.22 each
2,862
Filed 2022-09-15 10:50
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$14,939
+2,862 vol
$5.22 each
2,862
Filed 2022-09-15 10:49
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$20,188
+3,875 vol
$5.21 each
Filed 2022-09-15 10:48
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$40,382
+7,751 vol
$5.21 each
7,751
Filed 2022-09-15 10:47
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$68,917
+13,228 vol
$5.21 each
13,228
Filed 2022-09-15 09:58
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$20,282
+3,893 vol
$5.21 each
3,893
Filed 2022-09-15 09:57
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$20,282
+3,893 vol
$5.21 each
3,893
Filed 2022-09-15 09:51
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$22,861
+4,388 vol
$5.21 each
10,496
Filed 2022-09-15 09:50
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$45,717
+8,775 vol
$5.21 each
14,883
Filed 2022-09-15 09:49
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$78,024
+14,976 vol
$5.21 each
75,302
Filed 2022-09-15 09:47
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$15,567
+2,988 vol
$5.21 each
7,031
Filed 2022-09-15 09:46
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$31,134
+5,976 vol
$5.21 each
7,998
Filed 2022-09-15 09:44
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$21,064
+4,043 vol
$5.21 each
4,043
Filed 2022-09-15 09:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$10,534
+2,022 vol
$5.21 each
2,022
Filed 2022-09-15 09:39
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$14,942
+2,868 vol
$5.21 each
6,750
Filed 2022-09-15 09:38
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$29,894
+5,738 vol
$5.21 each
7,679
Filed 2022-09-15 09:36
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$20,225
+3,882 vol
$5.21 each
3,882
Filed 2022-09-15 09:35
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$10,112
+1,941 vol
$5.21 each
1,941
Filed 2022-09-15 09:34
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$51,016
+9,792 vol
$5.21 each
16,340
Filed 2022-09-15 09:30
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$34,442
+6,548 vol
$5.26 each
6,548
Filed 2022-09-15 09:27
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$53,131
+10,198 vol
$5.21 each
17,019
Filed 2022-09-15 09:25
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$35,878
+6,821 vol
$5.26 each
6,821
Filed 2022-09-15 09:22
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
2,211
Filed 2022-09-15 09:20
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
2,211
Filed 2022-05-17 14:47
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$16,187
+3,101 vol
$5.22 each
Filed 2022-05-17 14:46
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$16,187
+3,101 vol
$5.22 each
Filed 2022-04-27 10:24
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2022-04-27 10:23
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-04-27 10:21
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
Filed 2022-04-27 10:20
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
Filed 2022-03-29 11:45
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$24,346
+4,673 vol
$5.21 each
Filed 2022-03-29 11:44
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$24,346
+4,673 vol
$5.21 each
Filed 2022-03-29 11:41
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$21,876
+4,199 vol
$5.21 each
Filed 2022-03-29 11:40
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$43,748
+8,397 vol
$5.21 each
Filed 2022-03-29 11:39
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$74,659
+14,330 vol
$5.21 each
Filed 2022-03-29 11:37
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$27,430
+5,265 vol
$5.21 each
Filed 2022-03-29 11:36
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$54,866
+10,531 vol
$5.21 each
Filed 2022-03-29 11:35
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$93,628
+17,971 vol
$5.21 each
Filed 2022-03-29 11:32
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$18,683
+3,586 vol
$5.21 each
Filed 2022-03-29 11:31
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$37,360
+7,171 vol
$5.21 each
Filed 2022-03-29 11:30
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$63,759
+12,238 vol
$5.21 each
Filed 2022-03-29 11:24
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$17,938
+3,443 vol
$5.21 each
Filed 2022-03-29 11:23
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$35,876
+6,886 vol
$5.21 each
Filed 2022-03-29 11:22
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$61,222
+11,751 vol
$5.21 each
Filed 2022-01-06 21:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$43,053
+8,185 vol
$5.26 each
Filed 2022-01-06 21:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$41,333
+7,858 vol
$5.26 each
Filed 2022-01-06 16:05
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
Filed 2022-01-06 16:05
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
Filed 2022-01-06 16:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2022-01-06 16:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-01-06 15:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2022-01-06 15:50
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$44,883
+8,533 vol
$5.26 each
Filed 2021-12-10 14:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
Filed 2021-12-10 13:58
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
Filed 2021-12-10 13:55
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$44,883
+8,533 vol
$5.26 each
Filed 2021-12-10 13:53
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-09-03 09:10
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-03 09:07
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:31
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:24
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-09-07 15:21
Tx date 2022-08-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-182,800 vol
17,200
Filed 2022-09-07 15:20
Tx date 2022-08-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$97,398
+17,200 vol
$5.66 each
200,000
Filed 2022-09-07 15:20
Tx date 2022-08-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$207,192
+36,400 vol
$5.69 each
182,800
Filed 2022-09-07 15:19
Tx date 2022-08-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$132,139
+23,000 vol
$5.75 each
146,400
Filed 2022-09-07 15:18
Tx date 2022-08-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$73,025
+12,700 vol
$5.75 each
123,400
Filed 2022-09-07 15:17
Tx date 2022-08-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$61,525
+10,700 vol
$5.75 each
110,700
Filed 2022-09-07 15:17
Tx date 2022-08-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$579,620
+100,000 vol
$5.80 each
100,000
Filed 2022-08-31 09:36
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-25,000 vol
21,523,233
Filed 2022-08-31 09:35
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

-45,000 vol
21,523,233
Filed 2022-08-16 16:09
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
248,482
Filed 2022-08-16 16:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,374 vol
689,387
Filed 2022-08-16 15:58
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
2,440,068
Filed 2022-08-16 15:53
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
528,231
Filed 2021-12-10 14:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-12-10 14:09
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-12-10 14:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,374 vol
Filed 2021-12-10 14:06
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
Filed 2021-12-10 13:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-12-10 13:09
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-12-10 13:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
Filed 2021-12-10 13:06
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,374 vol
Filed 2021-12-10 13:01
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
Filed 2021-05-20 12:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 12:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 12:32
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
Filed 2021-05-20 12:17
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,811 vol
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 10:55
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
Filed 2021-05-20 10:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,811 vol
Filed 2022-08-15 15:00
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
60,326
Filed 2022-03-29 11:35
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-08-14 16:54
Tx date 2022-08-11
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-380,103.05
-65,500 vol
$5.80 each
11,404,478
Filed 2022-08-03 16:31
Tx date 2022-08-02
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-201,338.55
-34,500 vol
$5.84 each
11,469,978
Filed 2022-08-02 09:21
Tx date 2022-07-29
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
10 - Acquisition or disposition in the public market
$-580,110
-100,000 vol
$5.80 each
11,504,478
Filed 2022-07-07 14:09
Tx date 2022-06-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-195,970 vol
0
Filed 2022-07-07 14:09
Tx date 2022-06-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$75,435
+14,370 vol
$5.25 each
195,970
Filed 2022-07-07 14:08
Tx date 2022-06-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$232,067
+44,100 vol
$5.26 each
181,600
Filed 2022-07-07 14:07
Tx date 2022-06-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$423,215
+80,000 vol
$5.29 each
137,500
Filed 2022-07-07 14:07
Tx date 2022-06-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$232,643
+43,900 vol
$5.30 each
57,500
Filed 2022-07-07 14:06
Tx date 2022-06-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$71,954
+13,600 vol
$5.29 each
13,600
Filed 2022-07-05 16:57
Tx date 2022-07-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$82,950
+15,800 vol
$5.25 each
21,678,733
Filed 2022-07-05 16:56
Tx date 2022-07-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$51,645
+9,800 vol
$5.27 each
21,662,933
Filed 2022-07-05 16:55
Tx date 2022-07-04
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$82,950
+15,800 vol
$5.25 each
21,748,733
Filed 2022-07-05 16:54
Tx date 2022-07-04
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$51,645
+9,800 vol
$5.27 each
21,732,933
Filed 2022-07-04 14:50
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
21,685,133
Filed 2022-04-13 12:29
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$99,452
+18,800 vol
$5.29 each
Filed 2021-11-22 22:19
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
Filed 2022-07-03 11:10
Tx date 2022-06-30
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$17,499
+3,277 vol
$5.34 each
17,207
Filed 2022-06-24 09:52
Tx date 2022-06-23
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Noah Ezra Goodman (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$515.00
+100 vol
$5.15 each
400
Filed 2022-06-20 14:22
Tx date 2022-06-20
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$99,998
+19,455 vol
$5.14 each
158,954
Filed 2022-06-17 21:53
Tx date 2022-06-15
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$1,748
+335 vol
$5.22 each
3,735
Filed 2022-06-17 21:37
Tx date 2022-06-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$14,433
+2,765 vol
$5.22 each
139,499
Filed 2022-06-17 21:29
Tx date 2022-06-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,906
+2,281 vol
$5.22 each
14,645
Filed 2022-06-17 21:19
Tx date 2022-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,661
+2,234 vol
$5.22 each
125,921
Filed 2022-06-17 21:11
Tx date 2022-06-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,665
+1,277 vol
$5.22 each
787,985
Filed 2022-06-16 21:36
Tx date 2022-06-16
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$10,360
+2,000 vol
$5.18 each
42,700
Filed 2022-06-16 21:32
Tx date 2022-06-16
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$93,240
+18,000 vol
$5.18 each
21,653,133
Filed 2022-06-16 21:29
Tx date 2022-06-16
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$93,240
+18,000 vol
$5.18 each
Filed 2022-06-16 21:22
Tx date 2022-06-16
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$93,240
+18,000 vol
$5.18 each
21,723,933
Filed 2022-06-15 09:24
Tx date 2022-06-14
$GUD
Knight Therapeutics Inc.
Armoyan, Sime
3 - 10% Security Holder of Issuer
Holder: Armco Alberta Inc. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
11,604,478
Filed 2022-06-06 14:27
Tx date 2022-05-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-488,844 vol
0
Filed 2022-06-06 14:26
Tx date 2022-05-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,240
+800 vol
$5.30 each
488,844
Filed 2022-06-06 14:26
Tx date 2022-05-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,638
+3,900 vol
$5.29 each
488,044
Filed 2022-06-06 14:25
Tx date 2022-05-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$59,308
+11,200 vol
$5.30 each
484,144
Filed 2022-06-06 14:24
Tx date 2022-05-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$112,793
+21,600 vol
$5.22 each
472,944
Filed 2022-06-06 14:24
Tx date 2022-05-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$261,115
+50,200 vol
$5.20 each
451,344
Filed 2022-06-06 14:23
Tx date 2022-05-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$221,793
+42,000 vol
$5.28 each
401,144
Filed 2022-06-06 14:22
Tx date 2022-05-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$259,545
+50,000 vol
$5.19 each
359,144
Filed 2022-06-06 14:21
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$223,963
+42,800 vol
$5.23 each
309,144
Filed 2022-06-06 14:20
Tx date 2022-05-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$417,400
+80,000 vol
$5.22 each
266,344
Filed 2022-06-06 14:19
Tx date 2022-05-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$364,508
+68,900 vol
$5.29 each
186,344
Filed 2022-06-06 14:18
Tx date 2022-05-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,798
+6,729 vol
$5.32 each
117,444
Filed 2022-05-18 16:53
Tx date 2022-05-18
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$103,400
+20,000 vol
$5.17 each
21,705,933
Filed 2022-05-18 16:51
Tx date 2022-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$103,400
+20,000 vol
$5.17 each
21,635,133
Filed 2022-05-18 16:50
Tx date 2022-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$103,400
+20,000 vol
$5.17 each
Filed 2022-05-18 14:48
Tx date 2022-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$99,999
+19,305 vol
$5.18 each
136,734
Filed 2022-05-17 14:47
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$16,187
+3,101 vol
$5.22 each
3,101
Filed 2022-05-17 14:46
Tx date 2022-04-21
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-17 14:46
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$16,187
+3,101 vol
$5.22 each
3,101
Filed 2022-05-17 14:43
Tx date 2022-04-21
$GUD
Knight Therapeutics Inc.
Di Ciurcio, Melina Paula
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-05-16 10:06
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$44,996
+8,620 vol
$5.22 each
13,930
Filed 2022-05-16 10:05
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$44,996
+8,620 vol
$5.22 each
13,930
Filed 2022-05-16 10:04
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$44,996
+8,620 vol
$5.22 each
13,930
Filed 2022-05-16 10:03
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$44,996
+8,620 vol
$5.22 each
13,930
Filed 2022-05-16 10:00
Tx date 2022-05-13
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$54,997
+10,536 vol
$5.22 each
18,501
Filed 2022-05-10 17:02
Tx date 2022-04-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,256,400 vol
110,715
Filed 2022-05-10 16:59
Tx date 2022-04-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$282,972
+52,900 vol
$5.35 each
1,367,115
Filed 2022-05-10 16:58
Tx date 2022-04-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$309,813
+57,815 vol
$5.36 each
1,314,215
Filed 2022-05-10 16:57
Tx date 2022-04-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$223,323
+41,915 vol
$5.33 each
1,256,400
Filed 2022-05-10 16:56
Tx date 2022-04-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$243,203
+45,715 vol
$5.32 each
1,214,485
Filed 2022-05-10 16:55
Tx date 2022-04-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$319,766
+59,915 vol
$5.34 each
1,168,770
Filed 2022-05-10 16:55
Tx date 2022-04-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$341,837
+63,715 vol
$5.37 each
1,108,855
Filed 2022-05-10 16:26
Tx date 2022-04-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$170,245
+31,815 vol
$5.35 each
1,045,140
Filed 2022-05-10 16:25
Tx date 2022-04-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$142,211
+26,615 vol
$5.34 each
1,013,325
Filed 2022-05-10 16:24
Tx date 2022-04-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$95,477
+17,815 vol
$5.36 each
986,710
Filed 2022-05-10 16:24
Tx date 2022-04-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$159,856
+29,915 vol
$5.34 each
968,895
Filed 2022-05-10 16:23
Tx date 2022-04-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$135,436
+25,415 vol
$5.33 each
938,980
Filed 2022-05-10 16:22
Tx date 2022-04-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$276,686
+51,815 vol
$5.34 each
913,565
Filed 2022-05-10 16:21
Tx date 2022-04-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$309,914
+58,415 vol
$5.31 each
861,750
Filed 2022-05-10 16:20
Tx date 2022-04-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$201,067
+37,915 vol
$5.30 each
803,335
Filed 2022-05-10 16:19
Tx date 2022-04-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$217,813
+40,715 vol
$5.35 each
765,420
Filed 2022-05-10 16:18
Tx date 2022-04-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$149,551
+27,915 vol
$5.36 each
724,705
Filed 2022-05-10 16:17
Tx date 2022-04-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$288,385
+54,215 vol
$5.32 each
696,790
Filed 2022-05-10 16:16
Tx date 2022-04-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$426,511
+80,015 vol
$5.33 each
642,575
Filed 2022-05-10 16:15
Tx date 2022-04-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$239,326
+45,515 vol
$5.26 each
562,560
Filed 2022-05-10 16:14
Tx date 2022-04-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,188
+36,515 vol
$5.21 each
517,045
Filed 2022-04-27 10:27
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$43,748
+8,397 vol
$5.21 each
8,397
Filed 2022-04-27 10:26
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$21,876
+4,199 vol
$5.21 each
4,199
Filed 2022-04-27 10:24
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
4,852
Filed 2022-04-27 10:23
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
2,426
Filed 2022-04-27 10:21
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
4,658
Filed 2022-04-27 10:20
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
2,329
Filed 2022-01-06 16:05
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
Filed 2022-01-06 16:05
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
Filed 2022-01-06 16:03
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$21,876
+4,199 vol
$5.21 each
Filed 2022-01-06 16:02
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$43,748
+8,397 vol
$5.21 each
Filed 2022-01-06 16:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2022-01-06 16:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 14:04
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$43,748
+8,397 vol
$5.21 each
Filed 2021-12-10 14:03
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$21,876
+4,199 vol
$5.21 each
Filed 2021-12-10 14:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
Filed 2021-12-10 13:58
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-04-17 19:16
Tx date 2022-04-13
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,070
+1,900 vol
$5.30 each
6,115
Filed 2022-04-14 18:15
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$6,240
+1,200 vol
$5.20 each
22,700
Filed 2022-04-14 17:55
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$100,032
+19,200 vol
$5.21 each
727,284
Filed 2022-04-14 17:53
Tx date 2022-01-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$95,040
+18,000 vol
$5.28 each
40,500
Filed 2022-04-14 17:35
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$98,990
+19,000 vol
$5.21 each
Filed 2022-04-14 17:34
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$100,032
+19,200 vol
$5.21 each
Filed 2022-04-14 17:02
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$100,032
+19,200 vol
$5.21 each
Filed 2022-04-14 09:47
Tx date 2020-09-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,500
+414 vol
$6.04 each
46,128
Filed 2022-04-14 09:19
Tx date 2020-09-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,918
+414 vol
$7.05 each
Filed 2022-01-04 22:04
Tx date 2022-01-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$95,040
+18,000 vol
$5.28 each
Filed 2021-12-06 09:25
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,200
+1,000 vol
$5.20 each
Filed 2021-12-06 09:24
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$100,032
+19,200 vol
$5.21 each
Filed 2022-04-13 12:34
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$250,000
+25,000 vol
$10.00 each
Filed 2022-04-13 12:33
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$360,000
+45,000 vol
$8.00 each
Filed 2022-04-13 12:29
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$99,452
+18,800 vol
$5.29 each
21,685,933
Filed 2022-04-13 12:19
Tx date 2022-04-08
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$532.00
+100 vol
$5.32 each
267,764
Filed 2022-04-13 12:18
Tx date 2022-04-08
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$267.00
+50 vol
$5.34 each
267,664
Filed 2022-04-13 12:14
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$89,590
+17,000 vol
$5.27 each
72,714
Filed 2022-01-03 18:37
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$250,000
+25,000 vol
$10.00 each
Filed 2022-01-03 18:36
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$360,000
+45,000 vol
$8.00 each
Filed 2021-11-22 22:19
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
Filed 2021-01-13 16:05
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,699
+10,000 vol
$5.27 each
Filed 2022-04-08 10:54
Tx date 2022-04-06
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,120
+400 vol
$5.30 each
11,800
Filed 2022-04-08 10:54
Tx date 2022-04-06
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,620
+2,000 vol
$5.31 each
11,400
Filed 2022-04-08 10:54
Tx date 2022-04-06
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,942
+1,500 vol
$5.29 each
9,400
Filed 2022-04-08 10:53
Tx date 2022-04-06
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,120
+400 vol
$5.30 each
7,900
Filed 2022-04-08 10:53
Tx date 2022-04-06
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$531.00
+100 vol
$5.31 each
7,500
Filed 2022-04-08 10:53
Tx date 2022-04-06
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,600
+2,000 vol
$5.30 each
7,400
Filed 2022-04-08 10:52
Tx date 2022-04-06
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,161
+600 vol
$5.27 each
5,400
Filed 2022-04-04 19:51
Tx date 2022-03-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-496,565 vol
480,530
Filed 2022-04-04 19:50
Tx date 2022-03-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$286,189
+54,915 vol
$5.21 each
977,095
Filed 2022-04-04 19:50
Tx date 2022-03-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,232,478
+425,615 vol
$5.25 each
922,180
Filed 2022-04-04 19:49
Tx date 2022-03-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$417,574
+80,015 vol
$5.22 each
496,565
Filed 2022-04-04 19:49
Tx date 2022-03-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$413,101
+80,015 vol
$5.16 each
416,550
Filed 2022-04-04 19:48
Tx date 2022-03-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$414,429
+80,015 vol
$5.18 each
336,535
Filed 2022-04-04 19:47
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$421,615
+80,015 vol
$5.27 each
256,520
Filed 2022-04-04 19:46
Tx date 2022-03-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$300,248
+55,615 vol
$5.40 each
176,505
Filed 2022-04-04 19:46
Tx date 2022-03-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$298,161
+55,215 vol
$5.40 each
120,890
Filed 2022-04-04 19:45
Tx date 2022-03-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$29,762
+5,515 vol
$5.40 each
65,675
Filed 2022-04-04 19:44
Tx date 2022-03-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$72,886
+13,515 vol
$5.39 each
60,160
Filed 2022-04-04 19:43
Tx date 2022-03-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$60,511
+11,215 vol
$5.40 each
46,645
Filed 2022-04-04 19:43
Tx date 2022-03-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$93,417
+17,315 vol
$5.40 each
35,430
Filed 2022-03-30 17:01
Tx date 2022-03-25
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-175,000
-20,000 vol
$8.75 each
120,000
Filed 2022-03-30 17:00
Tx date 2022-03-25
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
$-175,000
-20,000 vol
$8.75 each
130,000
Filed 2022-03-30 16:57
Tx date 2022-03-25
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
$-2,537,500
-290,000 vol
$8.75 each
2,179,548
Filed 2022-03-30 16:52
Tx date 2022-03-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
52 - Expiration of options
$-1,181,250
-135,000 vol
$8.75 each
424,758
Filed 2022-03-30 16:06
Tx date 2022-03-30
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$103,600
+20,000 vol
$5.18 each
117,429
Filed 2022-03-29 11:45
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$24,346
+4,673 vol
$5.21 each
4,673
Filed 2022-03-29 11:45
Tx date 2022-01-24
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-29 11:44
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$24,346
+4,673 vol
$5.21 each
4,673
Filed 2022-03-29 11:44
Tx date 2022-01-24
$GUD
Knight Therapeutics Inc.
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-29 11:43
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$24,174
+4,640 vol
$5.21 each
8,461
Filed 2022-03-29 11:43
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$24,174
+4,640 vol
$5.21 each
8,461
Filed 2022-03-29 11:41
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$21,876
+4,199 vol
$5.21 each
4,199
Filed 2022-03-29 11:40
Tx date 2022-03-14
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-29 11:40
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$43,748
+8,397 vol
$5.21 each
8,397
Filed 2022-03-29 11:39
Tx date 2022-03-14
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-29 11:39
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$74,659
+14,330 vol
$5.21 each
14,330
Filed 2022-03-29 11:38
Tx date 2022-03-14
$GUD
Knight Therapeutics Inc.
Bosano, Leopoldo Agustin
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-29 11:37
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$27,430
+5,265 vol
$5.21 each
11,373
Filed 2022-03-29 11:36
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$54,866
+10,531 vol
$5.21 each
16,639
Filed 2022-03-29 11:35
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$93,628
+17,971 vol
$5.21 each
17,971
Filed 2022-03-29 11:35
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2022-03-29 11:32
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$18,683
+3,586 vol
$5.21 each
6,012
Filed 2022-03-29 11:31
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$37,360
+7,171 vol
$5.21 each
12,023
Filed 2022-03-29 11:30
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$63,759
+12,238 vol
$5.21 each
20,423
Filed 2022-03-29 11:24
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$17,938
+3,443 vol
$5.21 each
5,772
Filed 2022-03-29 11:23
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$35,876
+6,886 vol
$5.21 each
11,544
Filed 2022-03-29 11:22
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$61,222
+11,751 vol
$5.21 each
19,609
Filed 2022-03-29 11:21
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$22,752
+4,367 vol
$5.21 each
8,566
Filed 2022-03-29 11:20
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$45,498
+8,733 vol
$5.21 each
17,130
Filed 2022-03-29 11:20
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$77,649
+14,904 vol
$5.21 each
29,069
Filed 2022-03-29 11:18
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$28,436
+5,458 vol
$5.21 each
10,181
Filed 2022-03-29 11:17
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$56,877
+10,917 vol
$5.21 each
20,363
Filed 2022-03-29 11:16
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$97,062
+18,630 vol
$5.21 each
35,009
Filed 2022-03-29 11:14
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$48,124
+9,237 vol
$5.21 each
16,427
Filed 2022-03-29 11:13
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$96,249
+18,474 vol
$5.21 each
32,855
Filed 2022-03-29 11:12
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$164,255
+31,527 vol
$5.21 each
559,758
Filed 2022-03-29 11:04
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options
$153,590
+29,480 vol
$5.21 each
2,469,548
Filed 2022-03-29 10:43
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$164,255
+31,527 vol
$5.21 each
280,009
Filed 2022-03-29 10:30
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$48,124
+9,237 vol
$5.21 each
16,427
Filed 2022-03-29 09:43
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$96,249
+18,474 vol
$5.21 each
32,855
Filed 2022-03-29 09:41
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$413,840
+79,432 vol
$5.21 each
768,819
Filed 2022-03-29 09:37
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$363,751
+69,818 vol
$5.21 each
122,915
Filed 2022-03-29 09:35
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Performance stock Unit
56 - Grant of rights
$135,001
+25,912 vol
$5.21 each
66,399
Filed 2022-03-28 19:47
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Performance stock Unit
56 - Grant of rights
$135,001
+25,912 vol
$5.21 each
Filed 2022-03-28 19:47
Tx date 2022-03-24
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Performance stock Unit
56 - Grant of rights
$135,001
+25,912 vol
$5.21 each
66,399
Filed 2022-03-28 16:48
Tx date 2022-03-22
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$11,214
+2,054 vol
$5.46 each
97,429
Filed 2022-03-28 16:47
Tx date 2022-03-22
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,736
+1,417 vol
$5.46 each
12,364
Filed 2022-03-28 16:43
Tx date 2022-03-22
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,282
+1,700 vol
$5.46 each
123,687
Filed 2022-03-28 16:39
Tx date 2022-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,273
+1,149 vol
$5.46 each
767,508
Filed 2022-03-09 22:30
Tx date 2022-02-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-171,875 vol
18,115
Filed 2022-03-09 22:28
Tx date 2022-02-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$97,777
+18,115 vol
$5.40 each
189,990
Filed 2022-03-09 22:27
Tx date 2022-02-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$124,907
+23,315 vol
$5.36 each
171,875
Filed 2022-03-09 22:26
Tx date 2022-02-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$219,947
+40,815 vol
$5.39 each
148,560
Filed 2022-03-09 22:25
Tx date 2022-02-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$130,018
+24,115 vol
$5.39 each
107,745
Filed 2022-03-09 22:24
Tx date 2022-02-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$193,246
+35,815 vol
$5.40 each
83,630
Filed 2022-02-10 10:03
Tx date 2022-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-585,335 vol
47,815
Filed 2022-02-10 10:03
Tx date 2022-01-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,771
+47,815 vol
$5.37 each
633,150
Filed 2022-02-10 10:02
Tx date 2022-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-585,335 vol
Filed 2022-02-10 09:37
Tx date 2022-01-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,771
+47,815 vol
$5.37 each
633,150
Filed 2022-02-10 09:37
Tx date 2022-01-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,771
+47,815 vol
$5.37 each
Filed 2022-02-09 18:29
Tx date 2022-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-585,335 vol
Filed 2022-02-08 17:31
Tx date 2022-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-633,150 vol
Filed 2022-02-09 18:29
Tx date 2022-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-585,335 vol
0
Filed 2022-02-09 18:28
Tx date 2022-01-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,771
+47,815 vol
$5.37 each
Filed 2022-02-08 17:31
Tx date 2022-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-633,150 vol
Filed 2022-02-08 17:31
Tx date 2022-01-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,771
+47,815 vol
$5.37 each
Filed 2022-02-08 17:31
Tx date 2022-01-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-633,150 vol
0
Filed 2022-02-08 17:31
Tx date 2022-01-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,771
+47,815 vol
$5.37 each
633,150
Filed 2022-02-08 17:30
Tx date 2022-01-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$427,728
+80,015 vol
$5.35 each
585,335
Filed 2022-02-08 17:29
Tx date 2022-01-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$426,511
+80,015 vol
$5.33 each
505,320
Filed 2022-02-08 17:29
Tx date 2022-01-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$424,047
+80,015 vol
$5.30 each
425,305
Filed 2022-02-08 17:28
Tx date 2022-01-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$423,327
+80,015 vol
$5.29 each
345,290
Filed 2022-02-08 17:27
Tx date 2022-01-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$425,407
+80,015 vol
$5.32 each
265,275
Filed 2022-02-08 17:27
Tx date 2022-01-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$413,481
+77,415 vol
$5.34 each
185,260
Filed 2022-02-08 17:26
Tx date 2022-01-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$226,152
+41,915 vol
$5.40 each
107,845
Filed 2022-02-08 17:25
Tx date 2022-01-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$77,732
+14,415 vol
$5.39 each
65,930
Filed 2022-02-08 17:24
Tx date 2022-01-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$143,680
+26,815 vol
$5.36 each
51,515
Filed 2022-02-08 17:23
Tx date 2022-01-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$131,317
+24,700 vol
$5.32 each
24,700
Filed 2022-01-28 10:51
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
21,685,133
Filed 2021-11-22 16:52
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
Filed 2022-01-19 14:29
Tx date 2021-11-19
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$80,850
+15,000 vol
$5.39 each
260,614
Filed 2021-11-19 13:52
Tx date 2021-11-19
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$80,850
+15,000 vol
$5.39 each
Filed 2022-01-06 21:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$43,053
+8,185 vol
$5.26 each
8,185
Filed 2022-01-06 21:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$41,333
+7,858 vol
$5.26 each
7,858
Filed 2022-01-06 21:49
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$74,507
+14,165 vol
$5.26 each
14,165
Filed 2022-01-06 16:05
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
2,329
Filed 2022-01-06 16:05
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
4,658
Filed 2022-01-06 16:03
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$21,876
+4,199 vol
$5.21 each
4,199
Filed 2022-01-06 16:02
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$43,748
+8,397 vol
$5.21 each
8,397
Filed 2022-01-06 16:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
4,852
Filed 2022-01-06 16:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
2,426
Filed 2022-01-06 15:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2022-01-06 15:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
8,888
Filed 2022-01-06 15:50
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$44,883
+8,533 vol
$5.26 each
8,533
Filed 2022-01-06 15:50
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$44,883
+8,533 vol
$5.26 each
Filed 2022-01-06 15:48
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$80,904
+15,381 vol
$5.26 each
15,381
Filed 2022-01-06 15:48
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$80,904
+15,381 vol
$5.26 each
Filed 2021-12-10 14:04
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$43,748
+8,397 vol
$5.21 each
Filed 2021-12-10 14:03
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$21,876
+4,199 vol
$5.21 each
Filed 2021-12-10 14:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$80,904
+15,381 vol
$5.26 each
Filed 2021-12-10 14:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$80,904
+15,381 vol
$5.26 each
Filed 2021-12-10 14:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
Filed 2021-12-10 13:58
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
Filed 2021-12-10 13:55
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$44,883
+8,533 vol
$5.26 each
Filed 2021-12-10 13:55
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$44,883
+8,533 vol
$5.26 each
Filed 2021-12-10 13:53
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2021-12-10 13:53
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2022-01-05 20:29
Tx date 2021-12-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,021,080 vol
0
Filed 2022-01-05 20:28
Tx date 2021-12-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$170,146
+32,415 vol
$5.25 each
1,021,080
Filed 2022-01-05 20:27
Tx date 2021-12-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$105,315
+20,100 vol
$5.24 each
988,665
Filed 2022-01-05 20:27
Tx date 2021-12-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$234,346
+44,715 vol
$5.24 each
968,565
Filed 2022-01-05 20:26
Tx date 2021-12-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$161,253
+30,515 vol
$5.28 each
923,850
Filed 2022-01-05 20:25
Tx date 2021-12-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$151,823
+28,915 vol
$5.25 each
893,335
Filed 2022-01-05 20:25
Tx date 2021-12-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$218,373
+41,715 vol
$5.23 each
864,420
Filed 2022-01-05 20:24
Tx date 2021-12-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$135,753
+25,915 vol
$5.24 each
822,705
Filed 2022-01-05 20:23
Tx date 2021-12-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$298,529
+57,415 vol
$5.20 each
716,775
Filed 2022-01-05 20:22
Tx date 2021-12-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$419,454
+80,015 vol
$5.24 each
796,790
Filed 2022-01-05 20:21
Tx date 2021-12-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$415,629
+80,015 vol
$5.19 each
659,360
Filed 2022-01-05 20:19
Tx date 2021-12-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$311,738
+59,615 vol
$5.23 each
579,345
Filed 2022-01-05 20:19
Tx date 2021-12-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$54,623
+10,400 vol
$5.25 each
519,730
Filed 2022-01-05 20:18
Tx date 2021-12-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,072
+36,315 vol
$5.23 each
509,330
Filed 2022-01-05 20:17
Tx date 2021-12-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$389,646
+74,615 vol
$5.22 each
473,015
Filed 2022-01-05 20:16
Tx date 2021-12-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$418,960
+80,000 vol
$5.24 each
398,400
Filed 2022-01-05 20:15
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$294,313
+56,200 vol
$5.24 each
318,400
Filed 2022-01-05 20:14
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$353,692
+67,800 vol
$5.22 each
262,200
Filed 2022-01-05 20:13
Tx date 2021-12-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$286,437
+54,600 vol
$5.25 each
194,400
Filed 2022-01-05 20:12
Tx date 2021-12-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$362,241
+68,900 vol
$5.26 each
139,800
Filed 2022-01-04 22:04
Tx date 2022-01-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$95,040
+18,000 vol
$5.28 each
59,700
Filed 2022-01-04 14:06
Tx date 2022-01-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,883
+1,300 vol
$5.29 each
766,359
Filed 2022-01-03 21:27
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,260
+1,000 vol
$5.26 each
21,667,133
Filed 2022-01-03 18:46
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,280
+1,000 vol
$5.28 each
21,667,133
Filed 2022-01-03 18:46
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,280
+1,000 vol
$5.28 each
Filed 2022-01-03 18:45
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$52,699
+10,000 vol
$5.27 each
21,666,133
Filed 2022-01-03 18:44
Tx date 2021-01-06
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,058
+200 vol
$5.29 each
21,656,133
Filed 2022-01-03 18:44
Tx date 2020-12-08
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$53,300
+10,000 vol
$5.33 each
21,655,933
Filed 2022-01-03 18:43
Tx date 2020-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$13,250
+2,500 vol
$5.30 each
21,645,933
Filed 2022-01-03 18:42
Tx date 2020-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$53,300
+10,000 vol
$5.33 each
21,643,433
Filed 2022-01-03 18:41
Tx date 2019-06-21
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$91,080
+12,000 vol
$7.59 each
21,633,433
Filed 2022-01-03 18:40
Tx date 2019-05-21
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$73,900
+10,000 vol
$7.39 each
21,621,433
Filed 2022-01-03 18:39
Tx date 2019-03-26
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$36,650
+5,000 vol
$7.33 each
21,611,433
Filed 2022-01-03 18:38
Tx date 2019-03-25
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$96,888
+13,200 vol
$7.34 each
21,606,433
Filed 2022-01-03 18:37
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$250,000
+25,000 vol
$10.00 each
21,593,233
Filed 2022-01-03 18:36
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$360,000
+45,000 vol
$8.00 each
21,568,233
Filed 2021-12-23 15:44
Tx date 2021-12-23
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,864
+3,600 vol
$5.24 each
765,059
Filed 2021-12-17 18:27
Tx date 2021-12-15
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,996
+1,915 vol
$5.22 each
1,915
Filed 2021-12-17 18:26
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-17 18:24
Tx date 2021-12-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,470
+2,389 vol
$5.22 each
95,375
Filed 2021-12-17 18:23
Tx date 2021-12-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,831
+734 vol
$5.22 each
10,947
Filed 2021-12-17 18:21
Tx date 2021-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,278
+1,969 vol
$5.22 each
121,987
Filed 2021-12-17 18:19
Tx date 2021-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,699
+1,475 vol
$5.22 each
761,459
Filed 2021-12-15 14:45
Tx date 2021-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$93,060
+18,000 vol
$5.17 each
759,984
Filed 2021-12-14 15:49
Tx date 2021-12-14
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$147,345
+28,500 vol
$5.17 each
741,984
Filed 2021-12-14 15:49
Tx date 2021-12-14
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$27,972
+5,400 vol
$5.18 each
713,484
Filed 2021-12-14 14:00
Tx date 2021-12-14
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$47,840
+9,200 vol
$5.20 each
92,986
Filed 2021-12-13 21:58
Tx date 2021-12-13
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$82,160
+15,800 vol
$5.20 each
83,786
Filed 2021-12-10 14:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
528,231
Filed 2021-12-10 14:09
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
248,482
Filed 2021-12-10 14:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,374 vol
689,387
Filed 2021-12-10 14:06
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
2,440,068
Filed 2021-12-10 14:04
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$43,748
+8,397 vol
$5.21 each
8,397
Filed 2021-12-10 14:03
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 14:03
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$21,876
+4,199 vol
$5.21 each
4,199
Filed 2021-12-10 14:02
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 14:01
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$80,904
+15,381 vol
$5.26 each
15,381
Filed 2021-12-10 14:01
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 14:00
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$24,268
+4,658 vol
$5.21 each
4,658
Filed 2021-12-10 13:59
Tx date 2021-09-13
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 13:58
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,134
+2,329 vol
$5.21 each
2,329
Filed 2021-12-10 13:56
Tx date 2021-09-13
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 13:55
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$44,883
+8,533 vol
$5.26 each
8,533
Filed 2021-12-10 13:54
Tx date 2021-09-13
$GUD
Knight Therapeutics Inc.
Ramos Marques Marino, Daniela
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 13:53
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$46,750
+8,888 vol
$5.26 each
8,888
Filed 2021-12-10 13:52
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
2,426
Filed 2021-12-10 13:51
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$25,278
+4,852 vol
$5.21 each
4,852
Filed 2021-12-10 13:49
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 13:41
Tx date 2021-12-06
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$12,639
+2,426 vol
$5.21 each
Filed 2021-12-10 13:28
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 13:26
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Percario, Mônica Barbanti Cabral de Vasconcellos
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-12-10 13:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-12-10 13:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
528,231
Filed 2021-12-10 13:09
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
Filed 2021-12-10 13:09
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,933 vol
248,482
Filed 2021-12-10 13:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
Filed 2021-12-10 13:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
2,440,068
Filed 2021-12-10 13:06
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,374 vol
Filed 2021-12-10 13:06
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,374 vol
689,387
Filed 2021-12-10 13:01
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
Filed 2021-12-10 13:01
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,798 vol
Filed 2021-05-20 12:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 12:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 12:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 12:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 12:32
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
Filed 2021-05-20 12:32
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
Filed 2021-05-20 12:17
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,811 vol
Filed 2021-05-20 12:17
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,811 vol
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 10:55
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
Filed 2021-05-20 10:55
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
Filed 2021-05-20 10:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,811 vol
Filed 2021-05-20 10:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
50 - Grant of options

+46,811 vol
Filed 2021-12-09 18:42
Tx date 2021-11-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,022
+35,705 vol
$5.32 each
3,267,170
Filed 2021-12-06 21:32
Tx date 2021-11-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,022
+35,705 vol
$5.32 each
Filed 2021-12-06 21:35
Tx date 2021-11-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-3,287,670 vol
70,900
Filed 2021-12-06 21:34
Tx date 2021-11-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$224,980
+42,900 vol
$5.24 each
3,358,570
Filed 2021-12-06 21:33
Tx date 2021-11-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$148,033
+28,000 vol
$5.29 each
3,315,670
Filed 2021-12-06 21:32
Tx date 2021-11-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$108,574
+20,500 vol
$5.30 each
3,287,670
Filed 2021-12-06 21:32
Tx date 2021-11-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$190,022
+35,705 vol
$5.32 each
3,267,170
Filed 2021-12-06 21:31
Tx date 2021-11-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$285,676
+54,000 vol
$5.29 each
3,231,465
Filed 2021-12-06 21:30
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$205,841
+39,100 vol
$5.26 each
3,177,465
Filed 2021-12-06 21:30
Tx date 2021-11-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$374,267
+70,215 vol
$5.33 each
3,138,365
Filed 2021-12-06 21:29
Tx date 2021-11-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$145,829
+27,315 vol
$5.34 each
3,068,150
Filed 2021-12-06 21:28
Tx date 2021-11-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$230,111
+43,215 vol
$5.32 each
3,040,835
Filed 2021-12-06 21:27
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,336,235
+2,151,170 vol
$5.27 each
2,997,620
Filed 2021-12-06 21:27
Tx date 2021-11-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,350
+5,400 vol
$5.25 each
846,450
Filed 2021-12-06 21:26
Tx date 2021-11-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$413,151
+78,715 vol
$5.25 each
841,050
Filed 2021-12-06 21:25
Tx date 2021-11-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$169,246
+32,315 vol
$5.24 each
762,335
Filed 2021-12-06 21:24
Tx date 2021-11-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$69,895
+13,315 vol
$5.25 each
730,020
Filed 2021-12-06 21:23
Tx date 2021-11-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$91,980
+17,615 vol
$5.22 each
716,705
Filed 2021-12-06 21:23
Tx date 2021-11-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$348,836
+67,115 vol
$5.20 each
699,090
Filed 2021-12-06 21:22
Tx date 2021-11-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,387,089
+266,415 vol
$5.21 each
631,975
Filed 2021-12-06 21:21
Tx date 2021-11-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$983,905
+189,515 vol
$5.19 each
365,560
Filed 2021-12-06 21:20
Tx date 2021-11-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$199,067
+38,115 vol
$5.22 each
176,045
Filed 2021-12-06 09:25
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$5,200
+1,000 vol
$5.20 each
41,700
Filed 2021-12-06 09:24
Tx date 2021-12-03
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$100,032
+19,200 vol
$5.21 each
40,700
Filed 2021-11-24 10:04
Tx date 2021-11-23
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$183,573
+35,100 vol
$5.23 each
708,084
Filed 2021-11-24 10:01
Tx date 2021-11-23
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$39,375
+7,500 vol
$5.25 each
67,986
Filed 2021-11-22 22:19
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
21,685,133
Filed 2021-11-22 16:55
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,184
+800 vol
$5.23 each
672,984
Filed 2021-11-22 16:52
Tx date 2021-11-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$95,220
+18,000 vol
$5.29 each
21,541,233
Filed 2021-11-19 18:02
Tx date 2021-11-16
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$34,130
+6,300 vol
$5.42 each
245,614
Filed 2021-11-19 18:01
Tx date 2021-11-16
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,459
+3,600 vol
$5.41 each
239,314
Filed 2021-11-19 17:48
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,375
+10,000 vol
$5.24 each
235,714
Filed 2021-11-19 17:48
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,187
+25,000 vol
$5.29 each
225,714
Filed 2021-11-19 17:48
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,187
+25,000 vol
$5.29 each
200,714
Filed 2021-11-19 17:47
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$70,157
+13,300 vol
$5.28 each
175,614
Filed 2021-11-19 17:46
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,250
+10,000 vol
$5.22 each
105,714
Filed 2021-11-19 17:45
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,375
+10,000 vol
$5.24 each
Filed 2021-11-19 17:44
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,187
+25,000 vol
$5.29 each
Filed 2021-11-19 17:44
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,187
+25,000 vol
$5.29 each
Filed 2021-11-19 17:43
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$70,157
+13,300 vol
$5.28 each
Filed 2021-11-19 17:42
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,250
+10,000 vol
$5.22 each
Filed 2021-11-19 13:55
Tx date 2021-11-16
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$34,146
+6,300 vol
$5.42 each
Filed 2021-11-19 13:55
Tx date 2021-11-16
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$34,146
+6,300 vol
$5.42 each
245,614
Filed 2021-11-19 13:55
Tx date 2021-11-16
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,476
+3,600 vol
$5.41 each
239,314
Filed 2021-11-19 13:55
Tx date 2021-11-16
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$19,476
+3,600 vol
$5.41 each
Filed 2021-11-19 13:52
Tx date 2021-11-19
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$80,850
+15,000 vol
$5.39 each
260,614
Filed 2021-11-19 13:45
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,400
+10,000 vol
$5.24 each
235,714
Filed 2021-11-19 13:45
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,400
+10,000 vol
$5.24 each
Filed 2021-11-19 13:45
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,250
+25,000 vol
$5.29 each
225,714
Filed 2021-11-19 13:45
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,250
+25,000 vol
$5.29 each
Filed 2021-11-19 13:44
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,250
+25,000 vol
$5.29 each
Filed 2021-11-19 13:44
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$132,250
+25,000 vol
$5.29 each
200,714
Filed 2021-11-19 13:44
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$528.00
+100 vol
$5.28 each
175,714
Filed 2021-11-19 13:44
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$70,224
+13,300 vol
$5.28 each
Filed 2021-11-19 13:44
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$70,224
+13,300 vol
$5.28 each
175,614
Filed 2021-11-19 13:43
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$16,275
+3,100 vol
$5.25 each
162,314
Filed 2021-11-19 13:43
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$70,875
+13,500 vol
$5.25 each
159,214
Filed 2021-11-19 13:43
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$210,000
+40,000 vol
$5.25 each
145,714
Filed 2021-11-19 13:42
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,300
+10,000 vol
$5.23 each
Filed 2021-11-19 13:42
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,300
+10,000 vol
$5.23 each
105,714
Filed 2021-11-19 13:41
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,000
+10,000 vol
$5.20 each
95,714
Filed 2021-11-19 13:30
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$94,320
+18,000 vol
$5.24 each
672,184
Filed 2021-11-15 14:23
Tx date 2021-11-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$94,500
+18,000 vol
$5.25 each
654,184
Filed 2021-11-09 10:17
Tx date 2021-10-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-168,675 vol
137,930
Filed 2021-11-07 19:16
Tx date 2021-10-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-306,605 vol
Filed 2021-11-07 19:16
Tx date 2021-10-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-306,605 vol
0
Filed 2021-11-07 19:12
Tx date 2021-10-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,250
+1,000 vol
$5.25 each
23,415
Filed 2021-11-07 19:07
Tx date 2021-10-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$297,144
+57,915 vol
$5.13 each
306,605
Filed 2021-11-07 19:07
Tx date 2021-10-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$415,653
+80,015 vol
$5.19 each
248,690
Filed 2021-11-07 19:06
Tx date 2021-10-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$417,046
+80,015 vol
$5.21 each
168,675
Filed 2021-11-07 19:05
Tx date 2021-10-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$286,614
+54,615 vol
$5.25 each
88,660
Filed 2021-11-07 19:04
Tx date 2021-10-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$32,079
+6,115 vol
$5.25 each
34,045
Filed 2021-11-07 19:03
Tx date 2021-10-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$23,703
+4,515 vol
$5.25 each
27,930
Filed 2021-11-07 19:03
Tx date 2021-10-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
$5,250
+1,000 vol
$5.25 each
Filed 2021-11-07 19:02
Tx date 2021-10-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$117,636
+22,415 vol
$5.25 each
22,415
Filed 2021-10-06 12:42
Tx date 2021-09-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,398
+7,315 vol
$5.25 each
7,315
Filed 2021-10-06 12:40
Tx date 2021-09-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,244
+6,915 vol
$5.24 each
231,990
Filed 2021-10-06 12:39
Tx date 2021-09-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$298,785
+57,115 vol
$5.23 each
225,075
Filed 2021-10-06 12:39
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$417,886
+80,015 vol
$5.22 each
167,960
Filed 2021-10-06 12:39
Tx date 2021-09-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$418,502
+80,015 vol
$5.23 each
87,945
Filed 2021-10-06 12:38
Tx date 2021-09-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,219
+615 vol
$5.24 each
7,930
Filed 2021-10-06 12:38
Tx date 2021-09-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,398
+7,315 vol
$5.25 each
Filed 2021-10-06 12:34
Tx date 2021-09-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-231,990 vol
0
Filed 2021-10-06 12:30
Tx date 2021-09-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,244
+6,915 vol
$5.24 each
Filed 2021-10-06 12:29
Tx date 2021-09-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$298,785
+57,115 vol
$5.23 each
Filed 2021-10-06 12:28
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$417,886
+80,015 vol
$5.22 each
Filed 2021-10-06 12:27
Tx date 2021-09-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$418,502
+80,015 vol
$5.23 each
Filed 2021-10-06 12:26
Tx date 2021-09-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,219
+615 vol
$5.24 each
Filed 2021-10-06 12:25
Tx date 2021-09-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,398
+7,315 vol
$5.25 each
Filed 2021-09-21 16:46
Tx date 2021-09-21
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,560
+300 vol
$5.20 each
10,213
Filed 2021-09-20 17:14
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,120
+600 vol
$5.20 each
9,913
Filed 2021-09-20 12:30
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Noah Ezra Goodman (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$1,036
+200 vol
$5.18 each
300
Filed 2021-09-20 11:38
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$526.00
+100 vol
$5.26 each
4,800
Filed 2021-09-20 11:37
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$518.00
+100 vol
$5.18 each
4,700
Filed 2021-09-20 11:37
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,036
+200 vol
$5.18 each
4,600
Filed 2021-09-20 11:36
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$518.00
+100 vol
$5.18 each
4,400
Filed 2021-09-20 11:36
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,554
+300 vol
$5.18 each
4,300
Filed 2021-09-20 11:36
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$518.00
+100 vol
$5.18 each
4,000
Filed 2021-09-20 11:36
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,036
+200 vol
$5.18 each
3,900
Filed 2021-09-20 11:35
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,036
+200 vol
$5.18 each
3,700
Filed 2021-09-20 11:34
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,036
+200 vol
$5.18 each
3,500
Filed 2021-09-20 11:34
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$518.00
+100 vol
$5.18 each
3,300
Filed 2021-09-20 11:34
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,036
+200 vol
$5.18 each
3,200
Filed 2021-09-20 11:33
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,360
+2,000 vol
$5.18 each
3,000
Filed 2021-09-20 11:33
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,136
+800 vol
$5.17 each
1,000
Filed 2021-09-20 11:33
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$517.00
+100 vol
$5.17 each
200
Filed 2021-09-20 11:32
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$517.00
+100 vol
$5.17 each
100
Filed 2021-09-20 11:31
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-20 11:28
Tx date 2021-09-20
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$103,600
+20,000 vol
$5.18 each
21,500
Filed 2021-09-17 17:47
Tx date 2021-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$12,754
+2,402 vol
$5.31 each
60,486
Filed 2021-09-17 17:44
Tx date 2021-09-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,651
+876 vol
$5.31 each
9,313
Filed 2021-09-17 17:43
Tx date 2021-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,535
+1,984 vol
$5.31 each
120,018
Filed 2021-09-17 17:40
Tx date 2021-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,598
+1,996 vol
$5.31 each
636,184
Filed 2021-09-15 09:49
Tx date 2021-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,500
+2,000 vol
$5.25 each
58,084
Filed 2021-09-06 14:11
Tx date 2021-08-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$408,468
+80,015 vol
$5.10 each
213,845
Filed 2021-09-06 14:07
Tx date 2021-08-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-645,150 vol
0
Filed 2021-09-06 14:05
Tx date 2021-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$283,599
+55,115 vol
$5.15 each
645,150
Filed 2021-09-06 14:04
Tx date 2021-08-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$377,670
+72,215 vol
$5.23 each
590,035
Filed 2021-09-06 14:03
Tx date 2021-08-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$197,117
+37,615 vol
$5.24 each
517,820
Filed 2021-09-06 14:03
Tx date 2021-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$176,235
+33,715 vol
$5.23 each
480,205
Filed 2021-09-06 14:01
Tx date 2021-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$375,194
+72,615 vol
$5.17 each
446,490
Filed 2021-09-06 14:00
Tx date 2021-08-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$411,725
+80,015 vol
$5.15 each
373,875
Filed 2021-09-06 13:59
Tx date 2021-08-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$406,460
+80,015 vol
$5.08 each
293,860
Filed 2021-09-03 17:16
Tx date 2021-08-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$408,468
+80,015 vol
$5.10 each
Filed 2021-09-03 17:16
Tx date 2021-08-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$408,468
+80,015 vol
$5.10 each
213,845
Filed 2021-09-03 09:24
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
3,968
Filed 2021-09-03 09:23
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
3,968
Filed 2021-09-03 09:21
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
3,821
Filed 2021-09-03 09:20
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
3,821
Filed 2021-09-03 09:19
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
4,100
Filed 2021-09-03 09:18
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
4,100
Filed 2021-09-03 09:12
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
4,723
Filed 2021-09-03 09:11
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
9,446
Filed 2021-09-03 09:10
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
2,653
Filed 2021-09-03 09:07
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
2,653
Filed 2021-09-02 16:31
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:29
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:27
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:26
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:25
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:24
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:21
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:19
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:18
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 16:15
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-09-02 18:24
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Emblem, Susan Caroline
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
3,400
Filed 2021-09-02 18:21
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
16,379
Filed 2021-09-02 16:31
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
2,654
Filed 2021-09-02 16:30
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
6,108
Filed 2021-09-02 16:29
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
3,969
Filed 2021-09-02 16:27
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
3,822
Filed 2021-09-02 16:26
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
4,101
Filed 2021-09-02 16:25
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
4,724
Filed 2021-09-02 16:24
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bussab, Adriano
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
2,654
Filed 2021-09-02 16:22
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Saverio, Stephani
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
6,108
Filed 2021-09-02 16:21
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Lodola de San Martin, Nicolas Maria
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
3,969
Filed 2021-09-02 16:19
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Montejo, Ricardo Adolfo
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
3,822
Filed 2021-09-02 16:18
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Bertasi, Fernanda Pollo
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
4,101
Filed 2021-09-02 16:15
Tx date 2021-09-01
$GUD
Knight Therapeutics Inc.
Martens, Jeffrey
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
9,447
Filed 2021-08-25 12:02
Tx date 2021-08-24
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,066
+200 vol
$5.33 each
634,188
Filed 2021-08-24 11:20
Tx date 2021-08-24
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,748
+2,200 vol
$5.34 each
633,988
Filed 2021-08-23 20:24
Tx date 2021-08-23
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$23,048
+4,300 vol
$5.36 each
631,788
Filed 2021-08-18 14:20
Tx date 2021-08-18
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$109,800
+20,000 vol
$5.49 each
85,714
Filed 2021-08-18 14:16
Tx date 2021-08-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Dana Caplan (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$8,084
+1,500 vol
$5.39 each
1,500
Filed 2021-08-18 14:15
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Dana Caplan (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-18 14:13
Tx date 2021-08-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$97,200
+18,000 vol
$5.40 each
627,488
Filed 2021-08-18 14:12
Tx date 2021-08-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$97,020
+18,000 vol
$5.39 each
609,488
Filed 2021-08-04 20:03
Tx date 2021-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-2,562,727 vol
133,830
Filed 2021-08-04 20:03
Tx date 2021-07-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$451,446
+86,345 vol
$5.23 each
844,325
Filed 2021-08-04 20:02
Tx date 2021-07-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$450,444
+86,345 vol
$5.22 each
757,980
Filed 2021-08-04 20:01
Tx date 2021-07-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$452,965
+86,345 vol
$5.25 each
671,635
Filed 2021-08-04 20:00
Tx date 2021-07-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$323,709
+61,700 vol
$5.25 each
585,290
Filed 2021-08-04 19:59
Tx date 2021-07-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,925
+1,700 vol
$5.25 each
523,590
Filed 2021-08-04 19:58
Tx date 2021-07-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$236,152
+45,045 vol
$5.24 each
521,890
Filed 2021-08-04 19:55
Tx date 2021-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$409,980
+80,015 vol
$5.12 each
2,375,822
Filed 2021-08-04 19:54
Tx date 2021-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$271,189
+53,815 vol
$5.04 each
2,295,807
Filed 2021-08-04 19:48
Tx date 2021-07-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$216,889
+42,715 vol
$5.08 each
2,241,992
Filed 2021-08-04 19:47
Tx date 2021-07-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$192,078
+37,715 vol
$5.09 each
2,199,277
Filed 2021-08-04 19:44
Tx date 2021-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$300,860
+58,515 vol
$5.14 each
2,161,562
Filed 2021-08-04 19:42
Tx date 2021-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$278,996
+54,415 vol
$5.13 each
2,103,047
Filed 2021-08-04 19:41
Tx date 2021-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$411,429
+80,015 vol
$5.14 each
2,048,632
Filed 2021-08-04 19:39
Tx date 2021-07-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,933,683
+760,882 vol
$5.17 each
1,968,617
Filed 2021-08-04 19:37
Tx date 2021-07-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$411,437
+80,015 vol
$5.14 each
1,207,735
Filed 2021-08-04 19:35
Tx date 2021-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$408,076
+80,015 vol
$5.10 each
1,127,720
Filed 2021-08-04 19:34
Tx date 2021-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,751,603
+524,115 vol
$5.25 each
1,047,705
Filed 2021-07-14 20:28
Tx date 2021-07-14
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$95,400
+18,000 vol
$5.30 each
591,488
Filed 2021-07-07 15:30
Tx date 2021-07-07
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$94,320
+18,000 vol
$5.24 each
573,488
Filed 2021-07-02 19:06
Tx date 2021-06-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-196,770 vol
476,845
Filed 2021-07-02 18:55
Tx date 2021-06-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$348,158
+66,345 vol
$5.25 each
673,615
Filed 2021-07-02 18:50
Tx date 2021-06-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,155,125
+410,500 vol
$5.25 each
607,270
Filed 2021-07-02 18:49
Tx date 2021-06-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$79,179
+15,100 vol
$5.24 each
196,770
Filed 2021-07-02 18:47
Tx date 2021-06-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$188,168
+35,845 vol
$5.25 each
181,670
Filed 2021-07-02 18:46
Tx date 2021-06-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,066
+6,300 vol
$5.25 each
145,825
Filed 2021-07-02 18:44
Tx date 2021-06-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$142,800
+27,200 vol
$5.25 each
139,525
Filed 2021-07-02 18:42
Tx date 2021-06-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$97,361
+18,545 vol
$5.25 each
112,325
Filed 2021-07-02 18:40
Tx date 2021-06-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$98,353
+18,745 vol
$5.25 each
93,780
Filed 2021-07-02 18:39
Tx date 2021-06-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$360,152
+68,645 vol
$5.25 each
75,035
Filed 2021-07-02 18:37
Tx date 2021-06-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,056
+5,345 vol
$5.25 each
6,390
Filed 2021-07-02 18:34
Tx date 2021-06-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,486
+1,045 vol
$5.25 each
1,045
Filed 2021-07-02 17:03
Tx date 2021-07-02
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,956
+1,900 vol
$5.24 each
56,084
Filed 2021-07-02 17:00
Tx date 2021-07-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$94,320
+18,000 vol
$5.24 each
555,488
Filed 2021-06-18 19:53
Tx date 2021-06-15
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,996
+1,915 vol
$5.22 each
4,215
Filed 2021-06-18 19:52
Tx date 2021-06-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,529
+1,998 vol
$5.27 each
54,184
Filed 2021-06-18 19:51
Tx date 2021-06-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,857
+732 vol
$5.27 each
8,437
Filed 2021-06-18 19:49
Tx date 2021-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,795
+1,669 vol
$5.27 each
118,034
Filed 2021-06-18 19:47
Tx date 2021-06-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,047
+1,527 vol
$5.27 each
537,488
Filed 2021-06-08 16:12
Tx date 2021-05-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-163,835 vol
0
Filed 2021-06-08 16:09
Tx date 2021-05-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$333,781
+63,845 vol
$5.23 each
163,835
Filed 2021-06-08 16:07
Tx date 2021-05-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$388,445
+74,345 vol
$5.22 each
99,990
Filed 2021-06-08 16:04
Tx date 2021-05-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$132,187
+25,645 vol
$5.15 each
25,645
Filed 2021-05-27 11:18
Tx date 2021-05-27
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,430
+2,000 vol
$5.21 each
2,000
Filed 2021-05-27 11:15
Tx date 2019-05-07
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-26 15:04
Tx date 2021-05-26
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,015
+1,915 vol
$5.23 each
52,186
Filed 2021-05-26 11:27
Tx date 2021-05-26
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$176,400
+33,600 vol
$5.25 each
535,961
Filed 2021-05-26 11:08
Tx date 2021-05-25
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,600
+2,400 vol
$5.25 each
502,361
Filed 2021-05-26 10:43
Tx date 2021-05-26
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$176,400
+33,600 vol
$5.25 each
Filed 2021-05-26 10:43
Tx date 2021-05-26
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$176,400
+33,600 vol
$5.25 each
536,261
Filed 2021-05-26 10:41
Tx date 2021-05-25
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,175
+2,700 vol
$5.25 each
502,661
Filed 2021-05-26 10:41
Tx date 2021-05-25
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$14,175
+2,700 vol
$5.25 each
Filed 2021-05-24 15:40
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-24 15:38
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-24 15:37
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-24 15:35
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-24 15:34
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights
$45,002
+7,965 vol
$5.65 each
7,965
Filed 2021-05-24 15:33
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$299,998
+53,097 vol
$5.65 each
53,097
Filed 2021-05-24 15:32
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$228,751
+40,487 vol
$5.65 each
40,487
Filed 2021-05-24 15:30
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-24 15:29
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-24 15:27
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
56 - Grant of rights
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-24 15:25
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
56 - Grant of rights
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-20 13:15
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 13:13
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 13:11
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 13:04
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 13:01
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$45,002
+7,965 vol
$5.65 each
Filed 2021-05-20 12:57
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 12:54
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 12:47
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 12:46
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 12:36
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$299,998
+53,097 vol
$5.65 each
Filed 2021-05-20 11:33
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$228,751
+40,487 vol
$5.65 each
Filed 2021-05-20 11:31
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:30
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:29
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:27
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:24
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$45,002
+7,965 vol
$5.65 each
Filed 2021-05-20 11:19
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 11:18
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 11:12
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 11:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 10:57
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$299,998
+53,097 vol
$5.65 each
Filed 2021-05-20 10:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other

+40,487 vol
Filed 2021-05-20 13:15
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-20 13:14
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 13:13
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-20 13:13
Tx date 2019-05-07
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 13:11
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-20 13:11
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 13:10
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 13:06
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
85,000
Filed 2021-05-20 13:04
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-20 13:04
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 13:03
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2021-05-20 13:01
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$45,002
+7,965 vol
$5.65 each
7,965
Filed 2021-05-20 13:00
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 12:59
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2021-05-20 12:57
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-20 12:56
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 12:54
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-20 12:53
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 12:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
528,238
Filed 2021-05-20 12:47
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-20 12:46
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 12:46
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-20 12:45
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 12:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
248,489
Filed 2021-05-20 12:36
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$299,998
+53,097 vol
$5.65 each
53,097
Filed 2021-05-20 12:33
Tx date 2016-08-31
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 12:32
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
689,404
Filed 2021-05-20 12:20
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,186,470 vol
1,186,470
Filed 2021-05-20 12:17
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+46,811 vol
2,440,081
Filed 2021-05-20 12:09
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:33
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$228,751
+40,487 vol
$5.65 each
40,487
Filed 2021-05-20 11:31
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:31
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-20 11:31
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:31
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:30
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:30
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-20 11:29
Tx date 2019-05-07
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:29
Tx date 2019-05-07
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:29
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-20 11:29
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:28
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:28
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:27
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
5,310
Filed 2021-05-20 11:27
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:26
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:26
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:26
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
Filed 2021-05-20 11:26
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2021-05-20 11:24
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$45,002
+7,965 vol
$5.65 each
7,965
Filed 2021-05-20 11:24
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other
$45,002
+7,965 vol
$5.65 each
Filed 2021-05-20 11:23
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:23
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:22
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
Filed 2021-05-20 11:22
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2021-05-20 11:19
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-20 11:19
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 11:18
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:18
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:18
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 11:18
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-20 11:17
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:17
Tx date 2014-08-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
528,238
Filed 2021-05-20 11:16
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:15
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
85,000
Filed 2021-05-20 11:15
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
Filed 2021-05-20 11:12
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
14,381
Filed 2021-05-20 11:12
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$81,252
+14,381 vol
$5.65 each
Filed 2021-05-20 11:11
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:11
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
7,190
Filed 2021-05-20 11:10
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
97 - Other
$40,623
+7,190 vol
$5.65 each
Filed 2021-05-20 11:08
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:08
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
Filed 2021-05-20 11:07
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+24,940 vol
248,489
Filed 2021-05-20 10:57
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$299,998
+53,097 vol
$5.65 each
53,097
Filed 2021-05-20 10:57
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other
$299,998
+53,097 vol
$5.65 each
Filed 2021-05-20 10:55
Tx date 2016-08-31
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 10:55
Tx date 2016-08-31
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 10:55
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
689,404
Filed 2021-05-20 10:55
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+61,391 vol
Filed 2021-05-20 10:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other

+40,487 vol
Filed 2021-05-20 10:52
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
97 - Other

+40,487 vol
40,487
Filed 2021-05-20 10:49
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 10:49
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 10:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+46,811 vol
2,440,081
Filed 2021-05-20 10:44
Tx date 2021-05-18
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+46,811 vol
Filed 2021-05-20 10:32
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,186,470 vol
1,186,470
Filed 2021-05-20 10:32
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,186,470 vol
Filed 2020-07-03 16:15
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2014-08-27 18:03
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
Filed 2014-08-27 18:03
Tx date 2014-08-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+85,000 vol
Filed 2014-06-06 15:23
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,186,470 vol
Filed 2014-06-06 15:23
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+1,186,470 vol
Filed 2014-06-05 11:24
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
Filed 2014-06-05 11:24
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
Filed 2014-06-05 11:20
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
Filed 2014-06-05 11:20
Tx date 2014-06-02
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
Filed 2021-05-04 12:20
Tx date 2021-04-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-494,626 vol
0
Filed 2021-05-04 12:15
Tx date 2021-04-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$237,902
+45,821 vol
$5.19 each
494,626
Filed 2021-05-04 12:15
Tx date 2021-04-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$447,134
+86,321 vol
$5.18 each
448,805
Filed 2021-05-04 12:14
Tx date 2021-04-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$68,313
+13,000 vol
$5.25 each
362,484
Filed 2021-05-04 12:13
Tx date 2021-04-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,609
+19,600 vol
$5.29 each
349,484
Filed 2021-05-04 12:10
Tx date 2021-04-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,070
+5,300 vol
$5.30 each
329,884
Filed 2021-05-04 12:09
Tx date 2021-04-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$155,796
+29,400 vol
$5.30 each
324,584
Filed 2021-05-04 12:07
Tx date 2021-04-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$275,538
+52,221 vol
$5.28 each
295,184
Filed 2021-05-04 12:05
Tx date 2021-04-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$455,714
+86,321 vol
$5.28 each
242,963
Filed 2021-05-04 12:04
Tx date 2021-04-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$91,747
+17,321 vol
$5.30 each
156,642
Filed 2021-05-04 12:02
Tx date 2021-04-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$413,080
+78,121 vol
$5.29 each
139,321
Filed 2021-05-04 12:00
Tx date 2021-04-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$286,572
+53,200 vol
$5.39 each
61,200
Filed 2021-04-06 08:44
Tx date 2021-03-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,800
+728 vol
$5.22 each
7,705
Filed 2021-04-06 08:42
Tx date 2021-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,712
+1,669 vol
$5.22 each
116,365
Filed 2021-04-06 08:40
Tx date 2021-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,544
+2,020 vol
$5.22 each
499,961
Filed 2021-04-06 08:33
Tx date 2021-03-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,740
+1,866 vol
$5.22 each
50,271
Filed 2021-04-05 19:30
Tx date 2021-03-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-2,259,583 vol
8,000
Filed 2021-04-05 19:29
Tx date 2021-03-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$43,657
+8,000 vol
$5.46 each
2,267,583
Filed 2021-04-05 19:29
Tx date 2021-03-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$227,241
+41,921 vol
$5.42 each
2,259,583
Filed 2021-04-05 19:28
Tx date 2021-03-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$467,462
+86,321 vol
$5.42 each
2,217,662
Filed 2021-04-05 19:26
Tx date 2021-03-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$450,880
+86,321 vol
$5.22 each
2,131,341
Filed 2021-04-05 19:26
Tx date 2021-03-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,196,868
+439,321 vol
$5.00 each
2,045,020
Filed 2021-04-05 19:25
Tx date 2021-03-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$434,980
+86,321 vol
$5.04 each
1,605,699
Filed 2021-04-05 19:24
Tx date 2021-03-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$439,606
+86,321 vol
$5.09 each
1,519,378
Filed 2021-04-05 19:22
Tx date 2021-03-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$438,312
+86,321 vol
$5.08 each
1,433,057
Filed 2021-04-05 19:21
Tx date 2021-03-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$428,444
+84,621 vol
$5.06 each
1,346,736
Filed 2021-04-05 19:18
Tx date 2021-03-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$426,925
+84,321 vol
$5.06 each
Filed 2021-04-05 19:17
Tx date 2021-03-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$439,641
+86,321 vol
$5.09 each
1,262,115
Filed 2021-04-05 19:16
Tx date 2021-03-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$447,315
+86,321 vol
$5.18 each
1,175,794
Filed 2021-04-05 19:15
Tx date 2021-03-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$452,002
+86,321 vol
$5.24 each
1,089,473
Filed 2021-04-05 19:14
Tx date 2021-03-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$451,320
+86,321 vol
$5.23 each
1,003,152
Filed 2021-04-05 19:13
Tx date 2021-03-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$447,237
+86,321 vol
$5.18 each
916,831
Filed 2021-04-05 19:12
Tx date 2021-03-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$453,832
+86,321 vol
$5.26 each
830,510
Filed 2021-04-05 19:12
Tx date 2021-03-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$342,404
+64,421 vol
$5.32 each
744,189
Filed 2021-04-05 19:11
Tx date 2021-03-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$390,972
+75,521 vol
$5.18 each
679,768
Filed 2021-04-05 19:10
Tx date 2021-03-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$435,316
+86,321 vol
$5.04 each
604,247
Filed 2021-04-05 19:09
Tx date 2021-03-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$432,891
+86,321 vol
$5.01 each
517,926
Filed 2021-04-05 19:07
Tx date 2021-03-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$436,836
+86,321 vol
$5.06 each
431,605
Filed 2021-04-05 19:06
Tx date 2021-03-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$444,803
+86,321 vol
$5.15 each
345,284
Filed 2021-04-05 19:05
Tx date 2021-03-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$448,385
+86,321 vol
$5.19 each
258,963
Filed 2021-03-05 10:32
Tx date 2021-02-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,120,473 vol
172,642
Filed 2021-03-05 10:31
Tx date 2021-02-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$446,072
+86,321 vol
$5.17 each
1,293,115
Filed 2021-03-05 10:30
Tx date 2021-02-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$453,927
+86,321 vol
$5.26 each
1,206,794
Filed 2021-03-05 10:29
Tx date 2021-02-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$452,356
+86,321 vol
$5.24 each
1,120,473
Filed 2021-03-05 10:28
Tx date 2021-02-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$452,365
+86,321 vol
$5.24 each
1,034,152
Filed 2021-03-05 10:27
Tx date 2021-02-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$465,874
+86,321 vol
$5.40 each
947,831
Filed 2021-03-05 10:26
Tx date 2021-02-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$473,522
+86,321 vol
$5.49 each
861,510
Filed 2021-03-05 10:25
Tx date 2021-02-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$473,746
+86,321 vol
$5.49 each
775,189
Filed 2021-03-05 10:24
Tx date 2021-02-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$471,614
+86,321 vol
$5.46 each
688,868
Filed 2021-03-05 10:23
Tx date 2021-02-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$465,451
+86,321 vol
$5.39 each
602,547
Filed 2021-03-05 10:22
Tx date 2021-02-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$460,349
+86,321 vol
$5.33 each
516,226
Filed 2021-03-05 10:21
Tx date 2021-02-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$468,878
+86,321 vol
$5.43 each
429,905
Filed 2021-03-05 10:21
Tx date 2021-02-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$459,077
+84,621 vol
$5.43 each
343,584
Filed 2021-03-05 10:19
Tx date 2021-02-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$461,567
+86,321 vol
$5.35 each
258,963
Filed 2021-02-09 16:25
Tx date 2021-01-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-169,284 vol
172,642
Filed 2021-02-09 16:23
Tx date 2021-01-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$457,501
+86,321 vol
$5.30 each
341,926
Filed 2021-02-09 16:22
Tx date 2021-01-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$462,663
+86,321 vol
$5.36 each
255,605
Filed 2021-02-09 16:20
Tx date 2021-01-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$429,932
+79,221 vol
$5.43 each
169,284
Filed 2021-02-09 16:18
Tx date 2021-01-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$125,458
+22,821 vol
$5.50 each
90,063
Filed 2021-02-09 16:17
Tx date 2021-01-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$93,995
+17,221 vol
$5.46 each
67,242
Filed 2021-02-09 10:13
Tx date 2021-01-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$267,437
+50,021 vol
$5.35 each
50,021
Filed 2021-01-14 15:24
Tx date 2021-01-14
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,650
+500 vol
$5.30 each
51,053
Filed 2021-01-14 15:20
Tx date 2021-01-14
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$23,714
+4,500 vol
$5.27 each
50,553
Filed 2021-01-14 15:17
Tx date 2021-01-14
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$23,714
+4,500 vol
$5.27 each
Filed 2021-01-13 16:34
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$5,260
+1,000 vol
$5.26 each
21,667,133
Filed 2021-01-13 16:33
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,699
+10,000 vol
$5.27 each
21,666,133
Filed 2021-01-13 16:08
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$9,240
+1,750 vol
$5.28 each
48,405
Filed 2021-01-13 16:05
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$52,699
+10,000 vol
$5.27 each
65,714
Filed 2021-01-13 15:59
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$42,240
+8,000 vol
$5.28 each
55,714
Filed 2021-01-13 15:58
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$10,540
+2,000 vol
$5.27 each
47,714
Filed 2021-01-13 15:56
Tx date 2021-01-13
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,120
+2,300 vol
$5.27 each
2,300
Filed 2021-01-13 15:47
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-01-10 21:32
Tx date 2021-01-06
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,058
+200 vol
$5.29 each
21,656,133
Filed 2021-01-07 17:44
Tx date 2020-12-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-8,521 vol
0
Filed 2021-01-07 17:43
Tx date 2020-12-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$44,058
+8,521 vol
$5.17 each
8,521
Filed 2020-12-21 19:01
Tx date 2020-12-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,153
+595 vol
$5.30 each
6,977
Filed 2020-12-21 18:59
Tx date 2020-12-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,352
+1,576 vol
$5.30 each
46,655
Filed 2020-12-21 18:57
Tx date 2020-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,036
+1,705 vol
$5.30 each
497,941
Filed 2020-12-21 18:55
Tx date 2020-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,467
+1,409 vol
$5.30 each
114,696
Filed 2020-12-09 10:30
Tx date 2020-12-08
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$53,300
+10,000 vol
$5.33 each
21,655,933
Filed 2020-12-04 18:08
Tx date 2020-12-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$51,645
+9,800 vol
$5.27 each
496,236
Filed 2020-12-04 09:46
Tx date 2020-12-03
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$13,250
+2,500 vol
$5.30 each
21,645,933
Filed 2020-12-04 09:45
Tx date 2020-12-03
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$53,300
+10,000 vol
$5.33 each
21,643,433
Filed 2020-12-01 15:31
Tx date 2020-11-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-137,800 vol
0
Filed 2020-12-01 15:30
Tx date 2020-11-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$333,600
+62,500 vol
$5.34 each
137,800
Filed 2020-12-01 15:28
Tx date 2020-11-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$399,007
+75,300 vol
$5.30 each
75,300
Filed 2020-11-09 09:11
Tx date 2020-10-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-172,642 vol
0
Filed 2020-10-05 14:52
Tx date 2020-09-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-625,310 vol
172,642
Filed 2020-10-04 19:05
Tx date 2020-09-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$500,696
+86,321 vol
$5.80 each
797,952
Filed 2020-10-04 19:04
Tx date 2020-09-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$507,576
+86,321 vol
$5.88 each
711,631
Filed 2020-10-04 19:03
Tx date 2020-09-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$396,174
+67,121 vol
$5.90 each
625,310
Filed 2020-10-04 19:01
Tx date 2020-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$513,903
+86,321 vol
$5.95 each
558,189
Filed 2020-10-04 19:00
Tx date 2020-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$515,094
+86,321 vol
$5.97 each
471,868
Filed 2020-10-04 18:59
Tx date 2020-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$321,672
+53,621 vol
$6.00 each
385,547
Filed 2020-10-04 18:58
Tx date 2020-09-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$211,107
+35,221 vol
$5.99 each
331,926
Filed 2020-10-04 18:57
Tx date 2020-09-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$480,772
+80,221 vol
$5.99 each
296,705
Filed 2020-10-04 18:56
Tx date 2020-09-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$312,486
+52,121 vol
$6.00 each
216,484
Filed 2020-10-04 18:54
Tx date 2020-09-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$467,300
+77,921 vol
$6.00 each
164,363
Filed 2020-10-04 18:51
Tx date 2020-09-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$135,040
+22,521 vol
$6.00 each
86,442
Filed 2020-10-04 18:50
Tx date 2020-09-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$257,241
+42,900 vol
$6.00 each
63,921
Filed 2020-10-04 18:49
Tx date 2020-09-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$125,558
+21,021 vol
$5.97 each
21,021
Filed 2020-09-28 16:52
Tx date 2020-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,709
+1,442 vol
$6.04 each
113,287
Filed 2020-09-28 16:50
Tx date 2020-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,742
+1,613 vol
$6.04 each
45,079
Filed 2020-09-28 16:48
Tx date 2020-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,539
+1,745 vol
$6.04 each
486,436
Filed 2020-09-28 16:45
Tx date 2020-09-15
$GUD
Knight Therapeutics Inc.
Utchanah, Arvind
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,424
+567 vol
$6.04 each
6,382
Filed 2020-07-03 16:38
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
150,000
Filed 2020-07-03 16:23
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+84,288 vol
223,549
Filed 2020-07-03 16:22
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+84,288 vol
503,298
Filed 2020-07-03 16:18
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+135,556 vol
628,013
Filed 2020-07-03 16:16
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2020-07-03 16:15
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Murray, Janice Jean
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-03 16:14
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2020-07-03 16:13
Tx date 2020-06-25
$GUD
Knight Therapeutics Inc.
Sujoy, Nicolas
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-03 16:11
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
40,000
Filed 2020-07-03 16:09
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
140,000
Filed 2020-07-03 15:55
Tx date 2020-07-01
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+189,848 vol
2,393,270
Filed 2020-06-19 10:31
Tx date 2020-06-15
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,124
+300 vol
$7.08 each
5,815
Filed 2020-06-19 10:29
Tx date 2020-06-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,354
+1,180 vol
$7.08 each
43,466
Filed 2020-06-19 10:24
Tx date 2020-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,462
+1,054 vol
$7.08 each
111,845
Filed 2020-06-19 10:21
Tx date 2020-06-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,034
+1,276 vol
$7.08 each
484,691
Filed 2020-05-05 21:40
Tx date 2020-04-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-2,635,165 vol
0
Filed 2020-04-27 15:33
Tx date 2020-04-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$358,501
+50,089 vol
$7.16 each
2,635,165
Filed 2020-04-27 15:32
Tx date 2020-04-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$612,783
+88,853 vol
$6.90 each
2,585,076
Filed 2020-04-27 15:30
Tx date 2020-04-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$624,103
+88,853 vol
$7.02 each
2,496,223
Filed 2020-04-27 15:27
Tx date 2020-04-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$608,056
+88,853 vol
$6.84 each
2,407,370
Filed 2020-04-27 15:26
Tx date 2020-04-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,463,470
+1,806,300 vol
$6.90 each
2,318,517
Filed 2020-04-27 15:24
Tx date 2020-04-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$585,017
+88,853 vol
$6.58 each
512,217
Filed 2020-04-27 15:22
Tx date 2020-04-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$571,591
+88,853 vol
$6.43 each
423,364
Filed 2020-04-27 15:20
Tx date 2020-04-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$577,004
+88,852 vol
$6.49 each
334,511
Filed 2020-04-27 15:19
Tx date 2020-04-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$574,105
+88,853 vol
$6.46 each
245,659
Filed 2020-04-09 08:13
Tx date 2020-03-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-1,901,666 vol
156,806
Filed 2020-04-09 08:11
Tx date 2020-03-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$566,944
+88,853 vol
$6.38 each
2,058,472
Filed 2020-04-09 08:10
Tx date 2020-03-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$408,608
+67,953 vol
$6.01 each
1,969,619
Filed 2020-04-09 08:09
Tx date 2020-03-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$519,345
+88,853 vol
$5.84 each
1,901,666
Filed 2020-04-09 08:08
Tx date 2020-03-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$527,991
+88,853 vol
$5.94 each
1,812,813
Filed 2020-04-09 08:07
Tx date 2020-03-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$504,054
+88,853 vol
$5.67 each
1,723,960
Filed 2020-04-09 08:05
Tx date 2020-03-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$483,298
+88,853 vol
$5.44 each
1,635,107
Filed 2020-04-09 08:04
Tx date 2020-03-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$469,623
+88,853 vol
$5.29 each
1,546,254
Filed 2020-04-09 08:03
Tx date 2020-03-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$479,255
+88,853 vol
$5.39 each
1,457,401
Filed 2020-04-09 08:02
Tx date 2020-03-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$451,080
+88,853 vol
$5.08 each
1,368,548
Filed 2020-04-09 08:00
Tx date 2020-03-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$448,325
+88,853 vol
$5.05 each
1,279,695
Filed 2020-04-09 07:59
Tx date 2020-03-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$471,969
+88,853 vol
$5.31 each
1,190,842
Filed 2020-04-09 07:58
Tx date 2020-03-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$480,401
+88,853 vol
$5.41 each
1,101,989
Filed 2020-04-09 07:56
Tx date 2020-03-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$503,458
+88,853 vol
$5.67 each
1,013,136
Filed 2020-04-09 07:55
Tx date 2020-03-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$504,160
+88,853 vol
$5.67 each
924,283
Filed 2020-04-09 07:54
Tx date 2020-03-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$552,763
+88,853 vol
$6.22 each
835,430
Filed 2020-04-09 07:53
Tx date 2020-03-10
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$571,689
+88,853 vol
$6.43 each
746,577
Filed 2020-04-09 07:52
Tx date 2020-03-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$580,885
+88,853 vol
$6.54 each
657,724
Filed 2020-04-09 07:51
Tx date 2020-03-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$605,559
+88,853 vol
$6.82 each
568,871
Filed 2020-04-09 07:49
Tx date 2020-03-05
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$609,869
+88,853 vol
$6.86 each
480,018
Filed 2020-04-09 07:47
Tx date 2020-03-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$410,054
+59,953 vol
$6.84 each
391,165
Filed 2020-04-09 07:46
Tx date 2020-03-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$610,029
+88,853 vol
$6.87 each
331,212
Filed 2020-04-09 07:45
Tx date 2020-03-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$590,037
+88,853 vol
$6.64 each
242,359
Filed 2020-03-16 11:53
Tx date 2020-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,679
+1,437 vol
$6.04 each
110,791
Filed 2020-03-16 11:51
Tx date 2020-03-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,712
+1,608 vol
$6.04 each
42,286
Filed 2020-03-16 11:48
Tx date 2020-03-15
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,379
+394 vol
$6.04 each
5,515
Filed 2020-03-16 11:46
Tx date 2020-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,503
+1,739 vol
$6.04 each
483,415
Filed 2020-03-02 15:11
Tx date 2020-02-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-267,612 vol
153,506
Filed 2020-03-02 15:09
Tx date 2020-02-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$589,628
+88,853 vol
$6.64 each
421,118
Filed 2020-03-02 15:08
Tx date 2020-02-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$443,067
+64,653 vol
$6.85 each
332,265
Filed 2020-03-02 15:06
Tx date 2020-02-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$622,148
+88,853 vol
$7.00 each
267,612
Filed 2020-03-02 15:04
Tx date 2020-02-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$628,901
+88,853 vol
$7.08 each
178,759
Filed 2020-03-02 15:01
Tx date 2020-02-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$644,717
+88,853 vol
$7.26 each
89,906
Filed 2020-03-02 14:57
Tx date 2020-02-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,760
+1,053 vol
$7.37 each
1,053
Filed 2019-12-18 11:22
Tx date 2019-12-15
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,034
+267 vol
$7.62 each
5,121
Filed 2019-12-18 11:17
Tx date 2019-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,999
+1,181 vol
$7.62 each
481,676
Filed 2019-12-18 11:15
Tx date 2019-12-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,321
+1,092 vol
$7.62 each
40,678
Filed 2019-12-18 11:12
Tx date 2019-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,444
+977 vol
$7.62 each
109,354
Filed 2019-11-04 15:34
Tx date 2019-10-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-88,012 vol
0
Filed 2019-11-04 15:33
Tx date 2019-10-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$58,613
+7,953 vol
$7.37 each
88,012
Filed 2019-11-04 15:32
Tx date 2019-10-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$22,080
+3,000 vol
$7.36 each
80,059
Filed 2019-11-04 15:31
Tx date 2019-10-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$55,665
+7,553 vol
$7.37 each
77,059
Filed 2019-11-04 15:31
Tx date 2019-10-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,088
+4,900 vol
$7.37 each
69,506
Filed 2019-11-04 15:30
Tx date 2019-10-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$160,448
+21,800 vol
$7.36 each
64,606
Filed 2019-11-04 15:29
Tx date 2019-10-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$85,492
+11,600 vol
$7.37 each
42,806
Filed 2019-11-04 15:29
Tx date 2019-10-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$40,425
+5,500 vol
$7.35 each
31,206
Filed 2019-11-04 15:28
Tx date 2019-10-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,857
+253 vol
$7.34 each
25,706
Filed 2019-11-04 15:28
Tx date 2019-10-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$733.50
+100 vol
$7.33 each
25,453
Filed 2019-11-04 15:27
Tx date 2019-10-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,398
+600 vol
$7.33 each
25,353
Filed 2019-11-04 15:26
Tx date 2019-10-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,685
+500 vol
$7.37 each
24,753
Filed 2019-11-04 15:25
Tx date 2019-10-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,246
+4,653 vol
$7.36 each
24,253
Filed 2019-11-04 15:24
Tx date 2019-10-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,905
+2,300 vol
$7.35 each
19,600
Filed 2019-11-04 15:24
Tx date 2019-10-04
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$32,296
+4,400 vol
$7.34 each
17,300
Filed 2019-10-09 15:54
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$745.00
+100 vol
$7.45 each
260,406
Filed 2019-10-09 15:54
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$744.50
+100 vol
$7.45 each
260,306
Filed 2019-10-09 15:54
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,720
+500 vol
$7.44 each
260,206
Filed 2019-10-09 15:53
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,458
+600 vol
$7.43 each
259,706
Filed 2019-10-09 15:53
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,485
+200 vol
$7.42 each
259,106
Filed 2019-10-09 15:51
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$77,910
+10,500 vol
$7.42 each
258,906
Filed 2019-10-09 15:51
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,223
+300 vol
$7.41 each
248,406
Filed 2019-10-09 15:50
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,960
+400 vol
$7.40 each
248,106
Filed 2019-10-09 15:50
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,478
+200 vol
$7.39 each
247,706
Filed 2019-10-09 15:31
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$95,723
+12,900 vol
$7.42 each
Filed 2019-09-30 16:22
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$95,723
+12,900 vol
$7.42 each
Filed 2019-10-04 13:35
Tx date 2019-09-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-247,506 vol
12,900
Filed 2019-09-30 16:22
Tx date 2019-09-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$95,723
+12,900 vol
$7.42 each
260,406
Filed 2019-09-30 16:20
Tx date 2019-09-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,444
+1,400 vol
$7.46 each
247,506
Filed 2019-09-30 16:20
Tx date 2019-09-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$92,380
+12,400 vol
$7.45 each
246,106
Filed 2019-09-30 16:19
Tx date 2019-09-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$55,450
+7,453 vol
$7.44 each
233,706
Filed 2019-09-30 16:19
Tx date 2019-09-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$67,613
+9,100 vol
$7.43 each
226,253
Filed 2019-09-30 16:18
Tx date 2019-09-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,678
+900 vol
$7.42 each
217,153
Filed 2019-09-30 16:16
Tx date 2019-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,717
+2,235 vol
$7.48 each
216,253
Filed 2019-09-30 16:16
Tx date 2019-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,699
+1,700 vol
$7.47 each
214,018
Filed 2019-09-30 16:15
Tx date 2019-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$70,870
+9,500 vol
$7.46 each
212,318
Filed 2019-09-30 16:15
Tx date 2019-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,195
+1,100 vol
$7.45 each
202,818
Filed 2019-09-30 16:14
Tx date 2019-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,233
+300 vol
$7.45 each
201,718
Filed 2019-09-30 16:14
Tx date 2019-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,976
+400 vol
$7.44 each
201,418
Filed 2019-09-30 16:13
Tx date 2019-09-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$743.50
+100 vol
$7.43 each
201,018
Filed 2019-09-30 15:16
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,750
+1,700 vol
$7.50 each
200,918
Filed 2019-09-30 15:16
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$68,908
+9,200 vol
$7.49 each
199,218
Filed 2019-09-30 15:15
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,497
+200 vol
$7.49 each
190,018
Filed 2019-09-30 15:15
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$71,808
+9,600 vol
$7.48 each
189,818
Filed 2019-09-30 15:14
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,242
+300 vol
$7.47 each
180,218
Filed 2019-09-30 15:14
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$62,748
+8,400 vol
$7.47 each
179,918
Filed 2019-09-30 15:11
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$746.50
+100 vol
$7.46 each
171,518
Filed 2019-09-30 15:10
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$48,490
+6,500 vol
$7.46 each
171,418
Filed 2019-09-30 15:09
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$745.50
+100 vol
$7.46 each
164,918
Filed 2019-09-30 15:09
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$40,624
+5,453 vol
$7.45 each
164,818
Filed 2019-09-30 15:08
Tx date 2019-09-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,976
+400 vol
$7.44 each
159,365
Filed 2019-09-30 15:02
Tx date 2019-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,603
+4,900 vol
$7.47 each
158,965
Filed 2019-09-30 15:01
Tx date 2019-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$47,744
+6,400 vol
$7.46 each
154,065
Filed 2019-09-30 15:01
Tx date 2019-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$79,023
+10,600 vol
$7.46 each
147,665
Filed 2019-09-30 15:00
Tx date 2019-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$88,304
+11,853 vol
$7.45 each
137,065
Filed 2019-09-30 15:00
Tx date 2019-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$81,895
+11,000 vol
$7.45 each
125,212
Filed 2019-09-30 14:59
Tx date 2019-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,528
+3,700 vol
$7.44 each
114,212
Filed 2019-09-30 14:58
Tx date 2019-09-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,916
+1,200 vol
$7.43 each
110,512
Filed 2019-09-30 14:43
Tx date 2019-09-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,000
+800 vol
$7.50 each
109,312
Filed 2019-09-30 14:43
Tx date 2019-09-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,897
+1,853 vol
$7.50 each
108,512
Filed 2019-09-30 14:42
Tx date 2019-09-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$147,000
+19,600 vol
$7.50 each
106,659
Filed 2019-09-30 14:42
Tx date 2019-09-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$29,230
+3,900 vol
$7.50 each
87,059
Filed 2019-09-30 14:41
Tx date 2019-09-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,619
+2,753 vol
$7.49 each
83,159
Filed 2019-09-30 14:27
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$77,010
+10,200 vol
$7.55 each
80,406
Filed 2019-09-30 14:26
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$754.50
+100 vol
$7.54 each
70,206
Filed 2019-09-30 14:26
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$136,474
+18,100 vol
$7.54 each
70,106
Filed 2019-09-30 14:25
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,507
+200 vol
$7.54 each
52,006
Filed 2019-09-30 14:24
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$91,113
+12,100 vol
$7.53 each
51,806
Filed 2019-09-30 14:24
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,942
+2,253 vol
$7.52 each
39,706
Filed 2019-09-30 14:24
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$751.50
+100 vol
$7.51 each
37,453
Filed 2019-09-30 14:23
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,506
+600 vol
$7.51 each
37,353
Filed 2019-09-30 14:22
Tx date 2019-09-03
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,750
+500 vol
$7.50 each
36,753
Filed 2019-09-18 11:47
Tx date 2019-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,707
+1,251 vol
$7.76 each
39,586
Filed 2019-09-18 11:37
Tx date 2019-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,675
+1,118 vol
$7.76 each
108,377
Filed 2019-09-18 11:17
Tx date 2019-09-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,498
+322 vol
$7.76 each
45,714
Filed 2019-09-18 11:07
Tx date 2019-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,499
+1,353 vol
$7.76 each
480,495
Filed 2019-09-18 11:03
Tx date 2019-09-15
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,439
+701 vol
$7.76 each
4,854
Filed 2019-09-09 10:33
Tx date 2019-08-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-2,345,349 vol
36,253
Filed 2019-09-09 10:30
Tx date 2019-08-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$68,350
+9,053 vol
$7.55 each
2,381,602
Filed 2019-09-09 10:30
Tx date 2019-08-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$22,620
+3,000 vol
$7.54 each
2,372,549
Filed 2019-09-09 10:29
Tx date 2019-08-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$80,571
+10,700 vol
$7.53 each
2,369,549
Filed 2019-09-09 10:28
Tx date 2019-08-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$752.50
+100 vol
$7.53 each
2,358,849
Filed 2019-09-09 10:27
Tx date 2019-08-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,256
+300 vol
$7.52 each
2,358,749
Filed 2019-09-09 10:26
Tx date 2019-08-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$98,905
+13,100 vol
$7.55 each
2,358,449
Filed 2019-09-09 10:24
Tx date 2019-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,460
+1,253 vol
$7.55 each
2,345,349
Filed 2019-09-09 10:23
Tx date 2019-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,198
+4,400 vol
$7.54 each
2,344,096
Filed 2019-09-09 10:23
Tx date 2019-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,850
+2,500 vol
$7.54 each
2,339,696
Filed 2019-09-09 10:22
Tx date 2019-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,851
+2,900 vol
$7.54 each
2,337,196
Filed 2019-09-09 10:22
Tx date 2019-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,554
+1,800 vol
$7.53 each
2,334,296
Filed 2019-09-09 10:19
Tx date 2019-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$95,504
+12,700 vol
$7.52 each
2,332,496
Filed 2019-09-09 10:19
Tx date 2019-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$39,078
+5,200 vol
$7.51 each
2,319,796
Filed 2019-09-09 10:18
Tx date 2019-08-28
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,032
+3,200 vol
$7.51 each
2,314,596
Filed 2019-09-09 10:14
Tx date 2019-08-27
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,775
+500 vol
$7.55 each
2,311,396
Filed 2019-09-09 10:11
Tx date 2019-08-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,775
+500 vol
$7.55 each
Filed 2019-09-09 10:09
Tx date 2019-08-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,898
+4,100 vol
$7.78 each
2,310,896
Filed 2019-09-09 10:08
Tx date 2019-08-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,555
+200 vol
$7.78 each
2,306,796
Filed 2019-09-09 10:08
Tx date 2019-08-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$162,804
+20,953 vol
$7.77 each
2,306,596
Filed 2019-09-09 10:01
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$35,467
+4,553 vol
$7.79 each
2,285,643
Filed 2019-09-09 10:00
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,892
+500 vol
$7.79 each
2,281,090
Filed 2019-09-09 09:55
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$82,468
+10,600 vol
$7.78 each
2,280,590
Filed 2019-09-09 09:55
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$777.50
+100 vol
$7.78 each
2,269,990
Filed 2019-09-09 09:51
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$395,493
+50,900 vol
$7.77 each
2,269,890
Filed 2019-09-09 09:51
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,329
+300 vol
$7.76 each
2,218,990
Filed 2019-09-09 09:50
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$149,768
+19,300 vol
$7.76 each
2,218,690
Filed 2019-09-09 09:49
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,326
+300 vol
$7.75 each
2,199,390
Filed 2019-09-09 09:48
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,950
+1,800 vol
$7.75 each
2,199,090
Filed 2019-09-09 09:48
Tx date 2019-08-21
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,872
+500 vol
$7.75 each
2,197,290
Filed 2019-09-09 09:40
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,939
+4,100 vol
$7.79 each
2,196,790
Filed 2019-09-09 09:39
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,677
+1,500 vol
$7.79 each
2,192,690
Filed 2019-09-09 09:38
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$238,480
+30,653 vol
$7.78 each
2,191,190
Filed 2019-09-09 09:38
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,987
+4,500 vol
$7.78 each
2,160,537
Filed 2019-09-09 09:37
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,972
+3,600 vol
$7.77 each
2,156,037
Filed 2019-09-09 09:37
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$117,176
+15,100 vol
$7.76 each
2,152,437
Filed 2019-09-09 09:36
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$134,075
+17,300 vol
$7.75 each
2,137,337
Filed 2019-09-09 09:36
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,966
+900 vol
$7.74 each
2,120,037
Filed 2019-09-09 09:34
Tx date 2019-08-20
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,865
+500 vol
$7.73 each
2,119,137
Filed 2019-09-06 15:46
Tx date 2019-08-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,099,490
+1,303,160 vol
$7.75 each
2,118,637
Filed 2019-09-06 15:41
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$185,640
+23,800 vol
$7.80 each
815,477
Filed 2019-09-06 15:40
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$779.50
+100 vol
$7.79 each
791,677
Filed 2019-09-06 15:39
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,033
+2,700 vol
$7.79 each
791,577
Filed 2019-09-06 15:39
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$73,910
+9,500 vol
$7.78 each
788,877
Filed 2019-09-06 15:38
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,324
+1,200 vol
$7.77 each
779,377
Filed 2019-09-06 15:38
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,024
+4,900 vol
$7.76 each
778,177
Filed 2019-09-06 15:37
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$69,750
+9,000 vol
$7.75 each
773,277
Filed 2019-09-06 15:37
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$79,722
+10,300 vol
$7.74 each
764,277
Filed 2019-09-06 15:37
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$773.50
+100 vol
$7.74 each
753,977
Filed 2019-09-06 15:36
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$51,018
+6,600 vol
$7.73 each
753,877
Filed 2019-09-06 15:36
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$772.50
+100 vol
$7.72 each
747,277
Filed 2019-09-06 15:36
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,088
+400 vol
$7.72 each
747,177
Filed 2019-09-06 15:35
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,034
+653 vol
$7.71 each
746,777
Filed 2019-09-06 15:35
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,160
+800 vol
$7.70 each
746,124
Filed 2019-09-06 15:34
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,072
+400 vol
$7.68 each
745,324
Filed 2019-09-06 15:34
Tx date 2019-08-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,534
+200 vol
$7.67 each
744,924
Filed 2019-09-06 14:12
Tx date 2019-08-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,103,340
+142,000 vol
$7.77 each
744,724
Filed 2019-09-06 14:12
Tx date 2019-08-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,184
+153 vol
$7.74 each
602,724
Filed 2019-09-06 14:12
Tx date 2019-08-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,865
+500 vol
$7.73 each
602,571
Filed 2019-09-06 14:11
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,156
+400 vol
$7.89 each
602,071
Filed 2019-09-06 14:10
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,368
+3,600 vol
$7.88 each
601,671
Filed 2019-09-06 14:10
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,444
+1,200 vol
$7.87 each
598,071
Filed 2019-09-06 14:08
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,990
+1,400 vol
$7.85 each
596,871
Filed 2019-09-06 14:08
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$80,752
+10,300 vol
$7.84 each
595,471
Filed 2019-09-06 14:07
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,405
+3,500 vol
$7.83 each
585,171
Filed 2019-09-06 14:07
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$39,882
+5,100 vol
$7.82 each
581,671
Filed 2019-09-06 14:07
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$102,311
+13,100 vol
$7.81 each
576,571
Filed 2019-09-06 14:06
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,902
+500 vol
$7.80 each
563,471
Filed 2019-09-06 14:06
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$313,560
+40,200 vol
$7.80 each
562,971
Filed 2019-09-06 14:05
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,118
+400 vol
$7.79 each
522,771
Filed 2019-09-06 14:05
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$43,624
+5,600 vol
$7.79 each
522,371
Filed 2019-09-06 14:04
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,784
+2,800 vol
$7.78 each
516,771
Filed 2019-09-06 14:04
Tx date 2019-08-14
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,850
+753 vol
$7.77 each
513,971
Filed 2019-09-05 16:37
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$37,824
+4,800 vol
$7.88 each
513,218
Filed 2019-09-05 16:36
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,362
+300 vol
$7.88 each
508,418
Filed 2019-09-05 16:36
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$45,646
+5,800 vol
$7.87 each
508,118
Filed 2019-09-05 16:35
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$786.50
+100 vol
$7.87 each
502,318
Filed 2019-09-05 16:35
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$127,332
+16,200 vol
$7.86 each
502,218
Filed 2019-09-05 16:34
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$182,905
+23,300 vol
$7.85 each
486,018
Filed 2019-09-05 16:33
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,276
+800 vol
$7.84 each
462,718
Filed 2019-09-05 16:32
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$79,968
+10,200 vol
$7.84 each
461,918
Filed 2019-09-05 16:32
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,103
+1,800 vol
$7.83 each
451,718
Filed 2019-09-05 16:32
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,660
+2,000 vol
$7.83 each
449,918
Filed 2019-09-05 16:31
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,715
+1,500 vol
$7.81 each
447,918
Filed 2019-09-05 16:30
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$780.50
+100 vol
$7.80 each
446,418
Filed 2019-09-05 16:29
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$100,620
+12,900 vol
$7.80 each
446,318
Filed 2019-09-05 16:29
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$53,751
+6,900 vol
$7.79 each
433,418
Filed 2019-09-05 16:28
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,750
+2,153 vol
$7.78 each
426,518
Filed 2019-09-05 16:11
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,624
+1,600 vol
$7.89 each
424,365
Filed 2019-09-05 16:11
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,308
+800 vol
$7.88 each
422,765
Filed 2019-09-05 16:10
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$44,128
+5,600 vol
$7.88 each
421,965
Filed 2019-09-05 16:10
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,575
+200 vol
$7.88 each
416,365
Filed 2019-09-05 16:09
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,675
+2,500 vol
$7.87 each
416,165
Filed 2019-09-05 16:09
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,359
+300 vol
$7.87 each
413,665
Filed 2019-09-05 16:08
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,004
+1,400 vol
$7.86 each
413,365
Filed 2019-09-05 16:08
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,485
+2,100 vol
$7.85 each
411,965
Filed 2019-09-05 16:07
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,491
+700 vol
$7.84 each
409,865
Filed 2019-09-05 16:07
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$32,144
+4,100 vol
$7.84 each
409,165
Filed 2019-09-05 16:06
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,575
+2,500 vol
$7.83 each
405,065
Filed 2019-09-05 16:01
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,347
+300 vol
$7.83 each
402,565
Filed 2019-09-05 16:00
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,498
+3,900 vol
$7.82 each
402,265
Filed 2019-09-05 15:59
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$781.50
+100 vol
$7.82 each
398,365
Filed 2019-09-05 15:58
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,335
+3,500 vol
$7.81 each
398,265
Filed 2019-09-05 15:58
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,902
+500 vol
$7.80 each
394,765
Filed 2019-09-05 15:57
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$71,760
+9,200 vol
$7.80 each
394,265
Filed 2019-09-05 15:57
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,897
+500 vol
$7.79 each
385,065
Filed 2019-09-05 15:56
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$34,276
+4,400 vol
$7.79 each
384,565
Filed 2019-09-05 15:54
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,120
+1,300 vol
$7.79 each
380,165
Filed 2019-09-05 15:53
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,892
+1,400 vol
$7.78 each
378,865
Filed 2019-09-05 15:53
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,330
+1,200 vol
$7.78 each
377,465
Filed 2019-09-05 15:52
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,550
+200 vol
$7.75 each
376,265
Filed 2019-09-05 15:52
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$272,448
+35,200 vol
$7.74 each
376,065
Filed 2019-09-05 15:51
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,036
+1,300 vol
$7.72 each
340,865
Filed 2019-09-05 15:51
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$771.00
+100 vol
$7.71 each
339,565
Filed 2019-09-05 15:50
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,240
+1,200 vol
$7.70 each
339,465
Filed 2019-09-05 15:50
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,680
+1,000 vol
$7.68 each
338,265
Filed 2019-09-05 15:49
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,835
+500 vol
$7.67 each
337,265
Filed 2019-09-05 15:48
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,935
+253 vol
$7.65 each
336,765
Filed 2019-09-05 15:48
Tx date 2019-08-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,292
+300 vol
$7.64 each
336,512
Filed 2019-09-04 14:44
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,996
+4,100 vol
$7.56 each
336,212
Filed 2019-09-04 14:44
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$95,885
+12,700 vol
$7.55 each
332,112
Filed 2019-09-04 14:43
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,454
+5,100 vol
$7.54 each
319,412
Filed 2019-09-04 14:43
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,507
+200 vol
$7.54 each
314,312
Filed 2019-09-04 14:42
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,873
+4,100 vol
$7.53 each
314,112
Filed 2019-09-04 14:42
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$46,655
+6,200 vol
$7.53 each
310,012
Filed 2019-09-04 14:41
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$42,112
+5,600 vol
$7.52 each
303,812
Filed 2019-09-04 14:41
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,254
+300 vol
$7.51 each
298,212
Filed 2019-09-04 14:40
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,522
+2,200 vol
$7.51 each
297,912
Filed 2019-09-04 14:39
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$45,750
+6,100 vol
$7.50 each
295,712
Filed 2019-09-04 14:38
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,497
+600 vol
$7.50 each
289,612
Filed 2019-09-04 14:38
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,498
+200 vol
$7.49 each
289,012
Filed 2019-09-04 14:36
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,876
+1,053 vol
$7.48 each
288,812
Filed 2019-09-04 14:35
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,458
+1,400 vol
$7.47 each
287,759
Filed 2019-09-04 14:35
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,353
+4,200 vol
$7.46 each
286,359
Filed 2019-09-04 14:34
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$169,342
+22,700 vol
$7.46 each
282,159
Filed 2019-09-04 14:34
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,691
+1,300 vol
$7.46 each
259,459
Filed 2019-09-04 14:33
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$44,700
+6,000 vol
$7.45 each
258,159
Filed 2019-09-04 14:32
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,416
+1,400 vol
$7.44 each
252,159
Filed 2019-09-04 14:32
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,346
+2,200 vol
$7.43 each
250,759
Filed 2019-09-04 14:31
Tx date 2019-08-09
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,904
+1,200 vol
$7.42 each
248,559
Filed 2019-09-04 14:19
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-240,712 vol
247,359
Filed 2019-09-04 14:12
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,789
+1,300 vol
$7.53 each
488,071
Filed 2019-09-04 14:11
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,096
+4,800 vol
$7.52 each
486,771
Filed 2019-09-04 14:10
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,272
+1,500 vol
$7.51 each
481,971
Filed 2019-09-04 14:10
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,265
+1,500 vol
$7.51 each
480,471
Filed 2019-09-04 14:09
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,000
+1,200 vol
$7.50 each
478,971
Filed 2019-09-04 14:09
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$100,013
+13,353 vol
$7.49 each
477,771
Filed 2019-09-04 14:08
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$77,095
+10,300 vol
$7.49 each
464,418
Filed 2019-09-04 14:08
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$58,344
+7,800 vol
$7.48 each
454,118
Filed 2019-09-04 14:07
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$74,750
+10,000 vol
$7.47 each
446,318
Filed 2019-09-04 14:06
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,374
+4,200 vol
$7.47 each
436,318
Filed 2019-09-04 14:06
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,620
+3,700 vol
$7.46 each
432,118
Filed 2019-09-04 14:05
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$90,266
+12,100 vol
$7.46 each
428,418
Filed 2019-09-04 14:05
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$33,547
+4,500 vol
$7.46 each
416,318
Filed 2019-09-04 14:04
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$68,540
+9,200 vol
$7.45 each
411,818
Filed 2019-09-04 14:03
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,696
+900 vol
$7.44 each
402,618
Filed 2019-09-04 14:03
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,631
+1,700 vol
$7.43 each
401,718
Filed 2019-09-04 14:02
Tx date 2019-08-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,936
+800 vol
$7.42 each
400,018
Filed 2019-09-04 13:42
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,232
+300 vol
$7.44 each
399,218
Filed 2019-09-04 13:42
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,230
+300 vol
$7.43 each
398,918
Filed 2019-09-04 13:41
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,804
+2,800 vol
$7.43 each
398,618
Filed 2019-09-04 13:41
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$101,654
+13,700 vol
$7.42 each
395,818
Filed 2019-09-04 13:40
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,224
+300 vol
$7.42 each
382,118
Filed 2019-09-04 13:40
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$125,970
+17,000 vol
$7.41 each
381,818
Filed 2019-09-04 13:39
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,924
+800 vol
$7.41 each
364,818
Filed 2019-09-04 13:39
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$189,832
+25,653 vol
$7.40 each
364,018
Filed 2019-09-04 13:38
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,697
+500 vol
$7.39 each
338,365
Filed 2019-09-04 13:38
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$59,859
+8,100 vol
$7.39 each
337,865
Filed 2019-09-04 13:37
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,477
+200 vol
$7.38 each
329,765
Filed 2019-09-04 12:30
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$43,147
+5,753 vol
$7.50 each
329,565
Filed 2019-09-04 12:30
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$17,227
+2,300 vol
$7.49 each
323,812
Filed 2019-09-04 12:29
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$16,456
+2,200 vol
$7.48 each
321,512
Filed 2019-09-04 12:28
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,446
+1,800 vol
$7.47 each
319,312
Filed 2019-09-04 12:28
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$103,555
+13,900 vol
$7.45 each
317,512
Filed 2019-09-04 12:27
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$744.50
+100 vol
$7.45 each
303,612
Filed 2019-09-04 12:27
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$126,480
+17,000 vol
$7.44 each
303,512
Filed 2019-09-04 12:26
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,974
+400 vol
$7.43 each
286,512
Filed 2019-09-04 12:26
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$187,236
+25,200 vol
$7.43 each
286,112
Filed 2019-09-04 12:25
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,940
+800 vol
$7.42 each
260,912
Filed 2019-09-04 12:24
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$89,040
+12,000 vol
$7.42 each
260,112
Filed 2019-09-04 12:24
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,966
+400 vol
$7.42 each
248,112
Filed 2019-09-04 12:23
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$29,640
+4,000 vol
$7.41 each
247,712
Filed 2019-09-04 12:23
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$740.50
+100 vol
$7.41 each
243,712
Filed 2019-09-04 12:22
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,580
+1,700 vol
$7.40 each
243,612
Filed 2019-09-04 12:21
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$739.50
+100 vol
$7.39 each
241,912
Filed 2019-09-04 12:21
Tx date 2019-08-06
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,129
+1,100 vol
$7.39 each
241,812
Filed 2019-09-04 12:05
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,797
+500 vol
$7.59 each
240,712
Filed 2019-09-04 12:05
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$98,670
+13,000 vol
$7.59 each
240,212
Filed 2019-09-04 12:04
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$48,913
+6,453 vol
$7.58 each
227,212
Filed 2019-09-04 12:04
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,332
+1,100 vol
$7.58 each
220,759
Filed 2019-09-04 12:03
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$31,037
+4,100 vol
$7.57 each
219,659
Filed 2019-09-04 12:03
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,704
+3,400 vol
$7.56 each
215,559
Filed 2019-09-04 12:02
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$45,300
+6,000 vol
$7.55 each
212,159
Filed 2019-09-04 12:02
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,652
+3,800 vol
$7.54 each
206,159
Filed 2019-09-04 12:01
Tx date 2019-08-02
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,012
+400 vol
$7.53 each
202,359
Filed 2019-09-04 11:40
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$69,069
+9,100 vol
$7.59 each
201,959
Filed 2019-09-04 11:40
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$758.50
+100 vol
$7.58 each
192,859
Filed 2019-09-04 11:39
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$60,640
+8,000 vol
$7.58 each
192,759
Filed 2019-09-04 11:39
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,028
+400 vol
$7.57 each
184,759
Filed 2019-09-04 11:38
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,780
+500 vol
$7.56 each
184,359
Filed 2019-09-04 11:37
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,875
+2,500 vol
$7.55 each
183,859
Filed 2019-09-04 11:37
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,866
+2,900 vol
$7.54 each
181,359
Filed 2019-09-04 11:36
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,260
+300 vol
$7.54 each
178,459
Filed 2019-09-04 11:34
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,096
+3,200 vol
$7.53 each
178,159
Filed 2019-09-04 11:34
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,525
+1,000 vol
$7.53 each
174,959
Filed 2019-09-04 11:33
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$42,112
+5,600 vol
$7.52 each
173,959
Filed 2019-09-04 11:32
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,024
+1,600 vol
$7.51 each
168,359
Filed 2019-09-04 11:32
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$125,417
+16,700 vol
$7.51 each
166,759
Filed 2019-09-04 11:31
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$83,250
+11,100 vol
$7.50 each
150,059
Filed 2019-09-04 11:30
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$749.50
+100 vol
$7.50 each
138,959
Filed 2019-09-04 11:29
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$44,191
+5,900 vol
$7.49 each
138,859
Filed 2019-09-04 11:29
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$748.50
+100 vol
$7.49 each
132,959
Filed 2019-09-04 11:26
Tx date 2019-08-01
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,096
+2,553 vol
$7.48 each
132,859
Filed 2019-08-16 15:59
Tx date 2019-08-13
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$349,168
+45,054 vol
$7.75 each
139,261
Filed 2019-08-16 15:39
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
4,153
Filed 2019-08-12 16:06
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-13 15:57
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
94,207
Filed 2019-08-12 16:17
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-12 16:17
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
94,207
Filed 2019-08-12 16:06
Tx date 2019-08-07
$GUD
Knight Therapeutics Inc.
Arvind, Utchanah
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
3,430
Filed 2019-08-08 16:40
Tx date 2019-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase

-4,327,670 vol
130,306
Filed 2019-08-08 16:34
Tx date 2019-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,120
+2,400 vol
$7.55 each
4,457,976
Filed 2019-08-08 16:34
Tx date 2019-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$22,620
+3,000 vol
$7.54 each
4,455,576
Filed 2019-08-08 16:33
Tx date 2019-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$56,874
+7,553 vol
$7.53 each
4,452,576
Filed 2019-08-08 16:33
Tx date 2019-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$115,056
+15,300 vol
$7.52 each
4,445,023
Filed 2019-08-08 16:32
Tx date 2019-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$48,815
+6,500 vol
$7.51 each
4,429,723
Filed 2019-08-08 16:32
Tx date 2019-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$144,750
+19,300 vol
$7.50 each
4,423,223
Filed 2019-08-08 16:31
Tx date 2019-07-31
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$47,936
+6,400 vol
$7.49 each
4,403,923
Filed 2019-08-08 15:52
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,800
+500 vol
$7.60 each
4,397,523
Filed 2019-08-08 15:52
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,493
+2,700 vol
$7.59 each
4,397,023
Filed 2019-08-08 15:51
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,517
+200 vol
$7.58 each
4,394,323
Filed 2019-08-08 15:50
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,612
+1,400 vol
$7.58 each
4,394,123
Filed 2019-08-08 15:48
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,515
+200 vol
$7.58 each
4,392,723
Filed 2019-08-08 15:48
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,682
+2,600 vol
$7.57 each
4,392,523
Filed 2019-08-08 15:47
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$46,116
+6,100 vol
$7.56 each
4,389,923
Filed 2019-08-08 15:46
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,777
+500 vol
$7.55 each
4,383,823
Filed 2019-08-08 15:45
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$261,985
+34,700 vol
$7.55 each
4,383,323
Filed 2019-08-08 15:44
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,032
+800 vol
$7.54 each
4,348,623
Filed 2019-08-08 15:44
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,024
+800 vol
$7.53 each
4,347,823
Filed 2019-08-08 15:43
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$108,288
+14,400 vol
$7.52 each
4,347,023
Filed 2019-08-08 15:42
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,024
+2,400 vol
$7.51 each
4,332,623
Filed 2019-08-08 15:41
Tx date 2019-07-30
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$19,147
+2,553 vol
$7.50 each
4,330,223
Filed 2019-08-08 15:23
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,280
+1,500 vol
$7.52 each
4,327,670
Filed 2019-08-08 15:22
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$17,273
+2,300 vol
$7.51 each
4,326,170
Filed 2019-08-08 15:21
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$137,250
+18,300 vol
$7.50 each
4,323,870
Filed 2019-08-08 15:21
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,499
+200 vol
$7.50 each
4,305,570
Filed 2019-08-08 15:17
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$77,896
+10,400 vol
$7.49 each
4,305,370
Filed 2019-08-08 15:17
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,245
+300 vol
$7.49 each
4,294,970
Filed 2019-08-08 15:16
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,684
+3,300 vol
$7.48 each
4,294,670
Filed 2019-08-08 15:15
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$47,456
+6,353 vol
$7.47 each
4,291,370
Filed 2019-08-08 15:15
Tx date 2019-07-29
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,238
+300 vol
$7.46 each
4,285,017
Filed 2019-08-08 14:51
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$81,314
+10,900 vol
$7.46 each
4,284,717
Filed 2019-08-08 14:51
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,473
+600 vol
$7.46 each
4,273,817
Filed 2019-08-08 14:50
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$134,845
+18,100 vol
$7.45 each
4,273,217
Filed 2019-08-08 14:50
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,656
+1,700 vol
$7.45 each
4,255,117
Filed 2019-08-08 14:49
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$40,920
+5,500 vol
$7.44 each
4,253,417
Filed 2019-08-08 14:48
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$70,632
+9,500 vol
$7.43 each
4,247,917
Filed 2019-08-08 14:48
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$55,888
+7,522 vol
$7.43 each
4,238,417
Filed 2019-08-08 14:47
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,970
+400 vol
$7.42 each
4,230,895
Filed 2019-08-08 14:47
Tx date 2019-07-26
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$256,568
+34,578 vol
$7.42 each
4,230,495
Filed 2019-08-08 14:40
Tx date 2019-07-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$84,298
+11,300 vol
$7.46 each
4,195,917
Filed 2019-08-08 14:39
Tx date 2019-07-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$226,480
+30,400 vol
$7.45 each
4,184,617
Filed 2019-08-08 14:38
Tx date 2019-07-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,870
+2,000 vol
$7.43 each
4,154,217
Filed 2019-08-08 14:38
Tx date 2019-07-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,603
+2,100 vol
$7.43 each
4,152,217
Filed 2019-08-08 14:37
Tx date 2019-07-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$57,172
+7,700 vol
$7.42 each
4,150,117
Filed 2019-08-08 14:37
Tx date 2019-07-25
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,970
+3,500 vol
$7.42 each
4,142,417
Filed 2019-08-08 14:24
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,520
+1,000 vol
$7.52 each
4,138,917
Filed 2019-08-08 14:24
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,750
+900 vol
$7.50 each
4,137,917
Filed 2019-08-08 14:23
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,248
+300 vol
$7.50 each
4,137,017
Filed 2019-08-08 14:22
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$830,641
+110,900 vol
$7.49 each
4,136,717
Filed 2019-08-08 14:22
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,742
+500 vol
$7.49 each
4,025,817
Filed 2019-08-08 14:21
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$50,116
+6,700 vol
$7.48 each
4,025,317
Filed 2019-08-08 14:21
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$747.50
+100 vol
$7.47 each
4,018,617
Filed 2019-08-08 14:20
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,603
+4,900 vol
$7.47 each
4,018,517
Filed 2019-08-08 14:19
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,698
+1,300 vol
$7.46 each
4,013,617
Filed 2019-08-08 14:19
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$745.50
+100 vol
$7.46 each
4,012,317
Filed 2019-08-08 14:18
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,215
+700 vol
$7.45 each
4,012,217
Filed 2019-08-08 14:18
Tx date 2019-07-24
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,904
+1,600 vol
$7.44 each
4,011,517
Filed 2019-08-08 14:01
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,907
+253 vol
$7.54 each
4,009,917
Filed 2019-08-08 14:00
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$753.50
+100 vol
$7.54 each
4,009,664
Filed 2019-08-08 14:00
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,765
+500 vol
$7.53 each
4,009,564
Filed 2019-08-08 13:59
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,759
+900 vol
$7.51 each
4,009,064
Filed 2019-08-08 13:59
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,752
+500 vol
$7.50 each
4,008,164
Filed 2019-08-08 13:58
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$229,500
+30,600 vol
$7.50 each
4,007,664
Filed 2019-08-08 13:56
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$749.50
+100 vol
$7.50 each
3,977,064
Filed 2019-08-08 13:55
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$47,936
+6,400 vol
$7.49 each
3,976,964
Filed 2019-08-08 13:55
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$44,880
+6,000 vol
$7.48 each
3,970,564
Filed 2019-08-08 13:54
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$53,784
+7,200 vol
$7.47 each
3,964,564
Filed 2019-08-08 13:54
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$160,175
+21,500 vol
$7.45 each
3,957,364
Filed 2019-08-08 13:53
Tx date 2019-07-23
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,189
+1,100 vol
$7.45 each
3,935,864
Filed 2019-08-08 13:38
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$26,705
+3,500 vol
$7.63 each
3,934,764
Filed 2019-08-08 13:37
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$29,718
+3,900 vol
$7.62 each
3,931,264
Filed 2019-08-08 13:36
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$41,855
+5,500 vol
$7.61 each
3,927,364
Filed 2019-08-08 13:35
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,785
+5,100 vol
$7.61 each
3,921,864
Filed 2019-08-08 13:35
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$83,600
+11,000 vol
$7.60 each
3,916,764
Filed 2019-08-08 13:33
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$759.50
+100 vol
$7.59 each
3,905,764
Filed 2019-08-08 13:32
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$26,565
+3,500 vol
$7.59 each
3,905,664
Filed 2019-08-08 13:31
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$15,160
+2,000 vol
$7.58 each
3,902,164
Filed 2019-08-08 13:31
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,841
+1,300 vol
$7.57 each
3,900,164
Filed 2019-08-08 13:30
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,305
+1,100 vol
$7.55 each
3,898,864
Filed 2019-08-08 13:29
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,556
+1,400 vol
$7.54 each
3,897,764
Filed 2019-08-08 13:29
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$42,921
+5,700 vol
$7.53 each
3,896,364
Filed 2019-08-08 13:28
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$157,920
+21,000 vol
$7.52 each
3,890,664
Filed 2019-08-08 13:26
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,265
+1,500 vol
$7.51 each
3,869,664
Filed 2019-08-08 13:26
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$27,750
+3,700 vol
$7.50 each
3,868,164
Filed 2019-08-08 13:25
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$28,462
+3,800 vol
$7.49 each
3,864,464
Filed 2019-08-08 13:24
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$17,952
+2,400 vol
$7.48 each
3,860,664
Filed 2019-08-08 13:23
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,465
+1,400 vol
$7.47 each
3,858,264
Filed 2019-08-08 13:23
Tx date 2019-07-22
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,229
+700 vol
$7.47 each
3,856,864
Filed 2019-08-08 10:51
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$80,348
+10,600 vol
$7.58 each
3,856,164
Filed 2019-08-08 10:50
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$757.50
+100 vol
$7.58 each
3,845,564
Filed 2019-08-08 10:50
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$129,447
+17,100 vol
$7.57 each
3,845,464
Filed 2019-08-08 10:49
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,347
+1,500 vol
$7.57 each
3,828,364
Filed 2019-08-08 10:49
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$38,556
+5,100 vol
$7.56 each
3,826,864
Filed 2019-08-08 10:48
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$30,975
+4,100 vol
$7.55 each
3,821,764
Filed 2019-08-08 10:47
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$136,655
+18,100 vol
$7.55 each
3,817,664
Filed 2019-08-08 10:47
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$754.50
+100 vol
$7.54 each
3,799,564
Filed 2019-08-08 10:46
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,260
+300 vol
$7.54 each
3,799,464
Filed 2019-08-08 10:45
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$41,415
+5,500 vol
$7.53 each
3,799,164
Filed 2019-08-08 10:45
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$41,360
+5,500 vol
$7.52 each
3,793,664
Filed 2019-08-08 10:44
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$54,823
+7,300 vol
$7.51 each
3,788,164
Filed 2019-08-08 10:44
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$750.50
+100 vol
$7.50 each
3,780,864
Filed 2019-08-08 10:43
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,244
+300 vol
$7.48 each
3,780,764
Filed 2019-08-08 10:05
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,305
+1,100 vol
$7.55 each
3,780,464
Filed 2019-08-08 10:05
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,865
+3,300 vol
$7.54 each
3,779,364
Filed 2019-08-08 10:04
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,765
+500 vol
$7.53 each
3,776,064
Filed 2019-08-08 10:03
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$18,812
+2,500 vol
$7.53 each
3,775,564
Filed 2019-08-08 10:01
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$40,608
+5,400 vol
$7.52 each
3,773,064
Filed 2019-08-08 10:00
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,024
+1,600 vol
$7.51 each
3,767,664
Filed 2019-08-08 09:59
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,032
+3,200 vol
$7.51 each
3,766,064
Filed 2019-08-08 09:58
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$168,862
+22,500 vol
$7.50 each
3,762,864
Filed 2019-08-08 09:57
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$315,397
+42,053 vol
$7.50 each
3,740,364
Filed 2019-08-08 09:56
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,248
+300 vol
$7.50 each
3,698,311
Filed 2019-08-08 09:56
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$45,689
+6,100 vol
$7.49 each
3,698,011
Filed 2019-08-08 09:55
Tx date 2019-07-18
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,244
+300 vol
$7.48 each
3,691,911
Filed 2019-08-07 12:30
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$7,166
+953 vol
$7.52 each
3,691,611
Filed 2019-08-07 12:29
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,783
+3,300 vol
$7.51 each
3,690,658
Filed 2019-08-07 12:28
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$84,000
+11,200 vol
$7.50 each
3,687,358
Filed 2019-08-07 12:28
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$41,944
+5,600 vol
$7.49 each
3,676,158
Filed 2019-08-07 12:27
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,472
+1,400 vol
$7.48 each
3,670,558
Filed 2019-08-07 12:26
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$747.50
+100 vol
$7.47 each
3,669,158
Filed 2019-08-07 12:26
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$24,651
+3,300 vol
$7.47 each
3,669,058
Filed 2019-08-07 12:25
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$746.50
+100 vol
$7.46 each
3,665,758
Filed 2019-08-07 12:24
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,364
+3,400 vol
$7.46 each
3,665,658
Filed 2019-08-07 12:23
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,725
+500 vol
$7.45 each
3,662,258
Filed 2019-08-07 12:22
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,392
+1,800 vol
$7.44 each
3,661,758
Filed 2019-08-07 12:22
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$5,201
+700 vol
$7.43 each
3,659,958
Filed 2019-08-07 12:21
Tx date 2019-07-17
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,904
+1,200 vol
$7.42 each
3,659,258
Filed 2019-08-07 12:08
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$749,000
+100,000 vol
$7.49 each
3,658,058
Filed 2019-08-07 12:07
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$8,228
+1,100 vol
$7.48 each
3,558,058
Filed 2019-08-07 12:07
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,737
+500 vol
$7.47 each
3,556,958
Filed 2019-08-07 12:06
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$12,347
+1,653 vol
$7.47 each
3,556,458
Filed 2019-08-07 12:05
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$26,110
+3,500 vol
$7.46 each
3,554,805
Filed 2019-08-07 12:05
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$3,727
+500 vol
$7.46 each
3,551,305
Filed 2019-08-07 12:04
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$59,600
+8,000 vol
$7.45 each
3,550,805
Filed 2019-08-07 12:03
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$744.50
+100 vol
$7.45 each
3,542,805
Filed 2019-08-07 12:01
Tx date 2019-07-16
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$13,392
+1,800 vol
$7.44 each
3,542,705
Filed 2019-08-07 11:49
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,777
+900 vol
$7.53 each
3,540,905
Filed 2019-08-07 11:40
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$287,264
+38,200 vol
$7.52 each
3,540,005
Filed 2019-08-07 11:40
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$14,250
+1,900 vol
$7.50 each
3,501,805
Filed 2019-08-07 11:39
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$11,235
+1,500 vol
$7.49 each
3,499,905
Filed 2019-08-07 11:38
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,497
+200 vol
$7.49 each
3,498,405
Filed 2019-08-07 11:37
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$6,732
+900 vol
$7.48 each
3,498,205
Filed 2019-08-07 11:37
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,495
+200 vol
$7.47 each
3,497,305
Filed 2019-08-07 11:36
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,283
+2,853 vol
$7.46 each
3,497,105
Filed 2019-08-07 11:35
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,491
+200 vol
$7.46 each
3,494,252
Filed 2019-08-07 11:34
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,685
+1,300 vol
$7.45 each
3,494,052
Filed 2019-08-07 11:34
Tx date 2019-07-15
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,976
+400 vol
$7.44 each
3,492,752
Filed 2019-08-07 10:50
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,259
+300 vol
$7.53 each
3,492,352
Filed 2019-08-07 10:49
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,776
+1,300 vol
$7.52 each
3,492,052
Filed 2019-08-07 10:49
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$1,503
+200 vol
$7.51 each
3,490,752
Filed 2019-08-07 10:48
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$36,799
+4,900 vol
$7.51 each
3,490,552
Filed 2019-08-07 10:47
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$2,251
+300 vol
$7.50 each
3,485,652
Filed 2019-08-07 10:46
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$128,647
+17,153 vol
$7.50 each
3,485,352
Filed 2019-08-07 10:43
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$749.50
+100 vol
$7.50 each
3,468,199
Filed 2019-08-07 10:43
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$25,368,225
+3,386,946 vol
$7.49 each
3,468,099
Filed 2019-08-07 10:42
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,944
+2,800 vol
$7.48 each
81,153
Filed 2019-08-07 10:41
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$21,663
+2,900 vol
$7.47 each
78,353
Filed 2019-08-07 10:40
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$4,476
+600 vol
$7.46 each
75,453
Filed 2019-08-07 10:39
Tx date 2019-07-12
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$745.50
+100 vol
$7.46 each
74,853
Filed 2019-08-06 17:38
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$57,981
+7,700 vol
$7.53 each
74,753
Filed 2019-08-06 17:38
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$118,816
+15,800 vol
$7.52 each
67,053
Filed 2019-08-06 17:37
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$9,018
+1,200 vol
$7.51 each
51,253
Filed 2019-08-06 17:36
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$142,690
+19,000 vol
$7.51 each
50,053
Filed 2019-08-06 17:35
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$49,897
+6,653 vol
$7.50 each
31,053
Filed 2019-08-06 17:34
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$81,641
+10,900 vol
$7.49 each
24,400
Filed 2019-08-06 17:33
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$32,912
+4,400 vol
$7.48 each
13,500
Filed 2019-08-06 17:32
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$20,169
+2,700 vol
$7.47 each
9,100
Filed 2019-08-06 17:31
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$10,444
+1,400 vol
$7.46 each
6,400
Filed 2019-08-06 17:30
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
38 - Redemption, retraction, cancellation, repurchase
$37,250
+5,000 vol
$7.45 each
5,000
Filed 2019-07-26 12:02
Tx date 2019-07-08
$GUD
Knight Therapeutics Inc.
Knight Therapeutics Inc.
1 - Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-24 15:49
Tx date 2019-07-19
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,660
+1,008 vol
$7.60 each
107,259
Filed 2019-07-15 09:28
Tx date 2019-07-11
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$150,300
+20,000 vol
$7.51 each
45,392
Filed 2019-06-28 17:22
Tx date 2019-06-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,572
+1,128 vol
$7.60 each
38,335
Filed 2019-06-28 17:19
Tx date 2018-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,211
+872 vol
$8.27 each
22,327
Filed 2019-06-27 10:24
Tx date 2019-06-26
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$24,416
+3,200 vol
$7.63 each
479,142
Filed 2019-06-21 17:00
Tx date 2019-06-21
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$91,080
+12,000 vol
$7.59 each
21,633,433
Filed 2019-06-19 14:44
Tx date 2019-06-19
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,287
+1,222 vol
$7.60 each
475,942
Filed 2019-06-05 10:25
Tx date 2019-03-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+201 vol
22,388
Filed 2019-06-04 14:45
Tx date 2019-05-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+201 vol
Filed 2019-06-04 14:46
Tx date 2019-03-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,209
+960 vol
$7.51 each
23,147
Filed 2019-06-04 14:45
Tx date 2019-05-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+201 vol
36,335
Filed 2019-06-04 14:43
Tx date 2019-03-19
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$883,108
+115,138 vol
$7.67 each
492,457
Filed 2019-05-21 12:10
Tx date 2019-05-21
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$73,900
+10,000 vol
$7.39 each
21,621,433
Filed 2019-05-17 17:36
Tx date 2019-05-14
$GUD
Knight Therapeutics Inc.
Cameron, Kevin
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2019-05-17 17:33
Tx date 2019-05-07
$GUD
Knight Therapeutics Inc.
Cameron, Kevin
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-17 16:01
Tx date 2019-05-14
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2019-05-17 15:58
Tx date 2019-05-07
$GUD
Knight Therapeutics Inc.
Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-05-16 10:24
Tx date 2019-05-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$131,186
+17,800 vol
$7.37 each
474,720
Filed 2019-05-15 15:28
Tx date 2019-05-14
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
120,000
Filed 2019-05-15 15:26
Tx date 2019-05-14
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+25,000 vol
125,000
Filed 2019-05-15 15:24
Tx date 2019-05-14
$GUD
Knight Therapeutics Inc.
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
120,000
Filed 2019-05-15 15:22
Tx date 2019-05-14
$GUD
Knight Therapeutics Inc.
Harrison, Nancy Elizabeth
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
35,000
Filed 2019-04-24 16:28
Tx date 2019-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+173 vol
106,251
Filed 2019-04-24 16:27
Tx date 2019-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,300
+839 vol
$7.51 each
106,078
Filed 2019-04-11 10:09
Tx date 2019-04-10
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$66,780
+9,000 vol
$7.42 each
456,920
Filed 2019-04-08 15:26
Tx date 2019-04-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$26,460
+3,600 vol
$7.35 each
447,920
Filed 2019-04-08 15:24
Tx date 2019-04-04
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$26,568
+3,600 vol
$7.38 each
444,320
Filed 2019-03-28
Tx date 2019-03-25
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$38,220
+5,200 vol
$7.35 each
440,720
Filed 2019-03-28
Tx date 2019-03-26
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$36,650
+5,000 vol
$7.33 each
21,611,433
Filed 2019-03-28
Tx date 2019-03-25
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$96,888
+13,200 vol
$7.34 each
21,606,433
Filed 2019-03-26
Tx date 2019-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$136,800
+18,000 vol
$7.60 each
354,520
Filed 2019-03-26
Tx date 2019-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$134,820
+18,000 vol
$7.49 each
399,520
Filed 2019-03-26
Tx date 2019-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$135,360
+18,000 vol
$7.52 each
435,520
Filed 2019-03-26
Tx date 2019-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$135,720
+18,000 vol
$7.54 each
381,520
Filed 2019-03-26
Tx date 2019-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$134,100
+18,000 vol
$7.45 each
417,520
Filed 2019-03-26
Tx date 2019-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$68,220
+9,000 vol
$7.58 each
363,520
Filed 2019-03-22
Tx date 2019-03-19
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+161,252 vol
2,203,422
Filed 2019-03-20
Tx date 2019-03-19
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$99,999
+12,987 vol
$7.70 each
35,174
Filed 2019-03-20
Tx date 2019-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,965
+1,327 vol
$7.51 each
336,520
Filed 2019-01-25
Tx date 2018-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,401
+640 vol
$8.44 each
105,086
Filed 2019-01-25
Tx date 2019-01-03
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+153 vol
Filed 2019-01-25
Tx date 2019-01-03
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,401
+640 vol
$8.44 each
Filed 2019-01-25
Tx date 2018-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+153 vol
105,239
Filed 2019-01-17
Tx date 2018-12-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,178
+732 vol
$8.44 each
22,187
Filed 2018-12-19
Tx date 2018-12-17
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,794
+1,042 vol
$8.44 each
335,193
Filed 2018-10-18
Tx date 2018-09-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+110 vol
104,446
Filed 2018-10-18
Tx date 2018-09-25
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,301
+762 vol
$8.27 each
104,336
Filed 2018-09-19
Tx date 2018-09-14
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,452
+1,143 vol
$8.27 each
Filed 2018-09-19
Tx date 2018-09-17
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,452
+1,143 vol
$8.27 each
334,151
Filed 2018-09-19
Tx date 2018-09-14
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,023
+1,143 vol
$5.27 each
Filed 2018-09-19
Tx date 2018-09-17
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,998
+1,209 vol
$8.27 each
25,392
Filed 2018-09-19
Tx date 2018-09-14
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,998
+1,209 vol
$8.27 each
Filed 2018-09-17
Tx date 2018-09-14
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,998
+1,209 vol
$8.27 each
25,392
Filed 2018-09-17
Tx date 2018-09-14
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,023
+1,143 vol
$5.27 each
Filed 2018-09-17
Tx date 2018-09-14
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,452
+1,143 vol
$8.27 each
334,151
Filed 2018-08-30
Tx date 2018-08-14
$GUD
Knight Therapeutics Inc.
Harrison, Nancy Elizabeth
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+15,000 vol
15,000
Filed 2018-08-30
Tx date 2018-08-08
$GUD
Knight Therapeutics Inc.
Harrison, Nancy Elizabeth
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-14
Tx date 2018-06-26
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,405
+674 vol
$8.02 each
103,460
Filed 2018-08-14
Tx date 2018-06-26
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+114 vol
103,574
Filed 2018-07-18
Tx date 2018-06-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,175
+770 vol
$8.02 each
21,455
Filed 2018-06-19
Tx date 2018-06-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,286
+1,032 vol
$8.03 each
333,008
Filed 2018-06-05
Tx date 2018-06-04
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-48,120
-6,000 vol
$8.02 each
3,065,697
Filed 2018-06-05
Tx date 2018-06-04
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,200
-5,000 vol
$8.04 each
2,361,557
Filed 2018-06-05
Tx date 2018-06-04
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,000
-5,000 vol
$8.00 each
2,356,557
Filed 2018-06-05
Tx date 2018-06-04
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-93,264
-11,600 vol
$8.04 each
3,054,097
Filed 2018-06-04
Tx date 2018-05-31
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-40,200
-5,000 vol
$8.04 each
3,080,097
Filed 2018-06-04
Tx date 2018-05-31
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-30,818
-3,800 vol
$8.11 each
3,076,297
Filed 2018-06-04
Tx date 2018-06-01
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-36,984
-4,600 vol
$8.04 each
3,071,697
Filed 2018-06-01
Tx date 2018-05-30
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-40,600
-5,000 vol
$8.12 each
3,094,097
Filed 2018-06-01
Tx date 2018-05-31
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-4,020
-500 vol
$8.04 each
2,366,557
Filed 2018-06-01
Tx date 2018-05-31
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-36,135
-4,500 vol
$8.03 each
2,367,057
Filed 2018-06-01
Tx date 2018-05-30
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$-72,180
-9,000 vol
$8.02 each
3,085,097
Filed 2018-05-31
Tx date 2018-05-28
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-1,628
-200 vol
$8.14 each
2,392,557
Filed 2018-05-31
Tx date 2018-05-28
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-30,970
-3,800 vol
$8.15 each
2,392,757
Filed 2018-05-31
Tx date 2018-05-28
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-60,347
-7,400 vol
$8.15 each
Filed 2018-05-31
Tx date 2018-05-25
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-21,086
-2,600 vol
$8.11 each
2,396,557
Filed 2018-05-31
Tx date 2018-05-25
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,180
-1,500 vol
$8.12 each
2,399,157
Filed 2018-05-31
Tx date 2018-05-25
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-7,317
-900 vol
$8.13 each
2,400,657
Filed 2018-05-31
Tx date 2018-05-25
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,850
-5,000 vol
$8.17 each
2,401,557
Filed 2018-05-31
Tx date 2018-05-25
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-81,430
-10,000 vol
$8.14 each
Filed 2018-05-31
Tx date 2018-05-24
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,650
-5,000 vol
$8.13 each
2,406,557
Filed 2018-05-31
Tx date 2018-05-24
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-81,550
-10,000 vol
$8.15 each
Filed 2018-05-31
Tx date 2018-05-24
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,900
-5,000 vol
$8.18 each
2,411,557
Filed 2018-05-31
Tx date 2018-05-30
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-101,430
-12,600 vol
$8.05 each
2,371,557
Filed 2018-05-31
Tx date 2018-05-28
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-19,632
-2,400 vol
$8.18 each
2,389,157
Filed 2018-05-31
Tx date 2018-05-28
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-8,120
-1,000 vol
$8.12 each
2,391,557
Filed 2018-05-30
Tx date 2018-05-29
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,500
-5,000 vol
$8.10 each
2,384,157
Filed 2018-05-29
Tx date 2018-05-28
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-60,347
-7,400 vol
$8.15 each
2,389,157
Filed 2018-05-28
Tx date 2018-05-25
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-81,430
-10,000 vol
$8.14 each
2,396,557
Filed 2018-05-28
Tx date 2018-03-20
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$908,259
+117,498 vol
$7.73 each
377,319
Filed 2018-05-28
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,070
+886 vol
$7.98 each
20,685
Filed 2018-05-28
Tx date 2018-05-24
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-81,550
-10,000 vol
$8.15 each
2,406,557
Filed 2018-05-24
Tx date 2018-05-23
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-63,911
-7,900 vol
$8.09 each
2,416,557
Filed 2018-05-24
Tx date 2018-05-23
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,550
-5,000 vol
$8.11 each
2,424,457
Filed 2018-05-23
Tx date 2018-05-22
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-17,094
-2,100 vol
$8.14 each
2,429,457
Filed 2018-05-23
Tx date 2018-05-22
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-40,250
-5,000 vol
$8.05 each
2,431,557
Filed 2018-05-22
Tx date 2018-05-17
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,628
-700 vol
$8.04 each
2,439,357
Filed 2018-05-22
Tx date 2018-05-17
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,928
-1,600 vol
$8.08 each
2,436,557
Filed 2018-05-22
Tx date 2018-05-17
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-807.00
-100 vol
$8.07 each
2,438,157
Filed 2018-05-22
Tx date 2018-05-17
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-3,224
-400 vol
$8.06 each
2,438,257
Filed 2018-05-22
Tx date 2018-05-17
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,635
-700 vol
$8.05 each
2,438,657
Filed 2018-05-22
Tx date 2018-05-17
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-12,045
-1,500 vol
$8.03 each
2,440,057
Filed 2018-05-17
Tx date 2018-05-16
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-80,000
-10,000 vol
$8.00 each
2,441,557
Filed 2018-05-16
Tx date 2018-05-15
$GUD
Knight Therapeutics Inc.
Assouline, Sarit
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
40,000
Filed 2018-05-16
Tx date 2018-05-15
$GUD
Knight Therapeutics Inc.
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
100,000
Filed 2018-05-16
Tx date 2018-05-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
100,000
Filed 2018-05-16
Tx date 2018-05-15
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-62,634
-7,800 vol
$8.03 each
2,451,557
Filed 2018-05-16
Tx date 2018-05-15
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
100,000
Filed 2018-05-01
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+103 vol
102,786
Filed 2018-05-01
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,176
+774 vol
$7.98 each
102,683
Filed 2018-03-30
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,165
+1,150 vol
$7.97 each
331,976
Filed 2018-03-30
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$2,654
+333 vol
$7.97 each
24,183
Filed 2018-03-30
Tx date 2018-03-20
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+182,482 vol
2,042,170
Filed 2018-03-30
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,177
+1,150 vol
$7.98 each
Filed 2018-03-23
Tx date 2018-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Lilah Rose Goodman (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$777.00
+100 vol
$7.77 each
100
Filed 2018-03-23
Tx date 2018-03-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Orly Anne Goodman (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$777.00
+100 vol
$7.77 each
100
Filed 2018-03-23
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Orly Anne Goodman (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-23
Tx date 2014-02-28
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Lilah Rose Goodman (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-19
Tx date 2017-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,106
+1,068 vol
$7.59 each
330,826
Filed 2018-03-19
Tx date 2018-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,177
+1,150 vol
$7.98 each
331,976
Filed 2018-03-19
Tx date 2017-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,876
+906 vol
$7.59 each
Filed 2018-02-14
Tx date 2017-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,294
+693 vol
$7.64 each
101,787
Filed 2018-02-14
Tx date 2017-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+122 vol
101,909
Filed 2018-01-15
Tx date 2017-12-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,058
+793 vol
$7.64 each
19,799
Filed 2017-12-18
Tx date 2017-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,876
+906 vol
$7.59 each
330,664
Filed 2017-10-06
Tx date 2017-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+110 vol
100,282
Filed 2017-10-06
Tx date 2017-09-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,063
+810 vol
$8.72 each
19,006
Filed 2017-10-06
Tx date 2017-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+103 vol
101,094
Filed 2017-10-06
Tx date 2017-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,182
+709 vol
$8.72 each
100,991
Filed 2017-10-06
Tx date 2017-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,163
+627 vol
$9.83 each
100,172
Filed 2017-09-19
Tx date 2017-09-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,089
+813 vol
$8.72 each
168,717
Filed 2017-09-19
Tx date 2017-09-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,001
+1,147 vol
$8.72 each
23,850
Filed 2017-09-19
Tx date 2017-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,074
+926 vol
$8.72 each
329,758
Filed 2017-07-03
Tx date 2017-06-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,067
+719 vol
$9.83 each
18,196
Filed 2017-06-20
Tx date 2017-06-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$7,244
+737 vol
$9.83 each
167,904
Filed 2017-06-19
Tx date 2017-06-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,489
+355 vol
$9.83 each
22,703
Filed 2017-06-19
Tx date 2017-06-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$8,080
+822 vol
$9.83 each
328,832
Filed 2017-05-19
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership

-25,000 vol
21,523,233
Filed 2017-05-19
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
90 - Change in the nature of ownership

-45,000 vol
21,523,233
Filed 2017-05-19
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

+25,000 vol
327,342
Filed 2017-05-19
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership

+45,000 vol
300,175
Filed 2017-05-17
Tx date 2017-02-21
$GUD
Knight Therapeutics Inc.
Assouline, Sarit
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-05-17
Tx date 2017-05-16
$GUD
Knight Therapeutics Inc.
Assouline, Sarit
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
20,000
Filed 2017-05-17
Tx date 2017-05-16
$GUD
Knight Therapeutics Inc.
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
80,000
Filed 2017-05-17
Tx date 2017-05-16
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
80,000
Filed 2017-05-17
Tx date 2017-05-16
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
80,000
Filed 2017-04-12
Tx date 2017-02-27
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Options
52 - Expiration of options

-278,000 vol
0
Filed 2017-04-12
Tx date 2017-02-27
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options

-222,000 vol
0
Filed 2017-04-06
Tx date 2017-04-03
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-52,050
-5,000 vol
$10.41 each
2,459,357
Filed 2017-04-06
Tx date 2017-04-03
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-33,440
-3,200 vol
$10.45 each
2,464,357
Filed 2017-03-31
Tx date 2017-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,185
+500 vol
$10.37 each
99,457
Filed 2017-03-31
Tx date 2017-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan

+88 vol
99,545
Filed 2017-03-28
Tx date 2017-03-21
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+133,218 vol
1,859,688
Filed 2017-03-28
Tx date 2017-03-15
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,056
+584 vol
$10.37 each
17,477
Filed 2017-03-28
Tx date 2017-03-21
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+74,010 vol
419,010
Filed 2017-03-28
Tx date 2017-03-21
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+74,010 vol
419,010
Filed 2017-03-28
Tx date 2017-03-21
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$351,692
+34,821 vol
$10.10 each
259,821
Filed 2017-03-17
Tx date 2017-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,927
+668 vol
$10.37 each
258,010
Filed 2017-03-17
Tx date 2017-03-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,107
+589 vol
$10.37 each
167,167
Filed 2017-03-16
Tx date 2017-02-21
$GUD
Knight Therapeutics Inc.
Assouline, Sarit
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
1,100
Filed 2016-12-23
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
15 - Acquisition or disposition under a prospectus
$250,000
+25,000 vol
$10.00 each
21,593,233
Filed 2016-12-23
Tx date 2016-12-15
$GUD
Knight Therapeutics Inc.
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,668
+368 vol
$9.97 each
1,842
Filed 2016-12-23
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$250,000
+25,000 vol
$10.00 each
21,593,233
Filed 2016-12-23
Tx date 2016-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$5,194
+521 vol
$9.97 each
93,957
Filed 2016-12-23
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$100,000
+10,000 vol
$10.00 each
166,578
Filed 2016-12-23
Tx date 2016-12-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$6,420
+644 vol
$9.97 each
156,578
Filed 2016-12-23
Tx date 2016-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$10,588
+1,062 vol
$9.97 each
257,342
Filed 2016-12-22
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$100,000
+10,000 vol
$10.00 each
16,893
Filed 2016-12-22
Tx date 2016-12-22
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$50,000
+5,000 vol
$10.00 each
98,436
Filed 2016-09-26
Tx date 2016-09-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,842
+538 vol
$9.00 each
256,280
Filed 2016-09-26
Tx date 2016-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,636
+404 vol
$9.00 each
93,436
Filed 2016-09-26
Tx date 2016-09-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,636
+404 vol
$9.00 each
155,934
Filed 2016-09-23
Tx date 2016-08-31
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-09-23
Tx date 2016-09-21
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$2,160,000
+225,000 vol
$9.60 each
225,000
Filed 2016-08-31
Tx date 2016-08-31
$GUD
Knight Therapeutics Inc.
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
6,893
Filed 2016-06-20
Tx date 2016-06-16
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$1,152,309
+139,000 vol
$8.29 each
3,099,097
Filed 2016-06-20
Tx date 2016-06-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,853
+567 vol
$8.56 each
255,742
Filed 2016-06-20
Tx date 2016-06-16
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption
$920,189
+111,000 vol
$8.29 each
2,467,557
Filed 2016-06-20
Tx date 2016-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,638
+425 vol
$8.56 each
93,032
Filed 2016-06-20
Tx date 2016-06-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,638
+425 vol
$8.56 each
155,530
Filed 2016-06-03
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Long Zone Holdings Inc. (Indirect Ownership)
Common Shares
15 - Acquisition or disposition under a prospectus
$360,000
+45,000 vol
$8.00 each
21,568,233
Filed 2016-06-03
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Long Zone Holdings Inc.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$360,000
+45,000 vol
$8.00 each
21,568,233
Filed 2016-06-03
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$100,000
+12,500 vol
$8.00 each
92,607
Filed 2016-06-03
Tx date 2016-06-02
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$100,000
+12,500 vol
$8.00 each
155,105
Filed 2016-04-04
Tx date 2016-03-30
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,999
+1,328 vol
$7.53 each
22,348
Filed 2016-03-25
Tx date 2016-03-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,116
+415 vol
$7.51 each
142,605
Filed 2016-03-25
Tx date 2016-03-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,109
+414 vol
$7.51 each
80,107
Filed 2016-03-25
Tx date 2016-03-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,153
+553 vol
$7.51 each
255,175
Filed 2015-12-18
Tx date 2015-12-15
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$4,847
+648 vol
$7.48 each
254,622
Filed 2015-12-18
Tx date 2015-12-16
$GUD
Knight Therapeutics Inc.
Tendler, Sylvie
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
60,000
Filed 2015-12-18
Tx date 2015-12-16
$GUD
Knight Therapeutics Inc.
Schutter, Edward James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
40,000
Filed 2015-12-18
Tx date 2015-12-16
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
60,000
Filed 2015-12-18
Tx date 2015-12-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,635
+486 vol
$7.48 each
79,693
Filed 2015-12-18
Tx date 2015-12-16
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+125,000 vol
345,000
Filed 2015-12-18
Tx date 2015-12-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,635
+486 vol
$7.48 each
142,190
Filed 2015-12-18
Tx date 2015-12-16
$GUD
Knight Therapeutics Inc.
Goodman, Jonathan Ross
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+250,000 vol
1,726,470
Filed 2015-12-18
Tx date 2015-12-16
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+125,000 vol
345,000
Filed 2015-12-18
Tx date 2015-12-16
$GUD
Knight Therapeutics Inc.
Gale, James
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+20,000 vol
60,000
Filed 2015-09-23
Tx date 2015-09-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,118
+413 vol
$7.55 each
79,207
Filed 2015-09-23
Tx date 2015-09-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,110
+412 vol
$7.55 each
141,704
Filed 2015-09-11
Tx date 2015-09-09
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,356,557
Filed 2015-09-11
Tx date 2015-09-09
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
500,000
Filed 2015-09-11
Tx date 2015-09-09
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Tzalir Holdings Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
2,960,097
Filed 2015-09-11
Tx date 2015-09-09
$GUD
Knight Therapeutics Inc.
Jakobsohn, Meir
4 - Director of Issuer
Holder: Medison Biotech (1995) Ltd. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
5,014,230
Filed 2015-06-18
Tx date 2015-06-15
$GUD
Knight Therapeutics Inc.
Kadanoff, Jeffrey Lorne
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,118
+443 vol
$7.04 each
141,292
Filed 2015-06-18
Tx date 2015-06-15
$GUD
Knight Therapeutics Inc.
Khouri, Amal
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$3,111
+442 vol
$7.04 each
78,794
Filed 2015-06-18
Tx date 2015-06-15
$GUD
Knight Therapeutics Inc.
Lande, Robert Nathaniel
4 - Director of Issuer
Direct Ownership
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
$9,996
+1,420 vol
$7.04 each
21,020